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Abstract 
From genome sequencing and analyses, Streptomyces bacteria are predicted to 
produce hundreds of bioactive metabolite compounds; however, the products of 
some of these cryptic biosynthetic gene clusters are most often silent or produced 
in very small quantities in laboratory conditions. The AHFCA-dependent signalling 
system is an example of a regulatory systems that tightly control expression of 
cryptic biosynthetic gene clusters in Streptomyces bacteria. Bioinformatic analyses, 
using MEME and FIMO, were able to successfully reveal TetR repressor binding sites 
to gain insights into complex regulatory networks. 
 
The S. avermitilis cryptic biosynthetic gene cluster, which is proposed to be under 
the control of an AHFCA-dependent signalling system, has not been investigated 
before and genome mining predictions suggest the biosynthetic gene cluster could 
be involved in the biosynthesis of novel azoxy compounds. The 50 kb predicted 
azoxy biosynthetic gene cluster was captured using pESAC13A PAC technologies 
and introduced into S. coelicolor M1152 and S. lividans TK24 heterologous hosts. 
Comparative metabolic profiling successfully identified the predicted azoxy 
compounds in S. coelicolor M1152 by LC-MS and identification of the azoxy 
compounds were supported by UHPLC-ESI-TOF-MS analysis and incorporation of 
isotope-labelled L-serine.  
 
Consistent with the model of transcriptional regulation, exploitation of the 
S. avermitilis AHFCA-dependent signalling system through the inactivation of 
sav_2268 transcriptional repressor in S. lividans TK24 heterologous hosts unlocked 
the production of azoxy compounds and AHFCA signalling molecules. 
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1. Introduction 
1.1. The need for novel and effective antibiotics 
 Since the discovery of penicillin in 1929, a multitude of novel antibiotics have 
been discovered to combat pathogenic infections; however, despite the success 
story of penicillin and the discovery of many antibiotics during 1945-65 (Figure 
1-1), many pathogenic microorganisms have now developed resistance to these 
antibiotics. 1,2,3 Bacterial infections still remain as the second leading cause of death 
with approximately 17 million mortalities annually. 4 Over the past few decades, 
antibiotics resistance has been perpetuated by the rapid overuse and misuse of 
antimicrobial agents, and has led to the increase in multi-drug resistance organisms, 
such as methicillin and vancomycin-resistant Staphylococcus aureus. 5 
Due to the high cost, relatively poor return in investment and difficulty in finding 
novel and effective compounds, large pharmaceutical companies were losing 
interest in antimicrobial drug research. 1,6 With the rise and emergence of 
multidrug-resistant pathogens and long absence in antibiotic research from large 
pharmaceutical companies, the urgent need for new and novel antibiotics is ever 
increasing and some of the best sources of antimicrobial agents originate from soil 
bacterial microorganisms, such as Streptomyces bacteria (Figure 1-1). 7,8 
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Figure 1-1 – Many key antibiotics discovered originated from Streptomyces 
bacteria (highlighted in bold). Image adapted from reference 4. 
 
1.2. Streptomyces, a prolific source of specialised metabolites 
Streptomyces are Gram-positive filamentous bacteria, belonging to the 
Actinobacteria class, and have been extensively studied for their unique sporulating 
life cycle, complex transcriptional regulation, primary and secondary metabolism, 
and as a host for protein purification (Figure 1-2). 9,10,11 As soil-dwelling bacteria, 
Streptomyces live in an incredibly diverse microbial community, and are 
continuously competing and co-existing with other microorganisms to thrive in 
Platensimycin 2006 S. platensis
Daptomycin 2003 S. roseosporus
Linezolid 2000 Synthetic
Mupirocin 1985 Pseudomonas fluorescens
Ribostamycin 1970 S. ribosidificus
Fosfomycin 1969 S. fradiae
Tetrimethoprim 1968 Synthetic
Gentamicin 1963 Micromonospora purpurea
Fusidic acid 1963 Fusidium coccineum
Nalidixic acid 1962 Synthetic
Tinidazole 1959 Synthetic
Kanamycin 1957 S. kanamyceticus
Rifamycin 1957 Amycolatopsis mediterranei
Noviobiocin 1956 S. niveus
Vancomycin 1956 S. orientalis
Cycloserine 1955 S. garyphalus
Lincomycin 1952 S. lincolnensis
Erythromycin 1952 Saccharopolyspora erythraea
Virginiamycin 1952 S. virginiae
Isoniazid 1951 Synthetic
Viomycin 1951 S. vinaceus
Nystatin 1950 S. noursei
Tetracycline 1950 S. aureofaciens
Neomycin 1949 S. fradiae
Chloramphenicol 1949 S. venezuelae
Polymyxin 1947 Bacillus polymyxa
Nitrofurantoin 1947 Synthetic
Cephalosporins 1945 S. clavuligerus
Streptomycin 1944 S. griseus
Penicillin 1941 Penicillium chrysogenum1940
1950
1960
1970
2000
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their natural habitat. In response to specific nutrient conditions or presence of other 
invading microorganisms, Streptomyces are able secrete biologically active 
specialised metabolites and induce morphological differentiation (Figure 1-2). 12  
 
 
Figure 1-2 – The life cycle of Streptomyces bacteria begins with the germination of 
a free spore. Hyphae protudes from the bacteria, and grows across and into the 
substrate media. Under poor environmental conditions, hyphae expand into the air 
and differentiate into spore chains. Image adapted from reference 13. 
 
The first antibiotic compound ever isolated from a Streptomyces bacterium was 
streptothricin from S. lavendulae in 1942. Streptothricin exhibited antimicrobial 
activity against both Gram-positive and Gram-negative bacteria; however, it was too 
toxic to be used in humans. 14,15,16 Two years later in 1944, the first antibiotic 
discovered for human medicine was the bactericidal aminoglycoside streptomycin 
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from S. griseus, and was used to treat the disease, tuberculosis, by specifically 
targeting and inhibiting protein synthesis in Mycobacterium tuberculosis. 17,18,19,20 
After the discovery of streptothricin and streptomycin, a number of important 
antibiotics were discovered and developed during the golden age of antibiotics 
between the 1940s and 1960s (Figure 1-1); two-thirds of antibiotics approved for 
clinic originate from the Streptomyces genus of bacteria (Figure 1-1). 21 The plethora 
of specialised metabolites assembled by Streptomyces bacteria are of 
pharmaceutical and medicinal interest as they carry a range of unique biological 
activity, such as anticancer, anti-inflammatory, antimicrobial, antifungal and 
immunosuppressive properties. 22 There are currently over 600 Streptomyces 
strains described so far and from bioinformatic analyses, each Streptomyces bacteria 
is predicted to produce dozens of biologically active specialised metabolites. 23,24  
 
The Streptomyces genus of bacteria is one of the most highly sequenced and as of 
May 2014, there were 19 finished genomic sequences (Table 1-1) and 125 draft 
assemblies in the Genbank database. 25 The first Streptomyces bacteria to have its 
genome sequence sequenced was S. coelicolor A3(2) in 2002 and the linear 
chromosome of S. coelicolor contained 8.7 Mb with 7,825 predicted open reading 
frames (ORF); the largest number of ORFs reported in a single bacterium at the time 
of sequencing. 26 Before the genome sequencing of S. coelicolor A3(2), five 
compounds had already been discovered; grey spore pigment, actinorhodin (Act), 
prodiginines (Red), calcium-dependent antibiotic (CDA), and methylenomycin 
(Mm) compounds (Figure 1-3). The analyses of S. coelicolor genome sequence 
revealed an additional 18 cryptic biosynthetic gene clusters and bioinformatic 
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analyses has greatly assisted the identification of these specific cryptic 
compounds.26 
 
Table 1-1 – Genome information of Streptomyces bacteria. 
Name 
Size 
(Mbp) 
GC % ORF 
# of predicted natural product 
biosynthetic clusters 
Ref. 
Streptomyces coelicolor A3(2) 
Linear chromosome 8.67 72 7,825 23 26 
Linear SCP1plasmid 0.37 69 355 2 26 
Circular SCP2 plasmid 0.03 72 34 0 26 
Streptomyces griseus IFO 13350 
Linear chromosome 8.55 72 7,138 34 27 
Streptomyces venezuelae ATCC 10712 
Linear chromosome 8.23 72 7,536 31 28 
Circular pSVH1 plasmid 0.01 71 11 0 28 
Streptomyces avermitilis MA-4680 
Linear chromosome 9.03 71 7,574 38 29 
Linear SAP1 plasmid 0.09 69 96 0 29 
Streptomyces hygroscopicus subsp. Jinggangensis 5008 
Linear chromosome 10.15 72 8,849 29 30 
Linear pSHJG1 plasmid 0.16 69 183 0 30 
Circular pSHJG2 plasmid 0.07 71 75 0 30 
 
Shortly after the genome sequencing of S. coelicolor, S. avermitilis MA-4680, which 
is responsible for the production of the anthelmintic avermectin compounds, had its 
genome completely sequenced in 2003 (Table 1-1). 29,31 The discovery of 
avermectins proved to be significant in the treatment of various parasitic diseases; 
its semi-synthetic derivative ivermectin is currently used in human and veterinary 
medicine to treat diseases, such as onchocerciasis and lymphatic filariasis (Figure 
1-4). 32 In fact, the 2015 Nobel Prize in Physiology or Medicine was awarded to 
William Campbell and Satoshi Omura for the discovery and development of 
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avermectin compounds. 33 Genome analysis of S. avermitilis revealed a total of 38 
predicted specialised metabolite gene clusters and as of 2014, the products of 16 
biosynthetic gene clusters in S. avermitilis have been detected (bold lines in Table 
1-2); an untapped source of specialised metabolites are waiting to be discovered.29  
 
 
Figure 1-3 – Specialised metabolites discovered in S. coelicolor A3(2). 
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Figure 1-4 – Structure of avermectin B1a compound discovered in S. avermitilis 
MA-4680. Its semi-synthetic derivative ivermectin contains a single reduced bond. 
 
Table 1-2 – Specialised metabolites predicted/ detected in S. avermitilis. 
# Predicted/ observed compound Genes 
Approx. 
size (kb) 
Ref. 
1 Avermitilol, avermitlone sav_76 (ams) 1.1 34 
2 PK sav_100-101 5.2  
3 Microcin sav_257-sav_259 3.2  
4 Filipin sav_407-419 (pte) 81.6 35 
5 NRP sav_603-609 9.0  
6 NRP sav_838-869 50.8  
7 Avermectin sav_935-953 (ave) 80.9 31 
8 Isorenieratene sav_1019-1025 (crt) 8.7 35 
9 Melanin sav_1136-1137 (melC) 1.2 35 
10 PK-NRP sav_1249-1251 4.8  
11 PK sav_1550-1552 19.0  
12 Squalene sav_1650-1654 (hop) 6.7 36 
13 Geosmin, germacradienol sav_2163-2165 (geo) 4.4 37 
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14 AHFCA? sav_2266-2269 3.7  
15 PK sav_2276-2282 11.0  
16 PK sav_2367-2369 15.7  
17 Aromatic PK sav_2372-2388 17.7  
18 Siderophore sav_2465-2467 4.9  
19 Spore pigment sav_2835-2842 (spp) 7.3 35 
20 Oligomycin sav_2890-2903 (olm) 100.1 35 
21 Pentalenolactone sav_2989-sav_3002 (ptl) 14.1 38 
22 Albaflavenol, albaflavenone sav_3031-3032 (ezs) 2.5 39 
23 NRP sav_3155-3164 120.0  
24 NRP sav_3192-3203 21.4  
25 NRP sav_3636-3651 32.7  
26 Aromatic PK sav_3653-3666 12.6  
27 Avenolide sav_3704, sav_3706 3.4 40 
28 Ochronotic pigment sav_5149 (hpd) 1.1 41 
29 Nocardamine, desferrioxamine B sav_5269-5274 (sid) 7.2 42 
30 Melanin sav_5361-5362 1.2  
31 Microcin sav_5686-5689 4.3  
32 Ectoine, 5-hydroxyectoine sav_6395-6398 (ect) 3.2 35 
33 NRP sav_6631-6633 5.8  
34 Tetrahydroxynaphthalene sav_7130-7131 (rpp) 2.3 35 
35 NRP sav_7161-7165 7.9  
36 PK sav_7184-7186 8.0  
37 Siderophore sav_7320-7323 6.1  
38 PK sav_7360-7362 12.0  
Terpenes, polyketides, peptides and other compounds are highlighted in pale 
green, purple, blue and red respectively. Bold text indicate compounds that have 
been detected. Adapted from reference 35 and 
http://avermitilis.ls.kitasato-u.ac.jp/. 
 
1.3. Genome mining methodologies for the identification of novel 
specialised metabolites 
Methodologies and computational tools, such as the widely used Antibiotics & 
Secondary Metabolite Analysis SHell (antiSMASH), have been developed over the 
past years to aid in the annotation of genomes and predictions of novel 
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metabolites.  43 Recent developments of next-generation sequencing technologies 
and analytical chemistry instruments have resparked interests in antibiotic 
discovery. The identification and isolation of products from cryptic biosynthetic 
gene clusters (Figure 1-5) have been facilitated by highly sensitive analytical 
chemistry techniques, such as liquid chromatography - mass spectrometry 
(LC-MS).  44,45  
 
Figure 1-5 – Natural products isolated from cryptic biosynthetic gene clusters. 
 
Compounds of interest are normally detected by high performance liquid 
chromatography (HPLC) and can be further identified by ultraviolet (UV) 
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absorption. Most often the HPLC system is connected to a mass spectrometry and 
the sample can be directly injected into the mass spectrometry to obtain the 
mass/charge value (m/z) of all the compounds. Molecular formulae for the 
compounds of interest can be generated from the molecular ion m/z given by high 
resolution MS analysis and compared with similar compounds on the database, such 
as Reaxys. 46 Novel compounds of interest can be further isolated and purified using 
semi-preparative HPLC, and analysed by nuclear magnetic resonance (NMR) 
spectroscopy for structure determination. 47 
1.3.1. Prediction of substrate specificity from bioinformatic analysis  
Proposed biological functions of biosynthetic genes can provide considerable 
insights into structure of compounds of interest, as well as its physiochemical 
properties. Examples of two major classes of specialised metabolites are the 
polyketides (PK) and non-ribosomal peptides (NRP), which are assembled by large 
modular biosynthetic machinery enzymes called polyketide synthases (PKS) and 
non-ribosomal peptide synthetases (NRPS) respectively. 48 Substrate specificities of 
adenylation and acyltransferase domains, in NRPS and PKS respectively, have been 
modelled from X-ray crystal structures and the building blocks can be accurately 
predicted from sequence analysis alone. 49,50,51 Furthermore, sequence analysis can 
also predict the stereochemistry of ketoreductase tailoring reactions in PK 
biosynthesis. 52,53 Substrate predictions of NRPS or PKS can be exploited to aid in the 
identification of products assembled by cryptic biosynthetic gene clusters (Figure 
1-6). 44,45 
 
Chapter 1: Introduction 
11 
 
 
Figure 1-6 – Prediction of physicochemical properties and genomisotopic 
approach to identify products of cryptic biosynthetic gene clusters. 
 
The identification of coelichelin (Figure 1-5), from S. coelicolor, was greatly assisted 
by substrate predictions of the tri-modular CchH (SCO0492) NRPS enzyme. From 
the predicted structure, coelichelin was proposed to function as a siderophore and 
implied the predicted siderophore biosynthetic gene cluster would be expressed in 
an iron-deficient medium. Armed with this information, Lautru and co-workers 
were able to detect coelichelin in iron-deficient medium and consistent with their 
hypothesis, the production of coelichelin was decreased when ferric iron was added 
to the culture media. The proposed complex between ferric iron and coelichelin was 
detectable under UV-vis spectroscopy (Figure 1-6), and helped guide the 
purification of the ferri-coelichelin complex from S. coelicolor supernatant by HPLC 
and lead to structure determination by NMR spectroscopy. 54 
 
In another example, a genomisotopic approach was used to discover orfamide 
(Figure 1-5), a macrocyclic lipopeptide, from Pseudomonas fluorescens Pf-5 (Figure 
1-6). Leucine amino acids were predicted as substrates for OfaA (PFL2145), OfaB 
(PFL2146) and OfaC (PFL2147) NRPS. Isotope-labelled L-leucine-15N were fed to 
Substrates predictions
from sequence analysis
Physicochemical 
properties
Feeding labelled 
substrate
hν
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the bacteria and the expected incorporation of isotope precursor was detectable by 
NMR spectroscopy; this helped guide fractionation purification and structure 
elucidation of orfamide A. 55 
1.3.2. Heterologous expression/ comparative metabolic profiling approach 
to identify products of cryptic biosynthetic gene clusters 
Structure predictions in some complicated biosynthetic systems can be particularly 
challenging and sequence based approach would be unsuitable for identification of 
these complex metabolites. 44,45 
 
Putative biosynthetic genes or entire gene cluster can be introduced into 
heterologous hosts and comparative metabolic profiling approach by LC-MS 
analysis can detect the production of new compounds (Figure 1-7). Compounds that 
are only detected in heterologous hosts containing the genes are likely products of 
the biosynthetic genes, and can be further isolated and characterised. To further 
confirm the putative activity of biosynthetic genes, deletion of biosynthetic genes is 
expected to abolish the production of specific natural compounds (Figure 1-7). 44,45  
 
Heterologous expression approach was demonstrated in the discovery of 2-alkyl-4-
hydroxymethylfuran-3-carboxylic acids (AHFCA) (Figure 1-5), which are a novel 
class of small diffusible signalling molecules that induce the production of 
specialised metabolites in Streptomyces bacteria. 56  
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Figure 1-7 – Heterologous expression/comparative metabolic profiling approach 
to identify products of cryptic biosynthetic gene cluster. 
 
ScbA (SCO6266) in S. coelicolor and AfsA in S. griseus are the key biosynthetic 
enzymes for the assembly of γ-butyrolactones (GBL) signalling molecules (SCBs and 
A-factor respectively). Bioinformatic analyses identified an analogous protein in 
S. coelicolor called MmfL (SCP1.243) and the three gene operon mmfL, mmfH 
(scp1.244) and mmfP (scp1.245) were proposed to be responsible for the 
biosynthesis of signalling molecules. Comparative metabolic profiling of 
heterologous hosts with and without the mmfLHP operon successfully revealed five 
compounds named the methylenomycin furans (MMF), which belong to the AHFCA 
class of signalling molecules. Through a heterologous expression approach, a novel 
class of signalling molecules was discovered and they were shown to induce the 
production of methylenomycin antibiotics in S. coelicolor. 56 To further confirm the 
role of mmfLHP in the assembly of MMF signalling molecules, deletion of specific 
genes within the mmfLHP operon were shown to abolish the production of MMF and 
methylenomycins. 57 
Host + genes
Host - genes
host
host
Wild type
Mutant
Inactivation of biosynthetic gene
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1.3.3. Genetic modification to unlock and overproduce products of cryptic 
biosynthetic gene clusters 
Identification of products from cryptic biosynthetic gene clusters in heterologous 
hosts can be challenging if biosynthetic gene clusters are poorly or not expressed in 
laboratory conditions. Most often, these cryptic biosynthetic gene clusters are 
tightly regulated at the transcriptional level and are under the control of 
DNA-binding transcriptional factors. 44,45,58,59 Transcription factors can either 
activate or repress expression of cryptic biosynthetic gene clusters and genetic 
manipulation of these specific transcriptional regulators are often necessary to 
derepress expression and overproduce the compounds of interest. 60 
 
The awakening of silent and cryptic biosynthetic gene cluster was successfully 
demonstrated in S. ambofaciens ATCC23877 through the overexpression of a 
cluster-situated, pathway-specific transcriptional activator (Figure 1-8), which led 
to the discovery of four antitumour macrolide compounds named the stambomycins 
(Figure 1-5). Stambomycins are biosynthesised by a silent PKS gene cluster, 
spanning almost 150 kb and containing 25 genes; under laboratory growth 
conditions, the stambomycin biosynthetic genes were not or very poorly expressed. 
Within the stambomycin gene cluster, the samR0484 gene product encodes for a 
putative large ATP binding of LuxR (LAL) transcriptional activator and the 
overexpression of samR0484 was shown to activate the expression of the PKS genes 
and unlocked the production of the stambomycins (Figure 1-8). 61  
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Figure 1-8 – Inactivation or overexpression of transcriptional regulators/ 
comparative metabolic profiling approach to unlock and overproduce products of 
cryptic biosynthetic gene clusters. 
 
In some cryptic biosynthetic gene clusters, pathway-specific transcriptional 
activators may not be clearly identifiable or are absent. Transcriptional repressors, 
such as the TetR family of repressors, are essential in the regulation of cryptic 
biosynthetic gene clusters in response to endogenous or exogenous signals and thus, 
specific inactivation of transcriptional repressors can sometimes awaken silent 
biosynthetic gene clusters. 60 The gaburedin biosynthetic gene cluster in 
S. venezuelae does not have any transcriptional activators and is tightly regulated by 
two cluster-situated TetR repressors. Specific inactivation of gbnR repressor 
(sven_4187) in S. venezuelae and comparative metabolic profiling led to the 
discovery of gaburedins (Figure 1-5), a novel family of γ-aminobutyrate-derived 
Mutant
Wild type
Wild type + Activator
Wild type
Inactivation of 
repressor gene
Over-expression of 
activator gene
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urea compounds (Figure 1-9). Biosynthetic enzyme involved in gaburedin 
biosynthesis was further confirmed through the inactivation of gbnB gene, which 
encodes for a urea synthetase, and abolished the production of gaburedins (Figure 
1-7). 62 
 
 
Figure 1-9 – Inactivation of gbnR repressor led to the discovery of gaburedin 
compounds in S. venezuelae. Biosynthetic, repressor and signalling molecule genes 
are highlighted in grey, blue and red respectively. Image adapted from 
reference 62. 
 
Continuous and rapid advancement of technologies and methods have accelerated 
the discoveries of novel specialised metabolite; for instance, the recently developed 
isolation chip (iChip) has been used to culture the “unculturable” bacteria and has 
led to the discovery of teixobactin, a new class of antibiotics with undetectable 
resistance, from Eleftheria terrae. 63 In addition, other genetic approaches have been 
applied to activate silent or cryptic biosynthetic gene clusters, such as the 
refactoring of biosynthetic genes and genetic modification of pleiotropic 
transcriptional regulators. 64,65 
1.4. The TetR family of transcriptional repressors 
TetR repressors are widely distributed in bacterial organisms and most bacterial 
genomes contain at least one gene encoding for a putative TetR repressor. 66 The 
1kb
ATACCTTCGTGAAGGTTT ATACATTCTCGAAGGTAT ATACCTTCCAGACCGAAT
gbnA gbnB gbnC sgnR sgnL sgnP sgnHgbnR
GbnR
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TetR family of transcriptional repressors are primarily involved in regulating vital 
biological processes, such as antibiotic resistance and production (Table 1-3). 66,67,68  
 
Table 1-3 – TetR repressors co-crystallised with cognate ligand or DNA operator. 
TetR 
name  
Function 
Crystallised 
with ligand? 
Co-crystallised with DNA operator? Ref. 
TetR  Resistance Tetracycline TCTATCATTGATAGG 
69,
70 
QacR  Resistance Diamidine CTTATAGACCGATCGATCGGTCTATAAG 
71,
72 
CgmR  Resistance Methylene blue CGTAACTGTACCGACCGGTCGGTACAGTTACG 73 
DesT 
Lipid 
synthesis 
Acyl-CoA AGTGAACGCTTGTTGACT 74 
SimR  Resistance Simocyclinone TTCGTACGGCGTACGAA 
75,
76 
HrtR  
Heme 
homeostasis 
Heme ATGACACAGTGTCAT 77 
MS6564  Pleiotropic No TCATAAACGAGACGGTACGTCTCGTCTTGTG 78 
SlmA  Cell division No TTACGTGAGTACTCACGTAA 79 
CprB  Pleiotropic No ATACGGGACGCCCCGTTTAT 80 
ActR Resistance Actinorhodin No 81 
EthR  Antibiotic 
Hexadecyl 
octanoate 
No 82 
MphR  Resistance Erythromycin No 83 
Palindromic sequences are highlighted in red. 
 
To date, the National Center for Biotechnology Information (NCBI) public protein 
databases contains over 200,000 TetR repressor sequences and over 200 TetR 
crystal structures. 66,67 The structure of the TetR repressor from Escherichia coli, 
which regulates the resistance mechanism against tetracycline antibiotic, was the 
first to be elucidated in 1994 by X-ray crystallography. The TetR repressor protein 
functions as a homodimer and each identical monomer contains 10 α-helices (Figure 
1-10). Co-crystallisation studies of the TetR repressor with its cognate ligand and 
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DNA operator revealed -helix 1 – 4 at the N-terminus forms the DNA-binding 
domain and -helix 4 – 7 are involved in binding to the specific cognate ligand. 69  
 
 
 
Figure 1-10 – Structure of TetR repressor (PDB: 2TRT) from E. coli. 
 
The TetR family of transcriptional repressors contain a highly conserved 
helix-turn-helix (HTH) DNA-binding domain, which is primarily composed of 
-helix 2 and 3 (Figure 1-10). 70 The HTH DNA-binding domain is one of the most 
frequently observed DNA-binding domains in prokaryotic transcription factors; in 
fact, almost 95% of transcriptional factors utilise the HTH DNA-binding domain. 67 
Since the TetR repressors are homodimeric, TetR repressors often interact with 
semi-palindromic or dyad sequences (palindromic sequences are highlighted in red 
in Figure 1-9 and Table 1-3) and the HTH DNA-binding domain binds to major 
grooves of DNA. Co-crystallisation and mutational studies have revealed critical 
amino acid residues required for DNA binding and are mostly located on α-helix 
2 and 3 (Figure 1-11). 70 To date, predicting TetR repressor binding sites are still 
α1
α2
α3
α4
α7
α6
α5
α9
α8
α10
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extremely challenging and modelling of DNA binding sequence from primary amino 
acid sequences have been attempted. 84 
 
 
Figure 1-11 – Clustal Omega alignment of TetR repressor HTH DNA-binding 
domain. Amino acid residues that interact with DNA bases, phosphate backbone or 
both are highlighted in red, green and purple respectively. Adapted from 
reference 79. 
 
 
The tetracycline/TetR system regulates the resistance mechanism against 
tetracycline antibiotic in E. coli. Tetracycline is a broad spectrum polyketide 
antibiotic (Figure 1-12) that specifically inhibits protein translation and prevents 
the binding of aminoacyl-tRNA to the 30S ribosomal subunit. Various resistance 
mechanisms against tetracycline have evolved and developed in bacteria including 
ribosome protection and enzymatic inactivation of tetracycline; the most 
extensively studied resistance mechanism is the tetracycline/TetR efflux  
system.85,86 
 
1 2 3
HTH
DNA-binding domain
10          20  30   40       50      60    70        
| | | | | | |
SimR WMHPEPAGRRSARSHRTLSRDQIVRAAVKVADT-EGVEAASMRRVAAELGAGTMSLYYYVPTKEDLV
DesT -------MASPRAEQKQQTRHALMSAARHLMESGRGFGSLSLREVTRAAGIVPAGFYRHFSDMDQLG
TetR --------------MARLNRESVIDAALELLNE-TGIDGLTTRKLAQKLGIEQPTLYWHVKNKRALL
CgmR --------------MRTSKKEMILRTAIDYIGE-YSLETLSYDSLAEATGLSKSGLIYHFPSRHALL
QacR ----------------MNLKDKILGVAKELFIK-NGYNATTTGEIVKLSESSKGNLYYHFKTKENLF
HrtR ------MPKSTYFSLSDEKRNRVYDACLNEFQT-HSFHEAKIMHIVKALDIPRGSFYQYFEDLKDAY
MS6564 ----MTGGQQMGRRRSEKSRVAIVEATRALLLE-RGFDGLSIEAVAAKAGVGKQTIYRWWPSRHALV
SlmA --------MAEKQTAKRNRREEILQSLALMLESSDGSQRITTAKLAASVGVSEAALYRHFPSKTRMF
CprB ---------MARQLRAEQTRATIIGAAADLFDR-RGYESTTLSEIVAHAGVTKGALYFHFAAKEDLA
4
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Figure 1-12 – Structure of tetracycline aromatic polyketide antibiotic. 
 
The tetA gene product encodes for a tetracycline efflux pump and is responsible for 
exporting toxic tetracycline antibiotic out of E. coli (Figure 1-13). 87 The tetR 
repressor gene is located divergently adjacent to the tetA gene and the TetR 
repressor tightly regulates expression of tetA by binding specifically to the 15 bp tet 
operator (tetO) located within the tetR - tetA intergenic region (Figure 1-13).70,88,89  
 
In the presence of tetracycline, this molecule binds to the ligand-binding domain of 
the TetR repressor, which induces a cascade of conformational changes, and 
prevents the TetR repressor from binding to the tetO sequence (Figure 1-12).70,90,91 
Release of the TetR repressor from the tetO sequence allows transcription of tetA. 
The TetA efflux pump transports the toxic tetracycline molecules out of the E. coli 
bacteria (Figure 1-13). 89 
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Figure 1-13 – TetR repressor binds to the promoter of tetA and tightly regulates 
expression of tetA. Each identical monomer binds to semi-palindromic sequence 
(palindromic sequences are highlighted in red - monomer binding is highlighted 
with blue or red lines). The binding of tetracycline antibiotic (orange circle) to the 
TetR repressor derepresses the system. The TetA efflux pump exports the 
tetracycline antibiotic out of E. coli.  
 
1.5. The ArpA class of transcriptional repressors  
The ArpA class of the TetR family is an example of transcriptional repressors 
involved in regulation of specialised metabolites biosynthesis and are widespread 
in Streptomyces bacteria (Figure 1-14). Similar to the tetracycline/TetR system, 
presence of specific cognate signalling molecule abolishes the binding of ArpA to 
DNA operator sequence. However, ArpA repressors are most often involved in 
complex regulatory networks and controls, not only the expression of biosynthetic 
genes, but also the expression of itself and genes involved in the assembly of cognate 
signalling molecules. The exploitation of ArpA-like regulatory systems have led to 
the discoveries of novel metabolites (Figure 1-14). 92 
tetR tetA
Tetracycline
TetR
TCTATCATTGATAGG
AGATAGTAACTATCC
TetA
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Figure 1-14 – Specialised metabolites that are regulated by ArpA-like repressors. 
 
The cognate signalling molecules that bind to ArpA-like repressors in Streptomyces 
bacteria, such as the -butyrolactones, are derived from intermediates in fatty acid 
metabolism and glycolysis (Figure 1-15). The A-factor signalling molecule was the 
first to be discovered and is biosynthesised by AfsA (SGR_RS34400) (Figure 1-15). 93 
Analogous AfsA enzymes are widespread in Streptomyces bacteria and are proposed 
to produce a butenolide intermediate, which is subsequently modified to a 
butanolide or butenolide type signalling molecule (Figure 1-15). 94,95 
 
Genome mining analyses have identified analogous A-factor/ArpA systems in 
Streptomyces bacteria (Table 1-4) and have been reported to regulate different 
specialised metabolite biosynthetic gene clusters; for example, SCB/ScbR/ScbR2 
and MMF/MmfR/MmyR systems in S. coelicolor regulates the biosynthesis of 
coelimycin and methylenomycins respectively (Figure 1-14). 95 
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Figure 1-15 – Diverse butanolide and butenolide signalling molecules are derived 
from intermediates of fatty acid metabolism and glycolysis. Adapted from 
reference 94. 
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Table 1-4 – Analogous A-factor/ArpA regulatory systems in Streptomyces bacteria. 
Organism 
Signalling 
molecule 
AfsA-like 
enzyme 
ArpA-like 
receptor 
Antibiotic Activator Ref. 
S. acidiscabies ? SabA SabR, SabS 
Polyketide 
WS5995B 
? 96 
S. chattanogensis CHB ScgA ScgR ? ? 97 
S. coelicolor SCB ScbA 
ScbR, 
ScbR2 
Coelimycin CpkO 98,99 
S. coelicolor AHFCA MmfL 
MmfR, 
MmyR 
Methylenomycin MmyB 56,57 
S. griseus A-factor AfsA ArpA Streptomycin AdpA 27 
S. lavendulae IM-2 FarX FarA Indigoidine 
FarR1, 
FarR2 
100,101 
S. rochei 
SRB1, 
SRB2 
SrrX 
SrrA, SrrB, 
SrrC 
Lankamycin, 
Lankacydin 
SrrY 
102,103,
104 
S. tsukubaensis ? 
BulS1, 
BulS2 
BulR1, 
BulR2 
Tacrolimus BulY 105 
S. venezuelae AHFCA SgnL 
SgnR, 
GbnR 
Gaburedin None 62 
S. venezuelae SVB JadW1 
JadR2, 
JadR3 
Jadomycin JadR1 106,107 
S. virginiae VB BarX 
BarA, 
BarB 
Virginiamycin ? 108,109 
 
1.5.1. Regulation of streptomycin biosynthesis and morphological 
differentiation by the A-factor/ArpA signalling system in S. griseus 
The ArpA transcriptional repressor protein (SGR_3731) from S. griseus was the first 
and most extensively studied ArpA repressor in Streptomyces bacteria. 110 Deletion 
of the arpA gene in S. griseus resulted in overproduction of streptomycin (Figure 
1-4) and developed aerial hyphae earlier than the wild type strain. 111 The ArpA 
repressor binds to the 22 bp autoregulatory response element (ARE) sequence in 
the promoter of adpA (sgr4742) and directly regulates expression of adpA 
pleiotrophic transcriptional activator. 112 A-factor, which was discovered from 
S. griseus in 1960s, was demonstrated to be the cognate ligand for the ArpA 
repressor and in the presence of A-factor, binding of ArpA repressor to the ARE 
sequence was abolished (Figure 1-16). 112,113 The AdpA pleiotropic transcriptional 
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activators alters expression of more than a thousand genes and directly regulate 
expression of over five hundred genes; some of which are involved in morphological 
differentiation and streptomycin production. 114 
 
 
Figure 1-16 – ArpA repressor binds upstream and regulates the expression of 
adpA pleiotrophic regulator. In the presence of A-factor (red circle), the A-factor 
ligand binds to ArpA and prevents the repressor from binding to the 22 bp ARE 
sequence (palindromic sequences are highlighted in red). 
 
1.5.2. Regulation of coelimycin biosynthesis by the SCB/ScbR/ScbR2 
signalling system in S. coelicolor 
In S. coelicolor, the cryptic polyketide (cpk) gene cluster is involved in the 
biosynthesis of coelimycin, a polyketide alkaloid (Figure 1-14). The two ArpA-like 
transcriptional repressors, ScbR (sco6265) and ScbR2 (sco6286), as well as the two 
genes that encode for Streptomyces antibiotic regulatory proteins (SARP) 
transcriptional activators, cpkO (sco6280) and cpkN (sco6288), are all located and 
clustered together on the 58 kb cpk gene cluster. 115 
 
arpA adpA
A-factorArpA
AGGAACGGACCGCGCGGTACGC
~100kb
AdpA
Morphological 
differentiation
Streptomycin 
biosynthesis
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SARP family of transcriptional activators are commonly involved in increasing the 
expression of Streptomyces specialised metabolite biosynthetic gene  
clusters. 116 Coelimycin biosynthesis is dependent on the expression of cpkO as the 
deletion of cpkO abolishes the production of coelimycin. 117 CpkN has not been as 
extensively studied; however, overexpression of cpkN also results in the increase 
production of coelimycin. 118 
 
 
Figure 1-17 – ScbR and ScbR2 repressor binds to promoters of scbA and cpkO to 
regulate the production of SCB signalling molecules and coelimycin respectively. 
SCB signalling molecules only bind to the ScbR repressors and results in 
derepression of the system.  
 
In the SCB/ScbR/ScbR2 system, the ScbA enzyme, which shares 65% identity and 
74% similarity over 292 amino acids with AfsA, catalyses the analogous reaction in 
the biosynthesis of SCB signalling molecules and are the cognate ligands for ScbR 
(Figure 1-15). 119 The scbA gene is divergent and adjacent to the scbR repressor gene, 
whilst in the A-factor/ArpA system, the afsA gene is located over 100 kb away from 
arpA. From electromobility shift assays (EMSA) and DNase I footprinting, ScbR 
scbR cpkO
SCBScbR
CpkO
Coelimycin
biosynthesis
scbA
ScbA
~47kb ~1kb
scbR2 cpkN~6kb
ScbR2
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repressor was shown to bind to SiteA and SiteR ARE sequences located within the 
scbR - scbA intergenic region, as well as to SiteOA and SiteOB in the cpkO promoter 
(Figure 1-17 and Figure 1-18). The binding of ScbR repressor to the ARE sequences 
were abolished in the presence of SCB signalling molecules (Figure 1-17). 98,117 
 
 
Figure 1-18 – ScbR repressor was found to interact with (a) SiteA and SiteR in the 
scbR - scbA intergenic region, and (b) SiteOA and SiteOB in the cpkO. The ScbR2 
repressor could only interacted with SiteA and SiteOB. (c) The ARE sequences are 
highly conserved. Palindromic sequences are highlighted in red and conserved 
nucleotides are marked with asterisk. 
 
ScbR2 repressor, which shares 32% identity and 50% similarity over 194 amino 
acid with ScbR, is located on the other side of the cpk gene cluster (Figure 1-17) and 
(6890528 to 6892237 bps)
6891000 6891500 6892000
scbR
-35
SiteA
-10
pscbR
scbA
pscbA
-35-10
SiteR
(6936149 to 6939643 bps)
6937000 6938000 6939000
cpkG
SiteOB
SiteOA cpkO
pcpkO
-35 -10
a)
b)
c)
SiteA: GAAAAAAAACCGCTCAGTCTGTATCTTAA
SiteOB: CAAAACAGACTGTGTTAGCTGTTT
**** * ** *      **** *
SiteR:  GGAACCGGCAATGCGGTTTGTTCGATC 
SiteOA: ACAAACCGGTGTGCTGGTTTGTAAAGTCGTGG
******      *******    **    
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through similar EMSA and DNase I footprinting analyses, ScbR2 repressor was 
established to only bind to SiteA and SiteOB, which contains one half of the 
palindromic sequence (Figure 1-18). 120 Furthermore, binding of ScbR2 to the ARE 
sequences were not abolished in the presence of SCB signalling molecules, which 
suggests the SCB signalling molecules are not the cognate ligand for ScbR2. Instead, 
interactions between ScbR2 repressor and ARE sequences were prevented in the 
presence of endogenous metabolites produced by S. coelicolor; actinorhodin and 
undecylprodigiosin (Figure 1-3). 99,120 
 
The deletion of the ArpA-like repressors was able to over-produce coelimycin. 
Inactivation of scbR, as well as the addition of SCB signalling molecules did not result 
in the production of coelimycin, but instead, altered the levels of actinorhodin and 
undecylprodigiosin. 115,119,121 To further complicate the SCB/ScbR/ScbR2 system, 
other pleiotropic transcriptional regulators have been reported to directly regulate 
the cpk gene cluster, such as nutrient-sensing DasR regulator (SCO5231), PhoP 
phosphate response regulator (SCO4230) and AfsQ1/Q2 two component system 
(SCO4907/SCO4906). 122,123,124,125 
1.5.3. Regulation of methylenomycin biosynthesis by the MMF/MmfR/MmyR 
signalling system in S. coelicolor 
MmfL, which shares 27% identity and 40% similarity over 274 amino acids with 
AfsA in S. griseus, is required for the assembly of AHFCA signalling molecules (Figure 
1-15). Comparative metabolic profiling of heterologous hosts with and without the 
mmfLHP operon led to the discovery of MMF signalling molecules as discussed in 
Chapter 1.3.2. 56  
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The cassette of five genes, mmfR (scp1.242c), mmfL, mmfH, mmfP and mmyR 
(scp1.246), forms the AHFCA-dependent signalling system and is adjacent to a group 
of genes involved in the biosynthesis of methylenomycins, a colourless 
cyclopentanoid antibacterial metabolite (Figure 1-3 and Figure 1-19). The 19 kb 
Mm biosynthetic gene cluster contains a total of 21 genes, including biosynthetic, 
resistance and regulatory genes (Figure 1-19), and are all clustered on the linear 
SCP1 plasmid. 126 The production of methylenomycin is dependent on the 
expression of mmyB, which encodes for a putative xenobiotic response element 
(XRE) family of transcriptional activators, and the in-frame deletion of mmyB 
abolishes the production of methylenomycin. Preliminary bioinformatic analyses 
have identified two direct repeats of 16 bp sequence called the “B-box” sequence 
and are located in mmyB - mmyY intergenic region and promoter of mmyT 
(scp1.241c); MmyB activator is proposed to bind to the “B-box” sequence to activate 
expression of methylenomycin biosynthetic genes. 57  
 
Nutrient sensing transcriptional regulators may also play a role in controlling the 
production of methylenomycin. Acidic shock and limiting alanine conditions were 
shown to trigger the production of methylenomycin in S. coelicolor. 127 In addition, 
mmfL and mmyB genes both contain the rare TTA codon. 57 BldA, which encodes for 
the rare UUA leucine tRNA, is a global regulator of morphological differentiation and 
metabolite production, and predominantly accumulates during late exponential and 
stationary phase. 128,129,130 Therefore, translation of mmfL and mmyB is dependent 
on the presence of mature BldA.  
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Further preliminary bioinformatic analyses of Mm gene cluster have identified 
highly conserved 18 bp ARE sequence in mmfR - mmfL and mmyY - mmyB intergenic 
region and mmyR promoter (Figure 1-19). 57 EMSA studies have demonstrated that 
the MmfR repressor can bind to specific ARE sequences (Dean, R. et al. Manuscript 
in preparation). The MmyR repressor, which is 35% identical and 56% similar to 
MmfR over 110 amino acids, is also proposed to bind to the same ARE sequences. 57 
The exact cognate signalling molecule and DNA binding interactions for MmyR is 
currently under investigation; however, early results suggest the MmyR repressors 
do not bind to the same MMF signalling molecules as MmfR (Styles, K. Personal 
communication). 
 
 
Figure 1-19 – (a) In absence of MMF signalling molecules (red circle), MmfR 
repressor binds to mmfR - mmfL and mmyY - mmyB intergenic region and mmyR 
promoter to regulate the biosynthesis of methylenomycin and MMFs. 
(b) MmfR/MmyR repressors are proposed to bind to highly conserved 
semi-palindromic sequences (palindromic sequences are highlighted in red). 
S. coelicolor A3(2)
Methylenomycin biosynthetic gene cluster
(19,341 bp)
mmyB
mmfRmmfLmmfHmmfP mmyR
1 kb
Methylenomycin
biosynthesis
MmyB
MmfR
MmyR
MMF
MMF
mmyY-mmyB: TAAAAAACCTTCGGGAAGGTTTGACA
mmfR-mmfL: AAATATACCTGCGGGAAGGTATTATG
mmyR: AAACATACCCTCGGGAAGGTATGTTA
** * ***   ******** *    
a)
b)
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S1 nuclease protection analyses revealed transcripts of mmfR and mmfL were 
transcribed at the beginning of growth, and expression of mmyB and mmyR was 
induced 48 hours into growth. The presence of MmfR repressor is proposed to 
tightly regulate expression of mmyB, mmfL and itself by binding to conserved ARE 
sequences and turning off the production of methylenomycins and MMFs (Figure 
1-19). In presence of mature BldA, mmfL is translated to a functional protein and 
assembles the MMF signalling molecules. The signalling molecules bind to the MmfR 
repressor and begins to derepress the system; however, derepression of mmfR 
would also result in the increase transcription of mmfR. Once concentrations of the 
MMF signalling molecules reaches a critical threshold (through the biosynthesis of 
mmfLHP or from the environment as they are freely diffusible molecules), MmfR 
repressor is released from the mmyB promoter and the biosynthesis of 
methylenomycins is initiated. MmyR repressor is proposed to act as an off-switch to 
stop the production of methylenomycin compounds. Hence, specific inactivation of 
mmyR repressor gene unlocks and overproduces methylenomycin and MMF 
signalling molecules; whilst the deletion of mmfR results in no phenotypic difference 
when compared to the wild type strain. 57 
 
Genome mining analyses have identified analogous AHFCA-dependent signalling 
gene clusters in several other Streptomyces bacteria (4 to date), such as in 
S. venezuelae (Figure 1-9). Genetic inactivation of the analogous mmyR repressor 
(gbnR) in S. venezuelae led to the discovery of a novel family of natural products, the 
gaburedins (discussed in Chapter 1.3.3). 62 Exploitation of AHFCA-dependent 
signalling systems may lead to the discovery of other novel specialised metabolites 
in Streptomyces bacteria. 
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1.6. Aims of the project 
Systems that utilise TetR repressors and butenolide/butanolide signaling molecules 
are widely distributed in Streptomyces bacteria and are often involved in controlling 
natural product biosynthesis. In silico predictions of TetR transcriptional repressor 
binding sites would provide unprecedented information of transcriptional 
regulation involved in controlling the expression of cryptic natural product 
biosynthetic gene clusters. Results from such analyses can be further exploited in 
experiments aimed at discovering novel compounds. The project aims to investigate 
a previously identified putative AHFCA-dependent signalling system proposed to 
tightly regulate the expression of a predicted azoxy natural product biosynthetic 
gene cluster in Streptomyces avermitilis. The following objectives will be pursued: 
 
 Prediction of transcriptional repressor binding sites in putative AHFCA-
dependent and GBL-dependent signalling systems in Streptomyces bacteria. 
 Bioinformatic and genome mining analyses of compounds produced by the 
cryptic biosynthetic gene cluster proposed to be under the control of a putative 
AHFCA-dependent signalling system in S. avermitilis. 
 Identification of predicted cryptic metabolites using a heterologous 
expression/ comparative metabolic profiling approach.  
 Characterisation of predicted metabolites through the incorporation of 
isotope-labelled precursors and to determine antimicrobial activity of the 
metabolites. Compounds of interest will also be isolated by semi-preparative HPLC 
and structure determined by a combination of 1- and 2-D NMR spectroscopy. 
 Exploitation of AHFCA-dependent signalling systems to unlock and 
overproduce the metabolites of interest. 
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2. Materials and Methods 
Recipes and protocols were followed and adapted from the manufacturer's 
instructions and from the "PCR targeting system in Streptomyces coelicolor A3(2)" 
protocol and Practical Streptomyces Genetics book. 21,131 
2.1. Materials  
2.1.1. Microbial strains 
Table 2-1 – List of microbial strains used in this work. 
Strain Uses/ Genotype Obtained from 
Escherichia coli 
DH5α General cloning host. 
 
fhuA2 lac(del)U169 phoA glnV44 80’ 
lacZ(del)M15 gyrA96 recA1 relA1 endA1 thi-1 
hsdR17 
 
New England Biolabs 
TOP10 General cloning host. 
 
F- mcrA Δ(mrr-hsdRMS-mcrBC) 
80dlacZΔM15 ΔlacX74 nupG recA1 araD139 
Δ(ara, leu)7697 galE15 galK16 rpsL(StrR) 
endA1 - 
 
Invitrogen 
ET12567 Non-methylating host. 
 
ET12567: dam dcm hsdS cat tet 
JIC, Norwich, UK 
BW25113 Strain for PCR targeted deletion. 
 
F-, DE(araD-araB)567, lacZ4787(del)::rrnB-3, 
LAM-, rph 1, DE(rhaD-rhaB)568, hsdR514 
JIC, Norwich, UK 
 
ET12567/pUZ8002 ET12567 containing non-transmissible 
plasmid. 
 
pUZ8002 plasmid: tra neo RP4  
JIC, Norwich, UK 
DH10B/pESAC13A  Host containing pESAC13A constructs. 
 
DH10B: F- mcrA Δ(mrr-hsdRMS-mcrBC) 
80dlacZΔM15 ΔlacX74 endA1 recA1 deoR 
Δ(ara, leu)7697 araD139 galU galK nupG rpsL 
- 
Bio S&T, Canada 
This study. 
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pESAC13A: aacIV attp-integrase 
DH5α/pUB307 Strain for mobilising plasmids into bacteria. 
pUB307 plasmid: RP4 carb 
JIC, Norwich, UK 
DH5α/pR9604 Strain for mobilising plasmids into bacteria. 
Derivative of pUB307 with kanamycin 
resistance replaced with carbenicillin 
resistance. 
JIC, Norwich, UK 
DH5α/pER2 DH5α with pER2 plasmid. Remstam, E. (Corre 
Group), University of 
Warwick, Coventry, UK 
 
TOP10/pER2Δint DH5α with pER2Δint plasmid. This study. 
BW25113/pIJ790 Strain for PCR targeted deletions. 
BW25113 with pIJ790 plasmid 
JIC, Norwich, UK 
BW25113/pKD20 Strain for PCR targeted deletions. 
BW25113 with pKD20 plasmid 
JIC, Norwich, UK 
K12/pMK-RQ_SAV_2301 K12 with pMK-RQ_SAV_2301 construct. Life Technologies. 
This study. 
Streptomyces avermitilis 
MA-4680  Wild type strain. 
 
 USDA, USA 
Streptomyces lividans 
TK24 Derivative of Streptomyces lividans 66. 
str-6, SLP2-, SLP3- 
 
JIC, Norwich, UK 
Streptomyces coelicolor 
M1152 Derivative of Streptomyces coelicolor M145 
(SCP1- SCP2-). 
 
rpoB[C1298T] Δact red cpk cda  
 
JIC, Norwich, UK 
Bacillus subtilis  
168 Strain used in antimicrobial assay  
ind- tyr+  
Hodgson Group, 
University of Warwick, 
Coventry, UK 
 
Staphylococcus aureus 
 Strain used in antimicrobial assay  
 
Wellington Group, 
University of Warwick,  
Coventry, UK 
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2.1.2. Plasmids 
Table 2-2 – List of plasmids used in this work. 
Name Notes Obtained from 
pOSV556 ampR, hygR, ermE*, oriT , int_pSAM2 Pernodet Group, University of 
Paris-sud, France 
 
pCC4 Derivative of pOSV556 with 
kanamycin resistance replaced with 
apramycin resistance. 
 
Corre Group, University of 
Warwick, Coventry, UK 
 
pESAC13A-2H aacIV, ~130 kb insert from 
S. avermitilis (containing predicted 
azoxy gene cluster). 
Bio S&T, Canada 
This study. 
pESAC13A-19K aacIV, ~130 kb insert from 
S. avermitilis (containing predicted 
azoxy gene cluster). 
Bio S&T, Canada 
This study. 
 
pER2 Derivative of pCC4.  
sav_2267 and sav_2269 genes cloned 
into the HindIII and PstI sites. 
Remstan, E. (Corre Group), 
University of Warwick, 
Coventry, UK 
pER2Δint Derivative of pER2 with integrase 
system deleted. 
This study. 
pKD20 P araBAD, bet, exo, gam, repA101ts, 
bla 
JIC, Norwich, UK 
pIJ790 Derivative of pKD20 with ampicillin 
resistance replaced with 
chloramphenicol resistance. 
JIC, Norwich, UK 
pIJ777 Kanamycin disruption cassette  
amp, neo 
JIC, Norwich, UK 
pMK-RQ 
_SAV_2301 
pMK-RQ construct containing 
sav_2301 (TTA->GGA) 
neo 
Life Technologies. 
This study. 
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2.1.3. Primers 
Primers were diluted to a final concentration of 100 mM with sterile dH2O and 
stored at -20 ⁰C.  
Table 2-3 – List of primers used in this work. 
Primer Name Primer sequence 
Target 
gene 
Expected 
Size (bp) 
for_pESAC_SAV2283a AGATGCGGGTCGAGAAGGAGTACG 
sav_2283 480 
rev_pESAC_SAV2283a AGCCGAAGAAGGACTCGGTGATGG 
for_pESAC13_sav2266a GTGGCCGACCATGTGCAGCATGGG 
sav_2266 425 
rev_pESAC13_sav2266a GCGATGAGGCCAACCGGGAGTACC 
for_pESAC_sav2301a GCTACCGGCTCACGATCAACGAAA 
sav_2301 424 
rev_pESAC_sav2301a GATGCCGAGTTCGTCCGAGAGGTG 
for_integrase_screen GCGAAGCGGCATGCATTTAC 
int_pSAM2 
3214 
(552) rev_integrase_screen GATCGGGCCTTGATGTTAC 
for_avaA-B_screen CGGCGACGTATCGTTCAC sav_2267-
sav2269 
831 
(132) rev_avaA-B_screen GCCGACATGACCTGGAAG 
for_sav_2268_deletion_screen TCGCAGAACACCAAGTAG sav_2266-
sav_2270 
3,235 
(2,536) rev_sav2268_deletion_screen CTCATGACGTCCATATCG 
for_Target_SAV_2268 
GTTCACGAACGTATCTTTTATGCTT
CGGTCCCCGCCGTGATTCCGGGGAT
CCGTCGACC 
Kanamycin 
disruption 
cassette 
1,176 
rev_Target_SAV_2268 
CGTGGTGACCCGCGGCTCACCGGGC
CGTGGCCGGCCTCATGTAGGCTGGA
GCTGCTTC 
for_Target_SAV_2268_2 
GTCCCCGCCGTGGAGCCGGCAAAGG
AGGGGAGCGTCATGATTCCGGGGAT
CCGTCGACC 
Kanamycin 
disruption 
cassette 
1,176 
rev_Target_SAV_2268_2 
TGGCCGGCCTCAGCGGGCCGGGGCG
CCGCCGAGCGCCTGTGTAGGCTGGA
GCTGCTTC 
for_pKD20_screen GTACGGCCTTAATCCGTGGAC 
bet  534 
rev_pKD20_screen TCGCGGCGAAATATCTGGG 
for_SAV_2301_2 
ACAAAGCTTAGGAGGAACGGCATGC
TGAGCTTCTCG 
sav_2301 834 
rev_SAV_2301_2 
ACACTGCAGGCGGGCTCAGGCCGGC
TGG 
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2.1.4. Antibiotic solutions 
Antibiotic solutions were filter sterilised before use and stored at 4 ⁰C. 
Table 2-4 – List of antibiotics used in this work. 
Antibiotic Stock 
Solution 
(mg/mL) 
E. coli 
 (µg/mL) 
Streptomyces 
(µg/mL) 
Solvent 
Ampicillin 100 100 - dH2O 
Apramycin 50 50 50 dH2O 
Chloramphenicol 25 25 - Ethanol 
Hygromycin 50 - 50 (100) dH2O 
Kanamycin 50 25 - dH2O 
Nalidixic Acid 25 25 25 0.3M NaOH 
 
2.1.5. Solid media 
Recipe for solid medium were prepared as follows: 
Lysogeny Broth (LB) Agar Supplemented Minimal Medium Solid (SMMS) 
Agar Tryptone 10 g   
Yeast extract 5 g   Casaminoacid 2 g 
NaCl 10 g   TES buffer 8.68 g 
Agar 15 g   Agar 15 g 
dH2O to 1 L   dH2O to 1 L 
   
Soya Flour Mannitol (SFM) 
Agar 
After autoclave, add the following sterilised 
solutions. 
Soya Flour 20 g    
Mannitol 20 g   NaH2PO4 + K2HPO4 (50 mM each) 10 mL 
Agar 20 g  MgSO4 (1 M) 5 mL 
Tap water to 1 L   Glucose (50% w/v) 18 mL 
   Trace element solution 1 mL 
 
All solutions were autoclaved before use unless stated otherwise. 
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2.1.6. Liquid media 
Recipe for liquid medium were prepared as follows: 
Lysogeny Broth (LB) Medium Trace Element Solution 
Tryptone 10 g   ZnSO4.7H2O 0.1 g 
Yeast extract 5 g   FeSO4.7H2O 0.1 g 
NaCl 10 g   MnCl2.4H2O 0.1 g 
dH2O to 1 L   CaCl2.2H2O  0.1 g 
      NaCl 0.1 g 
Supplemented Minimal Medium (SMM) dH2O to 1 L 
Casaminoacid 2 g    
TES buffer 8.68 g   Filter sterilised and stored at 4 ⁰C. 
dH2O to 1 L    
pH 7.2   Valanimycin Producing Medium  
 (VPM)  
After autoclave add the following sterilised 
solutions: 
Maltose 
Peptone 
0.2% 
0.5% 
    Meat Extract 0.5% 
NaH2PO4 + K2HPO4  
(50 mM each) 10 mL   
Yeast Extract 
NaCl 
0.3% 
0.3% 
MgSO4 (1 M) 5 mL   MgSO4.7H2O 0.1% 
Glucose (50% w/v) 18 mL   pH 7.2 
Trace element solution 1 mL    
     
2xYT Medium 
  
Tryptone Soya Broth (TSB) 
Medium Tryptone 16 g 
Yeast Extract 10 g  Tryptone Soya Broth 30 g 
NaCl 5 g  dH2O to 1 L 
dH2O to 1L    
 
All solutions were autoclaved before use unless stated otherwise. 
2.2. Methods 
2.2.1. Bioinformatics analysis 
Genomes of Streptomyces bacteria were analysed by AntiSMASH Version 2.0 to 
determine the number of predicted specialised metabolite gene clusters and help 
identify putative AHFCA-dependent and GBL-dependent signalling systems. Cryptic 
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biosynthetic gene clusters were further annotated using Basic Local Alignment 
Search Tool (BLAST). 132,133 
 
The TetR repressor binding sites of putative AHFCA-dependent and GBL-dependent 
signalling systems were discovered using Motif Em for Motif Elicitation (MEME) and 
Finding Individual Motif Occurances (FIMO) tools from MEME Suite Version 4.9.0 
(http://meme-suite.org/). 134 Promoters of the TetR repressors and genes 
divergently adjacent to the repressor (300 bp upstream of the ORF start codon) 
were submitted to MEME and the program was allowed to enrich for three motifs. 
The program was constrained to search for palindromic patterns, and each 
submitted promoter sequence was searched on the "given strand" and for “zero or 
one site”. Motifs of interest, which were enriched by MEME, were further submitted 
to FIMO to search for individual hits to the motif across chromosome or plasmids. 
Statistical threshold of a p-value of less than 1E-4 was used to filter the individual 
hits.  
 
FIMO results can be viewed in the Electronic Supplementary Material accessible on 
http://www2.warwick.ac.uk/fac/sci/chemistry/research/corre/corregroup/repo
sitorypoon 
2.2.2. Growth, storage and manipulation of E. coli bacteria 
2.2.2.1. Growth of E. coli bacteria 
E. coli was grown overnight in liquid LB media or solid LB agar with appropriate 
antibiotics at 37 ⁰C. For liquid cultures, flasks and/or universal tubes were shaken 
at 200 rpm. 
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2.2.2.2. E. coli glycerol stocks preparation 
 E. coli glycerol stocks were prepared from overnight E. coli cultures and diluted with 
sterile 50% (w/v) glycerol to a final concentration of 25%. The glycerol stocks were 
stored at -80 ⁰C. 
2.2.2.3. Plasmid extraction (GeneJET Plasmid Miniprep Kit) 
The Thermo Scientific GeneJET Plasmid Miniprep kit was used for extraction and 
purification of plasmids from E. coli. The protocol was followed per in the 
manufacturer's instructions with the following changes: 135 
 Plasmids were extracted from 10 mL of overnight E. coli culture. 
 Prewarmed sterile dH2O (70 ⁰C) was used instead of elution buffer. 
 During the elution step, the DNA pellet was allowed to incubate at room 
temperature for 5 minutes with prewarmed sterile dH2O. 
2.2.2.4. Plasmid extraction (phenol/chloroform) 
A phenol/chloroform extraction was used for plasmid preparation of pESAC13A 
constructs. Plasmids were extracted from 10 mL of overnight E. coli cultures. The 
cells were pelleted by centrifugation (2,000 rpm for 10 minutes) and resuspended 
in 100 µL of solution I (50 mM Tris/HCl and 10 mM EDTA; pH 8). The suspended 
bacteria was lysed by solution II (200 mM NaOH and 1% SDS) and gently mixed. The 
proteins were precipitated with 150 µL of solution III (3 M potassium acetate; 
pH 5.5) and gently mixed. The tube was then centrifuged (13,200 rpm for 
5 minutes) to pellet the precipitated proteins. The supernatant was transferred to a 
fresh tube and 400 µL of pH 8 phenol/chloroform/isoamyl alcohol (25:24:1) was 
added to extract the DNA. The tubes were mixed gently for 2 minutes and 
centrifuged (13,200 rpm for 5 minutes) to separate the layers. The upper aqueous 
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layer was then transferred to a fresh tube and 600 µL of isopropanol was added to 
precipitate the DNA. The tubes were allowed to incubate on ice for 10 minutes and 
centrifuged (13,200 rpm for 5 minutes) to pellet the DNA. The pellet was further 
washed with 200 µL of 70% ethanol and centrifuged (13,200 rpm for 5 minutes). 
The supernatant was discarded and the DNA pellet was air dryed for 5 minutes at 
room temperature. The DNA pellet was resuspended in 50 µL of sterile dH2O and 
stored at -20 ⁰C. 
2.2.2.5. Preparation of electro-competent E. coli bacteria 
Electro-competent E. coli TOP10 or DH5α bacterial cells were prepared by washing 
mid-exponential phase E. coli bacteria (OD600 ~0.4 - 0.6) twice with ice cold glycerol 
(10% w/v). The supernatant was discarded and the pellet was resuspended in 
residual glycerol. The electro-competent E. coli bacteria were aliquotted into 
cryogenic tubes and stored at -80 ⁰C. 
2.2.2.6. Transformation of electro-competent E. coli bacteria 
Electroporation was performed to introduce plasmids into E. coli bacteria and was 
carried out in 0.2 cm electroporation cuvettes. Electro-competent E. coli bacteria 
(70 µL) and 3 µL of plasmids or ligation mixture were transferred to the ice-cold 
electroporation cuvette and electroporation was performed at 200 Ω, 25 μF and 
2,5 kV. Immediately after electroporation, 1 mL of ice cold LB was added to 
electroporation cuvette to recover the cells. The transformation mixture was 
transferred to a fresh tube and incubated at 37 ⁰C for 1 hour at 200 rpm. The mixture 
was plated onto LB agar with appropriate antibiotics. E. coli glycerol stocks were 
made from positive transformants. 
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2.2.3. Growth, storage and manipulation of Streptomyces bacteria 
2.2.3.1. Growth of Streptomyces bacteria 
Streptomyces bacteria were grown for 6 days in liquid or solid agar with appropriate 
antibiotics and incubated at 30 ⁰C. For liquid cultures, baffled flasks or flasks 
containing stainless steel spring were shaken at 220 rpm. 
2.2.3.2. Streptomyces glycerol spore stock preparation 
Streptomyces glycerol spore stocks were prepared from a confluent lawn of spores 
grown on SFM plates with appropriate antibiotics. Sterile dH2O (3 mL) was added 
to each plate and the spores were suspended with a sterile loop. The suspension was 
transferred to a tube and briefly vortexed to liberate the spores from the mycelia. 
The suspension was filtered through a sterile syringe with non-absorbent wool and 
pelleted by centrifugation (3,500 rpm for 5 minutes). The spore pellet was 
resuspended in the residual liquid and diluted with sterile 50% (w/v) glycerol to a 
final concentration of 25%. The Streptomyces glycerol spore stock was stored 
at -80 ⁰C. 
2.2.3.3. Streptomyces genomic DNA extraction 
Streptomyces genomic DNA was extracted using the MP Biomedicals FastDNA SPIN 
Kit for Soil DNA Extraction. The protocol was followed as per the manufacturer's 
instructions with the following changes: 136 
 Genomic DNA extraction was carried out on Streptomyces spores scrapped off a 
confluent lawn (dimension of 1 x 1 inch square). 
 Prewarmed sterile dH2O (70 ⁰C) was used instead of DES solution. 
 During the elution step, the DNA pellet was allowed to incubate at room 
temperature for 5 minutes with prewarmed sterile dH2O. 
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2.2.3.4. Intergenic conjugation 
Bacterial conjugation was performed to transfer plasmids from E. coli hosts into 
Streptomyces bacteria. E. coli hosts were grown to mid-exponential phase 
(OD600 ~0.4 - 0.6) and centrifuged (2,000 rpm for 10 minutes) to pellet the cells. The 
cells were washed twice with fresh LB to remove the antibiotics and the pellet was 
resuspended in 500 µL of LB media. Streptomyces spores were germinated by 
incubating 10 µL of Streptomyces spore glycerol stock in 500 µL of 2xYT media at 
50 ⁰C for 10 minutes.  
 
E. coli and Streptomyces bacteria were combined and briefly centrifuged (5,500 rpm 
for 30 seconds). The supernatant was discarded, and resuspended in 500 µL of 
sterile dH2O and serially diluted. Serially diluted conjugation mixture (100 µL) were 
then plated onto SFM agar + 10 mM MgCl2 and grown overnight at 30 ⁰C. After 
16-20 hours, the plates were overlayed with 1 mL of sterile dH2O with 25 µL of 
apramycin (50 mg/mL), 20 µL of nalidixic acid (50 mg/mL) and 25 µL of hygromycin 
(50 mg/mL); for S. lividans TK24, 100 µL of hygromycin (50 mg/mL) was used. The 
plates were further incubated at 30 ⁰C until spores were observed. Positive 
Streptomyces colonies were subcultured onto a fresh SFM agar plate with 
appropriate antibiotics and Streptomyces spore glycerol stocks were made from 
positive exconjugants. 
2.3. Molecular biology  
2.3.1. Polymerase chain reaction  
For accurate cloning of genes, New England Biolabs Phusion High-Fidelity DNA 
polymerase was used. For routine polymerase chain reactions (PCR), Fermentas 
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Routine PCR taq polymerase (recombinant) was used. The reaction mixture was 
prepared as follows: 
 
Reagent for routine  Volume 
10X Taq Buffer with (NH4)2SO4 5 µL 
MgCl2 (10 mM) 3 µL 
DMSO 2.5 µL 
dNTP (10 mM) 1 µL 
Primers (100 mM) 1 µL each 
DNA template (50 - 200 ng) 0.5 - 1 µL 
Fermentas Taq polymerase 1 unit 
Sterile dH2O 
 
to 50 µL 
 
Reagent for high fidelity  Volume 
5X Phusion GC buffer 10 µL 
DMSO 2.5 µL 
dNTP (10 mM) 1 µL 
Primers (100 mM) 1 µL each 
DNA template (50 - 200 ng) 0.5 - 1 µL 
Phusion Taq polymerase 1 unit 
Sterile dH2O to 50 µL 
 
For all routine PCR reactions, the following PCR cycle was used: 
Step 1: 98 ⁰C for 2 minutes 
Step 2: 98 ⁰C for 2 minutes 
Step 3: 55 ⁰C for 45 seconds 
Step 4: 72 ⁰C for X minutes 
Step 5: 72 ⁰C for 15 minutes 
Step 6: 4 ⁰C hold 
 
Step 2 to Step 4 were repeated for 30 times and the elongation step (Step 4) was 
incubated for 1 minute/ 1 kb. For high fidelity PCR reactions, a two step PCR cycle 
was used (the same PCR cycle as above with Step 3 omitted). 
2.3.2. Restriction enzyme digestion 
Plasmids and/or PCR products were digested using Fermentas FastDigest 
restriction enzymes. The following reaction mixture was prepared and incubated 
for 30 - 60 minutes at 37 ⁰C. After incubation, digested products were immediately 
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analysed by agarose gel electrophoresis and purified using the GeneJet Gel 
Extraction kit. 
Reagent Volume 
10X FastDigest buffer 5 µL 
DNA 10 - 30 µL 
FastDigest enzyme 1.5 µL 
Sterile dH2O to 50 µL 
 
2.3.3. DNA ligation 
Plasmids and/or PCR products were ligated together using Invitrogen T4 DNA 
ligase. An insert to vector molar concentration ratio of 3:1 was used for all DNA 
ligation reactions. The following reaction mixture was prepared, incubated for 
5 minutes at room temperature and transferred to 4 ⁰C overnight before 
electroporation. 
Reagent Volume 
5X DNA ligase reaction buffer 4 µL 
DNA (3:1 ratio) X µL 
T4 DNA ligase 1 unit 
Sterile dH2O to 20 µL 
 
2.3.4. Agarose gel electrophoresis 
A 1% agarose gel was prepared by dissolving 1 g of agarose powder in 100 mL of 
TAE buffer (40 mM Tris, 20 mM acetic acid and 1 mM EDTA) and 5 µL of GelRed was 
added to the agarose gel. For each sample, 5 µL of DNA was combined with 1 µL of 
Fermentas 6X DNA gel loading dye and loaded into the well. Fermentas FastRuler 
Low Range Medium Range, High Range DNA ladder and GeneRuler 1 kb DNA ladder 
were used as DNA markers (5 µL). Electrophoresis was carried out at 100 V for 
40 minutes.  
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2.3.5. Purification of DNA fragments from agarose gel  
PCR products and/or digested DNA fragments from agarose gel electrophoresis 
were excised and purified using the Thermo Scientific GeneJET Gel Extraction kit. 
The protocol was followed as per the manufacturer's instructions with the following 
changes: 137 
 Prewarmed sterile dH2O (70 ⁰C) was used instead of Elution Buffer. 
 During the elution step, the DNA pellet was allowed to incubate at room 
temperature for 5 minutes with prewarmed sterile dH2O. 
2.4. Analytical chemistry  
2.4.1. Organic extraction 
Streptomyces bacteria were grown in liquid (50 mL) or solid agar (25 mL) for 6 days. 
Culture or media were separated into two tubes for the acidified (pH 3) and neutral 
(pH 7) organic extraction. An equal volume of ethyl acetate was added to the culture 
and the pH of ethyl acetate was adjusted with 37% HCl. The upper ethyl acetate layer 
was evaporated in vacuo and residual was dissolved with HPLC grade methanol and 
water.  
 
For liquid organic extraction, the culture was centrifuged (4,000 rpm for 
20 minutes) to remove the bacteria and supernatant was extracted with ethyl 
acetate. The upper ethyl acetate layer was also treated with excess of magnesium 
sulphate to remove water and filtered. The ethyl acetate layer was evaporated 
in vacuo as described above. 
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2.4.2. Liquid chromatography – mass spectrometry 
LC-MS analysis was performed on the Agilent 1200 HPLC coupled to the Bruker High 
Capacity Trap (HCT) Ultra mass spectrometer operated in positive mode 
electrospray ionisation (ESI). Organic extracts were filtered on a spin column 
(4,500 rpm for 5 minutes) and 20 µL of the filtered extract was injected into the 
Agilent ZORBAX Eclipse Plus column (C18, 46 x 150 mm, 5 µm). The following 
solvent and linear gradient profile with a flow rate of 1 mL/minute was used for all 
LC-MS analysis (Table 2-5). 
Table 2-5 – Gradient profile for LC-MS analysis. 
Time 
(minutes) 
Water  
+ 0.1% formic acid (%) 
Methanol  
+ 0.1% formic acid (%) 
0 95 5 
5 95 5 
30 0 100 
35 0 100 
40 95 5 
55 95 5 
 
High resolution LC-MS analysis was performed on the Bruker MaXis or MaXis Impact 
ESI-Quadrupole-Time of Flight (TOF) mass spectrometry. The Mass spectrometer 
was connected to the Dionex 3000RS ultra high performance liquid chromatography 
(UHPLC) system and an Agilent ZORBAX Eclipse Plus column (C18, 2.1 x 100 mm, 
5 µm) was used. The following solvent and linear gradient profile with flow rate of 
0.2 mL/minute was used for all UHPLC-ESI-TOF-MS analysis (Table 2-6). 
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Table 2-6 – Gradient profile for UHPLC-ESI-TOF-MS analysis. 
Time 
(minutes) 
Water  
+ 0.1% formic acid (%) 
Acetonitrile  
+ 0.1% formic acid (%) 
0 95 5 
5 95 5 
20 0 100 
35 0 100 
 
2.5. Experimental methods 
2.5.1. S. avermitilis pESAC13A PAC genomic library  
S. avermitilis pESAC13A P1-derived artificial chromosome (PAC) genomic library 
was created by Bio S&T (www.biost.com). The following samples were prepared for 
the S. avermitilis pESAC13A PAC genomic library: 
 Three tubes containing S. avermitilis bacteria. 
 Genomic DNA of S. avermitilis (minimum of 10 µg). 
 Three pairs of primers for screening gene cluster of interest 
(for_pESAC_SAV2283a and rev_pESAC_SAV2283a; for_pESAC13_sav2266a and 
rev_pESAC13_sav2266a; for_pESAC_sav2301a and rev_pESAC_sav2301a, see 
Table 2-3). 
2.5.1.1. Preparation of S. avermitilis bacterial cells 
S. avermitilis glycerol spore stock (10 µL) was inoculated in 100 mL of TSB media 
and cultured for 30 hours. The cells were pelleted by centrifugation (4,000 rpm for 
10 minutes at 4 ⁰C) and supernatant was discarded. The pellets were then washed 
twice with 50 mL of buffer (200 mM NaCl, 10 mM Tris-HCl, 100 mM EDTA, pH 8) 
and flash frozen in liquid nitrogen for 5 minutes and stored at -80 ⁰C before shipping. 
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2.5.1.2. Isolation of S. avermitilis genomic DNA 
S. avermitilis was cultured in TSB media as above and bacterial cells from 25 mL of 
the culture was pelleted by centrifugation (4,000 rpm for 10 minutes). The cells 
were washed twice with STE buffer (100 mM NaCl, 10 mM Tris-HCl, 1 mM EDTA, 
pH 8). The bacterial pellet was resuspended in 5 mL of STE buffer and lysed with 
lysozyme dissolved in 5 mL of STE buffer (10 mg/mL) for 30 minutes on a gel rocker 
at room temperature. SDS (10%) was added and further incubated at room 
temperature for 5 minutes on the gel rocker.  
 
Both SDS and lysozyme were inactivated by incubating the tubes at 70 ⁰C for 
5 minutes and cooled down on ice for 5 minutes. The sample was then neutralised 
by addition of 1.25 mL of 5 M potassium acetate and further incubated on ice for 
5 minutes. Genomic DNA was purified twice using 5 mL of pH 8 
phenol/chloroform/isoamyl alcohol (25:24:1) and mixed gently for 5 minutes. The 
layers were separated by centrifugation (4,000 rpm for 10 minutes at 4 ⁰C). The 
upper aqueous layer was transferred to a fresh tube and 1 mL of 3 M sodium acetate 
and 6 mL of isopropanol were added to precipitate the DNA. The precipitated DNA 
was pelleted by centrifugation (13,200 rpm for 5 minutes) and washed twice with 
70% ethanol. The supernatant was discarded and genomic DNA pellet was then air 
dried for 5 minutes at room temperature. The DNA pellet was resuspended in 
500 L of sterile dH2O and stored at -80 ⁰C before shipping. 
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2.5.2. Heterologous expression of the predicted azoxy gene cluster in 
S. coelicolor M1152 and S. lividans TK24 
The two pESAC13A-2H and pESAC13A-19K constructs were introduced into 
S. coelicolor M1152 and S. lividans TK24 heterologous hosts by tri-parental 
conjugation and analysed by LC-MS. 
2.5.2.1. Tri-parental conjugation in S. lividans TK24 
Tri-parental conjugation was carried out between E. coli DH5α/pUB307, 
S. lividans TK24 and E. coli DH10B containing the pESAC13A constructs. E. coli 
strains were grown till mid exponential phase (OD600 ~0.4 - 0.6) and washed twice 
with LB to remove antibiotics. S. lividans spores were germinated by inoculating 
10 L of glycerol spore stock in 500 L of 2xYT media and incubated at 55 ⁰C for 
15 minutes. A conjugation mixture was prepared by combining 500 µL of 
S. lividans TK24, E. coli DH5α/pUB307 and E. coli DH10B containing the pESAC13A 
constructs and plated on SFM + 10 mM MgCl2. Positive exconjugants were selected 
with apramycin and nalidixic acid.  
2.5.2.2. Tri-parental conjugation in S. coelicolor M1152 
Tri-parental conjugation was carried out between E. coli DH5α/pR9604, 
E. coli ET12567 and E. coli DH10B containing the pESAC13A constructs. E. coli 
strains were prepared as above and resuspended in 500 µL of LB media. 
Tri-parental conjugation was performed by spotting 10 µL of each E. coli bacteria on 
the same location on LB agar. The plates were grown overnight at 37 ⁰C and streaked 
for single colonies on LB agar with apramycin, ampicillin and chloramphenicol.  
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Intergenic conjugation was carried out as described above between 
S. coelicolor M1152 and E. coli ET12567/pR9604 strains containing the pESAC13A 
constructs. Positive exconjugants were selected with apramycin and nalidixic acid. 
2.5.2.3. Comparative metabolic profiling of Streptomyces heterologous 
hosts 
Streptomyces glycerol spore stocks (10 µL) were inoculated onto 25 mL of SMMS 
agar or 50 mL of liquid SMM or VPM and incubated at 30 ⁰C for 6 days. Organic 
extraction was performed with ethyl acetate and extracts were analysed by LC-MS. 
The pH of the extractions was adjusted with 37% HCl. 
2.5.3. Genetic inactivation of sav_2268 repressor  
The entire sav_2268 repressor was deleted in S. lividans heterologous host strains 
by double homologous recombination. Intergenic conjugation was performed 
between E. coli ET12567/pUZ8002/pER2Δint and S. coelicolor M1152 or 
S. lividans TK24 heterologous host strains containing the pESAC13A constructs; 
exconjugants were selected with apramycin, nalidixic acid and hygromycin. Positive 
exconjugants were passaged on SFM agar containing apramycin and nalidixic acid. 
After each passage, single colonies were streaked on SFM agar containing apramycin 
and nalidixic acid and screened for hygromycin sensitivity.  
2.5.4. Characterisation of predicted metabolites 
The predicted metabolites were characterised by the incorporation of isotope 
precursors, structure determination by NMR spectroscopy and antimicrobial 
assays. 
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2.5.4.1. Feeding of isotope labelled amino acids 
Isotope-labelled L-serine-13C3-15N and L-threonine-13C4-15N were dissolved in 
sterile dH2O to a final concentration of 25 mM, filtered sterilised and stored at 4 ⁰C. 
Streptomyces heterologous host strains (10 µL) were inoculated onto 5 mL SMMS 
agar and grown for 6 days at 30 ⁰C. After the 1st day of growth, the Streptomyces 
bacteria were overlayed with 200 µL of 25 mM isotope-labelled L-serine or 
L-threonine for the next 4 days; sterile dH2O was used as a negative control. After 
feeding, the metabolites were extracted with ethyl acetate and analysed by LC-MS. 
2.5.4.2. Isolation of metabolites for NMR spectroscopy 
S. coelicolor M1152/pESAC13A-2H1 glycerol spore stocks (10 µL) were inoculated 
on 30 x 25 mL of SMMS agar plates and incubated for 6 days at 30 ⁰C. Organic 
extraction was performed on the agar with acidified ethyl acetate and treated with 
excess of magnesium sulphate to remove water. The ethyl acetate solvent was 
evaporated in vacuo and residual was dissolved in HPLC grade methanol and water. 
 
The scaled up crude extract was filtered on a spin column (4,500 rpm for 5 minutes) 
and injected into the Agilent ZORBAX Eclipse column (C18, 21.2 x 150 mm, 5 µm) 
connected to the Agilent 1200 HPLC system. Purification and fraction collection was 
guided by UV absorbance at 230 nm. The same solvents and gradients were used as 
in LC-MS analysis with a flow rate of 20 mL/minute (Table 2-5). 
 
Fractions containing the compounds of interest were confirmed by the Agilent 
6130B single Quadrupole LC/MS system. The fractions were pooled together, and 
the methanol solvent was evaporated in vacuo and residual water was removed by 
sublimation. The purified compounds were dissolved in deuterated chloroform and 
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analysed by a combination of 1- and 2-D NMR spectroscopy (1H, 13C, COSY, HSQC 
and HMBC) on the Bruker Avance II 700 Mhz. 
2.5.4.3. Antimicrobial assays  
E. coli, B. subtilis and S. aureus were grown to mid-exponential phase 
(OD600 ~0.4 - 0.6). After growth, 50 µL of the culture was diluted in 2 mL of fresh LB 
media. The diluted culture was overlayed on 50 mL of acidified (pH 5) LB agar and 
allowed to fully dry. The crude organic extract (20 µL) was added to 6 mm filter 
paper discs and allowed to dry. Apramycin (5 µL) and methanol/water (20 µL) were 
used as positive and negative controls respectively. The filter papers were carefully 
placed on top of the overlayed LB agar and the plates were incubated overnight at 
37 ⁰C. 
 
Antimicrobial assays against Streptomyces bacteria were performed as above. For 
the preparation of Streptomyces bacteria, Streptomyces glycerol spore stock (10 µL) 
were inoculated in 2 mL of sterile dH2O and overlayed on 50 mL of SFM agar. The 
filter paper discs were carefully placed on the dried SFM agar plates and were 
incubated for 2 days at 30 ⁰C. 
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3. AHFCA-dependent Signalling Systems 
From genome mining analyses, the cassette of 5 genes that form the 
AHFCA-dependent signalling system in S. coelicolor have been identified in several 
other Streptomyces bacteria, such as in S. venezuelae ATCC 10712 and 
S. avermitilis MA-4680 (Figure 3-1). 56,62 The gene organisation of the putative 
AHFCA-dependent signalling systems appear to be highly conserved across the 
Streptomyces species (Figure 3-1).  
 
 
Figure 3-1 – Analogous AHFCA-dependent signalling systems from Streptomyces 
species. Analogous genes are colour-coded. 
 
In the S. venezuelae AHFCA signalling gene cluster, there are two additional genes 
that are not present in the other systems (Figure 3-1); sven_4184 and sven_4186, 
which encode for a putative LysR transcriptional regulator and a hypothetical 
protein respectively. The members within the LysR family of transcriptional 
regulators are approximately 330 amino acids long and are also known to bind to 
dyad sequences as a homodimer. 138 The sven_4184 gene product is only 98 amino 
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acids long and appears to form a truncated LysR regulator; specifically the 
N-terminal DNA-binding domain. The sven_4184 gene product might not encode for 
a fully functional LysR-like transcriptional regulator, but the DNA-binding domain 
may still actively interact with DNA sequences. The sven_4186 gene product encodes 
for a hypothetical protein and other homologous partners could not be identified. 
 
In S. coelicolor and S. venezuelae, the AHFCA signalling gene cluster is adjacent to the 
methylenomycin and gaburedin biosynthetic gene cluster respectively. 57,62 Since 
the neighbouring biosynthetic gene clusters are all different and organisation of the 
signalling gene clusters are highly conserved, this implies the biosynthetic and 
signalling systems have not co-evolved and the signalling gene clusters were most 
likely transferred horizontally across Streptomyces bacteria. AHFCA-dependent 
signalling systems are predicted to tightly regulate expression of neighbouring 
cryptic biosynthetic gene clusters and preliminary bioinformatic analyses have 
identified highly conserved semi-palindromic DNA sequences in the promoters of 
key regulatory genes (Figure 1-9 and Figure 1-19); TetR repressors are predicted to 
bind to these sequences and regulate expression of biosynthetic genes. 57,62 
 
The putative AHFCA-dependent signalling systems discovered in 
S. avermitilis MA-4680 and S. hygroscopicus subsp. Jinggangensis 5008 (Figure 3-1) 
are also proposed to behave analogously and directly regulate neighbouring cryptic 
biosynthetic gene clusters. To our knowledge, the putative AHFCA-dependent 
signalling systems, as well as the adjacent cryptic biosynthetic gene clusters in 
S. avermitilis and S. hygroscopicus have not been investigated; analyses and 
exploitation of these complex regulatory systems may result in the discovery of 
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novel drug-like compounds. The first approach to decipher the complex 
AHFCA-dependent regulatory mechanisms is to predict TetR repressor binding 
sites; this would provide strategic targets to genetically manipulate cryptic 
biosynthetic gene clusters aimed at discovering novel natural compounds. 
3.1. MEME enrichment analysis of putative AHFCA-dependent signalling 
systems 
The AHFCA-dependent signalling system in S. coelicolor contains two TetR 
repressors named MmfR and MmyR (Figure 3-1). 57 TetR repressors, which are 
known to bind to semi-palindromic sequences, regulates the expression of itself and 
divergently adjacent genes. 89 Therefore, semi-palindromic DNA sequences are 
expected to be present in both of the TetR promoters (mmfR and mmyR). The MEME 
suite (http://meme-suite.org/), which contains a series of motif-based sequence 
analysis tools, was used to analyse TetR repressor binding sites. Firstly, statistically 
significant and over-represented de novo motifs were discovered by the MEME 
enrichment tool, which uses an expectation maximisation algorithm. 134  
 
To identify MmyR and MmfR DNA-binding sequences, an initial MEME analysis was 
performed on the promoters of TetR repressors as well as genes that are divergently 
adjacent to the repressors (300 bp upstream of start codon of ORFs). The MEME 
program was constrained to “search given strand only” and to “look for palindromes 
only”. The initial MEME analysis outputs three motifs (Figure 3-2); motifs with 
E-value of less than 1 or motifs that shared characteristic features of previously 
identified ARE sequences were further investigated (Figure 1-9, Figure 1-18 and 
Figure 1-19).  
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Figure 3-2 – Output from the initial MEME enrichment analysis of 
methylenomycin biosynthetic gene cluster. Motif 1 was further investigated as a 
potential MmyR/MmfR binding sequence. 
 
 
Initial MEME enrichment analysis of the S. coelicolor AHFCA-dependent signalling 
system identified a highly conserved 24 bp semi-palindromic motif (Figure 3-2) and 
shares resemblance to ARE sequences previously discovered (Figure 1-19). 57 Initial 
MEME enrichment analysis was also successful in revealing ARE sequences in the 
putative AHFCA-dependent signalling systems from S. venezuelae, S. avermitilis and 
S. hygroscopicus (Figure 3-1, Figure 3-3 and Appendix A).  
 
E-value: 5.9e-005
E-value: 1.3e+002
E-value: 2.3e+002
Motif 1
Motif 2
Motif 3
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Figure 3-3 – Initial MEME enrichment analysis identified highly conserved ARE 
motifs in S. coelicolor, S. venezuelae, S. avermitilis and S. hygroscopicus putative 
AHFCA-dependent signalling systems. Analogous MmyR and MmfR repressors are 
proposed to bind to these sequences. 
 
3.2. Regulation of neighbouring cryptic biosynthetic gene clusters by 
AHFCA-dependent signalling systems  
Additional TetR binding sites were searched across the whole genome using FIMO. 
The initial MEME motifs from Figure 3-3 were submitted to FIMO and allowed to 
scan through Streptomyces chromosomes and plasmids. The FIMO program 
parameters were set as default with a statistical threshold (p-value < 1E-4) and were 
allowed to search on the reverse complement of nucleotide sequences.  
 
S. coelicolor A3(2)
S. venezuelae ATCC 10712
S. avermitilis MA-4680
S. hygroscopicus subsp. Jinggangensis 5008 
E-value:  5.9e-005
E- value: 3.2e-010
E-value: 5.7e-008
E-value: 1.2e-008
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The pathway-specific MmyR and MmfR repressors in S. coelicolor are proposed to 
regulate the expression of AHFCA signalling genes and neighbouring Mm gene 
cluster; however, FIMO analyses revealed numerous ARE-like sequences across the 
whole genome and the TetR repressors may interact with any of these specific sites 
(Table 3-1 and Electronic Supplementary Material accessible on 
http://www2.warwick.ac.uk/fac/sci/chemistry/research/corre/corregroup/repo
sitorypoon). 57 In S. coelicolor A3(2), there are a total of 151 genes predicted to 
encode for TetR repressors, which includes 11 MmfR/MmyR paralogs, and would 
most likely bind to similar semi-palindromic sequences; the FIMO analysis may have 
identified these “false-positive” sites. 66  
 
Nonetheless, MmyR and MmfR repressors may bind to these specific ARE-like 
sequences to regulate expression of other genes outside of the Mm gene cluster. 
Cross-talks between different specialised metabolite gene clusters have been 
previously reported in S. coelicolor. For instance, the ScbR2 repressor in the 
SCB/ScbR/ScbR2 system could bind to endogenous actinorhodin and 
undecylprodigiosin metabolites, as well as regulate act and red biosynthetic genes 
by directly controlling the expression of actII-orf4 (sco5085), redD (sco5877) and 
redZ (sco5881) and indirect regulation via adpA (sco2792). 99,120,139,140 
 
Detailed analysis of FIMO results identified ARE-like sequences in other cryptic 
biosynthetic gene clusters; for example, individual hits in S. coelicolor were located 
in actinorhodin (Motif 4), coelimycin (Motif 11 and 19), calcium-dependent 
antibiotic (Motif 15), siderophore (Motif 30) and tetrahydroxynaphthalene 
(Motif 53) biosynthetic gene clusters (Table 3-2 and Electronic Supplementary 
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Material). The binding of the TetR repressors from AHFCA-dependent gene clusters 
were demonstrated to bind across the Streptomyces genome by Tan and co-workers. 
ShbR1 repressor (SHJG_7318), from the S. hygroscopicus putative 
AHFCA-dependent signalling system (Figure 3-1), could directly bind and repress 
the expression of adpA (shjg_4295) and was reported to indirectly affected 
validamycin production. 141,142 The AHFCA-dependent signalling system in 
S. coelicolor may cross-talk with other specialised metabolite biosynthetic gene 
clusters to coordinate the production of specific natural compounds. The binding of 
analogous MmyR and MmfR repressors to proposed ARE-like sequences needs to be 
further confirmed; chromatin immunoprecipitate-sequencing (ChIP-Seq) and 
transcriptome analysis could be carried out to determine global roles and effects of 
the TetR repressors. 
 
Table 3-1 – Analogous MmyR/MmfR binding sites across the genome. 
Name Number of unique sites  
Streptomyces coelicolor  
Chromosome 65 
SCP1 5 
SCP2 0 
Streptomyces venezuelae 
Chromosome 22 
Streptomyces avermitilis 
Chromosome 123 
SAP1 0 
Streptomyces hygroscopicus  
Chromosome 22 
pSHJG1 0 
pSHJG2 0 
 
More importantly, FIMO analyses discovered ARE sequences nearby AHFCA 
signalling gene clusters and were located in the promoters of putative 
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transcriptional activators and biosynthetic genes (Figure 3-4). The analogous 
MmyR/MmfR repressors are proposed to regulate putative transcriptional activator 
to control expression of neighbouring cryptic biosynthetic gene clusters. 
 
Table 3-2 – MmyR/MmfR binding sites in other specialised metabolite 
biosynthetic gene clusters in S. coelicolor. 
Motif Start End Matched Sequence 
Gene 
downstream 
of ARE 
sequence 
Proposed 
Function 
4 5532238 5532261 GATGTCCCTGCGCGAAGGGGTGAT sco5089 
Actinorhodin 
polyketide 
synthase ACP 
11 6894127 6894150 TGAAAACCGGCGAGGAGGTTTGTT sco6268 
Histidine 
kinase 
15 3606273 3606296 GACATGCCTGCCCGCGACTTCTTC sco3255 SpdB protein 
19 6937942 6937965 TACAAACCAGCACACCGGTTTGTC sco6280 
SARP family 
transcriptional 
regulator 
30 6357149 6357172 GACGGTCCCGCTCGCAGGTATGTG sco5813 
Hypothetical 
protein 
53 1272674 1272697 AAGGACCCGTCCGGGAGGTACGAC sco1201 Reductase 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-4 – (Next page) Specialised metabolite biosynthetic gene clusters are 
adjacent to AHFCA signalling gene clusters (refer to Appendix D, Appendix E, 
Appendix F and Appendix G respectively). MEME enrichment analysis reveals ARE 
sequences are located in the promoters of key regulatory genes and biosynthetic 
genes. Analogous genes are colour-coded. Asterisk indicate presence of rare TTA 
codon. 
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3.3. Investigations into the location of ARE sequences 
In the four putative AHFCA-dependent signalling systems, organisation of the genes 
are highly conserved and locations of ARE sequences are consistently found in 
promoters of the two TetR repressor genes and mmfL-like gene (Figure 3-4). The 
locations of ARE sequences compared to the promoter elements, which were 
predicted using BPROM, were investigated to determine whether binding of TetR 
repressor would regulate gene expression. 143  
 
In the analogous mmfR - mmfL intergenic region, the ARE sequences were either 
located downstream or overlapping the -10 to -35 boxes of the mmfL-like and 
mmfR-like genes; hence, binding of the TetR repressors to the ARE sequence is 
predicted to repress expressions of both divergently adjacent genes (Figure 3-5). 
 
 
 
Figure 3-5 – ARE sequences are downstream/ overlapping promoter elements of 
analogous mmyR and mmfL genes. The -10 and -35 boxes were predicted using 
BPROM (the promoter elements for sgnR and shbR1 could not be predicted). Black 
bars represent 100 bp in length and ARE sequences are represented as a turquoise 
box.   
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Unlike the analogous mmfR - mmfL intergenic region, genes that are divergently 
adjacent to the mmyR-like repressors are not as well conserved. In S. venezuelae and 
S. avermitilis, the mmyR-like gene is located divergently adjacent to an mmfH-like 
gene, whilst in S. coelicolor there are no genes divergent to the mmyR gene and in 
S. hygroscopicus, the mmyR-like gene is divergently adjacent to shjg_7323, which 
encodes for a putative monooxygenase (Figure 3-6). The ARE sequences are 
overlapping the promoter elements of analogous mmyR repressor and mmfH genes 
and binding of the repressor is expected to regulate expressions of divergently 
adjacent genes (Figure 3-6). 
 
 
Figure 3-6 – ARE sequences are downstream/ overlapping promoter elements of 
analogous mmfR gene. The -10 and -35 boxes were predicted using BPROM 
(promoter elements for shjg_7323 and sav_2267 could not be predicted). Black 
bars represent 100 bp in length and ARE sequences are represented as a turquoise 
box. 
 
FIMO analyses revealed a third ARE sequence, which was not located in the putative 
AHFCA signalling gene clusters, but was found in the promoters of genes that encode 
for proteins with different functions (Figure 3-7 and Table 3-3).  
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In S. coelicolor, S. avermitilis and S. hygroscopicus systems, the third ARE sequence is 
located upstream of a putative transcriptional activator (Figure 3-7 and Table 3-3), 
whilst in S. venezuelae, the third ARE sequence is found upstream of gbnA, which is 
proposed to be involved in the biosynthesis of gaburedins. 62  
 
 
Figure 3-7 – ARE sequences are downstream/ overlapping promoter elements of 
putative transcriptional activator/ biosynthetic genes. The -10 and -35 boxes were 
predicted using BPROM. Black bars represent 100 bp in length and ARE sequences 
are represented as a turquoise box. 
 
Genes divergently adjacent to putative transcriptional activators also encode for 
proteins with distinct functions (Figure 3-7 and Table 3-3); the mmyY, sven_4178 
and sav_2300 gene products code for a putative hypothetical protein, 
acetyltransferase and integral membrane lysyl-tRNA synthetase respectively. The 
ARE sequences are located downstream or overlap promoter elements of all of the 
putative transcriptional activators/ biosynthetic genes. In S. coelicolor and 
S. venezuelae, the ARE sequences also overlap promoter elements of divergently 
adjacent genes; binding of the repressor is expected to regulate expressions of the 
transcriptional activators/ biosynthetic genes, as well as divergently adjacent genes. 
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However, in S. venezuelae the predicted promoter elements for sven_4178 is located 
over 1 kb away from the start codon and it is unlikely that the predicted -10 and -35 
boxes are the promoter elements for sven_4178; this suggests sequencing errors in 
this specific region may have missed a possible ORF divergently adjacent to gbnA. 
The sven_4178 - gbnA intergenic region needs to be further investigated and 
resequenced. In S. avermitilis, the ARE sequence is located upstream of the sav_2300 
promoter elements; hence, the TetR repressors are proposed to not directly regulate 
expression of sav_2300. 
 
Table 3-3 – ARE sequences upstream of putative transcriptional activators/ 
biosynthetic genes in S. coelicolor, S. venezuelae, S. avermitilis and S. hygroscopicus. 
Organism/gene 
downstream of ARE 
sequence 
bp 
upstream 
of start 
codon 
Proposed function ARE sequence 
S. coelicolor 
mmyB 
13 DNA-binding protein AAAAAACCTTCGGGAAGGTTTGAC 
S. venezuelae 
sven_4179 
10 
Glutamate 
decarboxylase 
AGTTGATACCTTCGTGAAGGTTTTTATT 
S. avermitilis 
sav_2301 
175 
SARP family  
transcriptional 
activator 
AGAAAAATACCTTCTCAAAGGAATTATTCT 
S. hygroscopicus 
shjg_7323 
211 Monooxygenase AGCAAACCATCATTACGGAATTTTTTAT 
S. hygroscopicus 
shjg_7324 
76 
TylR-like  
regulatory protein 
GGGAAAACTACCTGTGGGAAGGTATTTT 
Putative transcriptional activators are highlighted in green.  
Palindromic sequences are highlighted in red. 
 
Predictions of ARE sequences and their respective location to the -10 and -35 boxes 
suggests that the AHFCA-dependent signalling systems are auto-regulatory. The 
ARE sequences are downstream or overlap promoter elements of TetR repressors 
and genes involved in the assembly of the cognate ligand. The TetR repressors are 
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proposed to not only regulate their own expression, but also regulate the assembly 
of AHFCA signalling molecules, which abolishes binding of the TetR repressors to 
ARE sequences (Figure 3-5 and Figure 3-6). In all of the putative AHFCA-dependent 
signalling systems, with the exception of S. venezuelae, the third ARE sequence is 
located in the promoters of putative pathway-specific transcriptional activator. The 
presence of transcriptional activators are expected to act as a signal amplifier to 
overexpress biosynthetic genes and to increase the production of specific natural 
compounds. In addition, rare TTA codon is also present in mmyB and sav_2301 
activators (Figure 3-4) and dependancy on BldA would further fine-tune the 
regulation of cryptic biosynthetic gene clusters. 57 
3.4. Highly conserved ARE motifs across Streptomyces bacteria 
The ARE sequences, which were found in signalling gene clusters and neighbouring 
cryptic biosynthetic gene clusters, can be further refined to generate a consensus 
ARE motif by resubmitting promoter sequences into the MEME program (Figure 3-8 
and Appendix B). The refined consensus ARE sequence motifs are highly conserved 
within and across the Streptomyces systems (Figure 3-8). The conserved pattern is 
more noticeable in the motifs for S. coelicolor, S. venezuelae and S. avermitilis, where 
they share the semi-palindromic sequence, AANATACCTTCNNGAAGGTATNTT 
(palindromic sequence is highlighted in red) (Figure 3-8).  
 
Few differences in the refined consensus ARE sequence motif were observed in 
S. hygroscopicus; for example, the S. hygroscopicus consensus motif contains a longer 
variable spacer of 2 bp and extremities of the motif are represented by a conserved 
AAA/TTT sequence instead of the ATA/TAT sequence as in S. coelicolor, 
S. venezuelae and S. avermitilis consensus motifs (Figure 3-8).  
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Figure 3-8 – Refined consensus ARE motifs for S. coelicolor, S. venezuelae, 
S. avermitilis and S. hygroscopicus. 
 
To investigate possible relationships between the consensus ARE motifs and HTH 
DNA-binding domains, TetR repressors were aligned using Clustal Omega. 144 From 
alignment results, amino acids proposed to be involved in interactions with DNA 
bases were different in S. hygroscopicus TetR repressors (Figure 3-9).  
 
In the SHJG_7322 repressor, an alanine residue was found in position 48 of α-helix 3, 
instead of glycine, which is conserved in the other analogous MmyR repressors. 
Based on the E. coli TetR repressor, this specific amino acid residue was shown to 
be involved in interactions with DNA bases (Figure 3-9). Although alanine and 
S. coelicolor A3(2)
S. venezuelae ATCC 10712
S. avermitilis MA-4680
S. hygroscopicus subsp. Jinggangensis 5008 
E-value:  2.0e-013
E- value: 5.3e-018
E-value: 1.3e-011
E-value: 4.9e-012
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glycine only differ by a single methyl group, these differences may significantly alter 
affinity to the ARE sequences. Furthermore, amino acid residues in α-helix 3, also 
known as the recognition helix, were shown to be primarily involved in the binding 
to extremities of their respective DNA sequence. 70 
 
 
As for the analogous MmfR repressors, amino acid residues in α-helix 3 are all 
conserved; however, the residue proposed to be involved with DNA contact in 
α-helix 2 all differ (Figure 3-9). SAV_2268, MmfR and SgnR repressors contain amino 
acids with non-polar side chains (isoleucine, valine and leucine amino acids 
respectively), whilst in ShbR1, a methionine amino acid was found, which consists 
of a straight-chain with a sulphur atom (Figure 3-9). Based on the E. coli TetR 
repressor, this specific amino acid residue was shown to be involved in interactions 
with beginnings of the variable spacer. The methionine at position 49 of α-helix 2 in 
ShbR1 may explain differences in the variable spacer region. Although amino acid 
residues required for DNA binding are based on the E. coli TetR repressor, 
preliminary bioinformatic analysis has provided insights into observed variation in 
the refined consensus ARE motifs. It should be noted that the amino acid residue 
differences in SHJG_7322 and ShbR1 are not conserved in the two repressors and 
implies they may bind to different DNA sequences (Figure 3-9). 
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Figure 3-9 – Clustal Omega alignment of analogous (a) MmyR and (b) MmfR 
repressors reveals DNA-binding domains are highly conserved; however, small 
variations were identified and could contribute to the differences in the consensus 
ARE motifs. Amino acid residues involved in DNA contact and phosphate backbone 
are highlighted in red and green respectively (based on E. coli TetR repressor). 
 
Early bioinformatic analyses of the S. coelicolor methylenomycin biosynthetic gene 
cluster published by O’Rourke and co-workers, identified highly conserved 18 bp 
sequences in the promoters of key regulatory genes (Figure 1-19). 57 MEME 
enrichment analysis successfully identify the same conserved sequences as well as 
further extend the consensus semi-palindromic sequence to 24 bp (Figure 3-8). 
MEME enrichment analysis was also successful in discovering ARE sequences in 
S. venezuelae, S. avermitilis and S. hygroscopicus, which were previously unknown. 62 
 
The prediction of TetR repressor binding sites upstream of putative transcriptional 
activators is of particular interest, as it provides specific targets to genetically 
manipulate in order to overproduce specific compounds from cryptic biosynthetic 
gene clusters. The S. hygroscopicus gene cluster contains two putative 
transcriptional activator genes (shjg_7324 and shjg_7325, which encode for 
TetR           RLNRESVIDAALELLNETGIDGLTTRKLAQKLGIEQPTLYWHVKNKRALL
ShbR1          IRSRGNILLAAARAFAQRGYPAVTMLDVAELSGMTKGAVYFHFTNKEALA
SAV_2268      IRTRGTILNAAAAAFATDGFPQVTIKDIADGAEMTKGAVYFHFPNKEALA
MmfR IKTRAQILEAASEIFASRGYRGASVKDVAERVGMTKGAVYFHFPSKESLA
SgnR RRTKVHILQSAAELFAERGYATVTLQDVAERAEMTKGAVYFHYTNKEALA
.:  :: :*   :   *    :  .:*:   : : ::*:*  .*.:* 
α1 α2 α3
TetR           RLNRESVIDAALELLNETGIDGLTTRKLAQKLGIEQPTLYWHVKNKRALL
MmyR MRTRDQVLDAAAEEFALHGYAGTNLATVAVRTGMTKGALYGHFPSKKALA
SHJG_7322      RRTHELLLDAAAAEFVRHGYVGANLQRVAAEANLTKGALYAHFTSKRLLA
GbnR RMTYDLVLGAAAAEFALHGFAGTNLADITARTGLTKGALYGHFSSKADLL
SAV_2270       LRTYDRVLDAAAYEFARYGYTNANLQNIADRIRLTKGALYGHFANKEELA
. : :: **   :   *    .   :: .  : : :** *. .*  * 
a)
b)
α4
DNA-binding domain
HTH
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TylR-like transcriptional regulator and streptomycin biosynthesis operon regulator 
respectively) and since the ARE sequence was only discovered in the shjg_7324 
promoter, overexpression of shjg_7324 is expected to unlock the production of 
specific natural compounds.  
 
Binding of analogous MmfR repressors to ARE sequences in S. coelicolor, 
S. venezuelae and S. avermitilis have been demonstrated through a combination of 
in vivo luciferase assays (Styles, K. Personal communication), in vitro EMSA 
(Malet, N., Harrison, P., Zhou, S., and Fullwood, A. Personal communication) and 
have ultimately led to the crystallisation of MmfR with MMF2 (Dean, R. et al. 
Manuscript in preparation). The MEME enrichment analysis provides an incredibly 
powerful approach for gaining insights into TetR repressor binding sites and to 
develop strategies to unlock the production of novel natural compounds.  
3.5. MEME enrichment analysis in other putative AHFCA-dependent 
signalling systems  
In addition to the four AHFCA-dependent signalling systems, genome mining 
analysis identified other putative AHFCA signalling gene clusters in Streptomyces 
bacteria (S. sclerotialus NRRL ISP-5269, S. sp. HGB0020, S. roseochromogenes subsp. 
Oscitans DC 12.976), as well as in Kitasatospora (Kitasatospora 
cheerianensis KCTC 2396), a closely related genus (Figure 3-10). 145 
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Figure 3-10 – AHFCA-dependent signalling system are widespread in 
Streptomyces bacteria. ARE sequences are shown as a turquoise bar and genes with 
proposed analogous activity are colour-coded. 
 
Using the same MEME enrichment analyses, TetR repressor binding sites were 
successfully identified in other putative AHFCA-dependent signalling systems and 
as expected, ARE sequences were discovered in the promoters of key regulatory 
genes (Figure 3-10, Figure 3-11 and Appendix C). Furthermore, newly identified 
consensus motifs are highly similar to motifs for S. coelicolor, S. venezuelae, 
S. hygroscopicus and S. avermitilis (Figure 3-8 and Figure 3-11). 
 
S. coelicolor A3(2) (19,341 bp)
1 kb
S. avermitilis MA-4680 (50,462 bp)
1kb
S. hygroscopicus subsp. Jinggangensis 5008 (17,307 bp)
1kb
S. venezuelae ATCC 10712 (11,669 bp)
S. sclerotialus NRRL ISP-5269 (19,981 bp)
1 kb
1 kb
K. cheerisanensis KCTC 2395 (23,758 bp)
1 kb
S. sp. HGB0020 (16,378 bp) 
S. roseochromogenes subsp. Oscitans DC 12.976 (13,607 bp)
1 kb
mmfR
mmfL
mmfP
mmfH
mmyR
mmyB
1kb
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Figure 3-11 – Refined consensus ARE motifs for S. sclerotialus, S. sp. HGB0020, 
S. roseochromogenes and K. cheerisaenensis. 
 
ARE sequences were found in the promoters of TetR repressor genes, mmfL-like 
genes and putative pathway-specific transcriptional activators or biosynthetic 
genes (Figure 3-10 and Table 3-4). Surprisingly, the gene organisation of the 
putative AHFCA signalling gene clusters are not as well conserved in 
S. roseochromogenes and in S. sp. HGB0020. In S. roseochromogenes, the analogous 
mmfL gene is not divergently adjacent to a TetR repressor, but divergently adjacent 
to a putative SARP transcriptional activator and in S. sp. HGB0020, the analogous 
mmfH gene is over 12 kb away from the mmfL analogue (Figure 3-10).  
 
The mechanism of AHFCA-dependent regulation in S. roseochromogenes is 
intriguing as the mmfL gene is divergently adjacent to the putative SARP 
S. sclerotialus NRRL ISP-5269
S. sp. HGB0020
S. roseochromogenes subsp
Oscitans DC 12.976
K. cheerisanensis KCTC 2395
E-value: 9.0e-004
E- value: 8.5e-022
E-value: 2.1e-005
E-value: 8.4e-007
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transcriptional activator and suggests the derepression of the system immediately 
allows expression of both genes. MEME enrichment analysis was also able to reveal 
two ARE sequences within the m878_26325 - m878_26320 intergenic region and 
most interestingly, the sequence directly upstream of the m878_26325 (mmfL-like) 
is not as palindromic as the sequence directly upstream of m878_26320 (Figure 3-10 
and Table 3-4); suggesting that the TetR repressors may have different affinities to 
the two ARE sequences within this specific intergenic region. 
 
MEME enrichment analysis successfully revealed ARE sequences in promoters of 
putative pathway-specific transcriptional activators in S. coelicolor, S. avermitilis, 
S. hygroscopicus and S. roseochromogenes (Figure 3-10, Table 3-3 and Table 3-4). 
The TetR repressors are hypothesised to bind to specific ARE sequence and tightly 
regulate expression of transcriptional activators; the expression of transcriptional 
activators amplifies signals for biosynthesis of metabolites. Overexpression of 
mmyB, sav_2301, shjg_7324 and m878_26320 transcriptional activators in their 
respective bacterium is expected to drive expression of cryptic biosynthetic gene 
clusters and overproduce the compounds of interest.  
 
 
 
 
 
 
 
Chapter 3: AHFCA-dependent Signalling Systems 
75 
 
Table 3-4 – ARE sequence upstream of putative pathway-specific transcriptional 
activators/ biosynthetic genes in S. sclerotialus, S. sp. HGB0020, 
S. roseochromogenes and K. cheerisanensis. 
Organism/gene 
downstream of ARE 
sequence 
bp 
upstream 
of start 
codon 
Proposed function ARE sequence 
S. sclerotialus 
orf1 
43 
Non-ribosomal 
peptide synthetase 
ATACCTCCGCGAAGGAAT 
S. sclerotialus 
ig96_rs0135515 
52 QncM-like ACP ATCCCAATGAGAAAAGAT 
S. sp. HGB0020 
hmpref1211_06619 
6 
Methylmalonyl-CoA 
carboxyltransferase 
TTAAAAAACCTTCACGAAGGAATTTAAA 
S. roseochromogenes 
m878_26320 
22 
156 
SARP family  
transcriptional 
activator 
AAAAAACCTACGGGACAGAATATT 
ATAAAACCTTCTCGAAGGTATCTT 
K. cheerisaenensis 
kch_13110 
117 
3-oxoacyl-ACP 
reductase 
AAAATACCTTCCCAAAGGTATGTT 
Putative transcriptional activators are highlighted in green.  
Palindromic sequences are highlighted in red. 
 
In the remaining 4 neighbouring cryptic biosynthetic gene clusters, MEME 
enrichment analyses were unable to identify ARE sequences upstream of putative 
transcriptional activators and this is explained from bioinformatic analyses; which 
suggests there are no cluster-situated transcriptional activator genes (Figure 3-10). 
Overexpression of transcriptional activator to discover products of cryptic 
biosynthetic gene clusters cannot be employed in S. venezuelae, S. sclerotialus, 
S. sp. HGB0020 and K. cheerisaenensis. To overcome this problem, genetic 
inactivation of analogous mmyR repressor in methylenomycin and gaburedin 
biosynthetic gene cluster unlocked the production of specific compounds; thus, the 
deletion of mmyR-like transcriptional repressor in all of the putative 
AHFCA-dependent signalling systems is expected to unlock the production of 
compounds from neighbouring cryptic biosynthetic gene clusters, as well as AHFCA 
signalling molecules (Figure 3-12). 57,62 Gene annotations for the 8 putative 
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AHFCA-dependent biosynthetic gene clusters and the identification of MmyR 
analogue are detailed in Appendix D to Appendix K. 
 
 
Figure 3-12 – Deletion of mmyR-like repressor (light blue) is expected to unlock the 
production of specific specialised metabolites and AHFCA signalling molecules (red 
circles). 
 
3.6. Acquisition of AHFCA-dependent signalling systems by horizontal 
transfer  
The ARE sequences, which are positioned in promoters of putative transcriptional 
activators and biosynthetic genes, vary significantly (Table 3-3 and Table 3-4) and 
the similarlity of ARE sequences were investigated by phylogenetic analysis (Figure 
3-13).  
 
The bootstrap consensus phylogenetic tree reveals that the ARE sequences appear 
to cluster according to their location within the AHFCA signalling gene cluster; for 
example, with the exception of hmpref1211_06616 sequence, all of the mmfL-like 
Biosynthesis of 
specialised metabolites
AHFCA 
signalling molecule
MmyR-like
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ARE sequences are within the same clade and implies the ARE sequences upstream 
of mmfL-like genes are most similar to each other (Figure 3-13).  
 
The same clustering pattern can be observed for the other signalling genes (Figure 
3-13). Intriguingly, ARE sequences that are located upstream of putative 
pathway-specific transcriptional activators do not cluster together and suggests the 
ARE sequences are not similar to each other (Figure 3-13, Table 3-3 and Table 3-4). 
To tightly regulate neighbouring cryptic biosynthetic gene cluster, it is essential for 
TetR repressors to bind strongly to the ARE sequence. ARE sequences upstream of 
the transcriptional activators/ biosynthetic genes are likely to have evolved 
individually over time to maximise its binding affinity to the TetR repressors. 
Clustering of ARE sequences upstream of specific AHFCA signalling genes implies 
the sequences have also evolved over time to optimise its binding strength to 
regulate specific genes functions. These observations were supported by 
preliminary in vivo luciferase assay results where MmfR demonstrated the strongest 
binding to the ARE sequence upstream of mmyB and the  ARE sequence upstream of 
the mmfL promoter showed the weakest binding affinity (Styles, K. Personal 
communication). 
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Figure 3-13 – ARE sequences are clustering according to their respective locations 
in the AHFCA signalling gene cluster. ARE sequences were aligned using Multiple 
Sequence Comparison by Log Expectation (MUSCLE) and bootstrap consensus tree 
was inferred using the maximum likelihood clustering method after 1000 
iterations. Genes with analogous functions are colour-coded. 
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Different cryptic biosynthetic gene clusters were located adjacent to conserved 
AHFCA signalling gene clusters and observations from phylogenetic analysis, 
suggests the AHFCA signalling gene clusters were likely acquired by Streptomyces 
bacteria through horizontal transfer. The selective advantage for acquiring 
AHFCA-dependent signalling system would allow the bacteria to tightly regulate 
expression of specialised metabolites biosynthetic gene cluster, in consequence 
more energy and metabolic flux are available for other essential biological 
functions.  95 
  
To further investigate differences/ similarities between ARE sequences at the 
nucleotide level (Figure 3-13), ARE sequences from each clade within the 
phylogenetic tree were submitted through the MEME program (Figure 3-14). 
Consensus motifs for AHFCA signalling genes reveal small differences (Figure 3-14). 
Out of the 4 motifs, the mmyR-like motif appears to be the least conserved with only 
7 nucleotides fully conserved in the motif, whilst mmfH-like, mmfR-like and 
mmfL-like motifs have at least 16 nucleotides conserved (Figure 3-14). A possible 
explanation for the varied ARE sequence upstream of MmyR-like repressor could be 
due to the predictive function of MmyR-like repressors. The MmyR repressor is 
speculated to act as an off-switch to turn off methylenomycin production and 
binding affinity to ARE sequence upstream of mmyR-like genes has most likely 
refined over time within Streptomyces bacteria to prevent untimely inhibition. The 
previously described “variable” region are also surprisingly well conserved in the 
consensus motifs (Figure 3-14). Selective conservation of the “variable” region 
would collectively contribute to binding affinity of TetR repressors. 
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Figure 3-14 – Consensus ARE sequences upstream of AHFCA signalling genes. The 
“conserved” regions from Figure 3-8 are highlighted in a grey box. 
 
3.7. Conclusions 
The production of metabolites from cryptic biosynthetic gene clusters are most 
often tightly regulated at the transcriptional level, and are silent or produced in very 
small quantities in laboratory conditions. 
 
The AHFCA-dependent signalling system, which is governed by the two TetR 
repressors, is an example of complex regulatory networks involved in controlling 
expression of cryptic biosynthetic gene clusters. From phylogenetic analyses, 
Streptomyces bacteria are speculated to have acquired AHFCA-dependent signalling 
MmfL-like
MmfR-like
MmfH-like
MmyR-like E-value : 2.2e-016
E-value : 1.5e-007
E-value : 8.3e-039
E-value : 5.1e-030
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system by horizontal transfer to regulate neighbouring biosynthetic gene clusters. 
Using bioinformatic tools, such as MEME and FIMO, TetR repressor binding sites 
were successfully identified in the methylenomycin biosynthetic gene cluster and 
were consistent with published preliminary bioinformatic analysis. 57 Genome 
mining analyses identified 7 additional putative AHFCA-dependent signalling 
systems and MEME enrichment analysis successfully revealed TetR binding sites in 
all of the systems. The TetR binding sites were located in the promoters of key 
regulatory genes, including putative transcriptional activators and TetR repressors. 
Specific inactivation of mmyR-like repressor, as well as the overexpression of 
putative transcriptional activators is expected to unlock the production of 
compounds from neighbouring cryptic biosynthetic gene clusters.  
 
MEME enrichment analysis has proven to be an immensly powerful tool at gaining 
insights into complex regulatory networks. Exploitations of AHFCA-dependent 
signalling systems should lead to the discovery of novel specialised metabolites. 
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4. GBL-dependent Signalling Systems 
The AHFCA class of compounds is an example of small diffusible signalling 
molecules involved in switching on the production of bioactive metabolites. Other 
signalling molecules, such as the γ-butyrolactones (Figure 1-15), derived from 
intermediates in fatty acid metabolism and glycolysis have been discovered and are 
also involved in regulating the production of natural compounds from cryptic 
biosynthetic gene clusters. 92,95 
4.1. MEME enrichment analysis of the SCB/ScbR/ScbR2 system 
To demonstrate whether the MEME enrichment analysis could predict TetR 
repressor binding sites in other analogous regulatory systems, the same analysis 
was performed on the extensively studied SCB/ScbR/ScbR2 system, which controls 
coelimycin biosynthesis in S. coelicolor (discussed in Chapter 1.5.2). 117,121 Previous 
published results have shown that both ScbR and ScbR2 repressors can bind to 
highly conserved semi-palindromic ARE sequences within the scbR - scbA intergenic 
region and the promoter of cpkO, which encodes for a SARP transcriptional activator 
(Figure 4-1). 98,99,117,120,140 
 
MEME enrichment analysis was successful at finding both SiteA and SiteR in the 
scbR - scbA intergenic region and SiteOB in the promoter of cpkO, as well as an ARE 
sequence upstream of cpkN (Figure 4-1, Figure 4-2 and Electronic Supplementary 
Material). The MEME analysis enriches for highly conserved sequences and despite 
the palindromic nature of SiteOA, the failure to identify SiteOA suggests it is not as 
well conserved as the other three ARE sequences (Figure 1-18).  
Chapter 4: GBL-dependent Signalling Systems 
83 
 
 
Figure 4-1 – MEME enrichment analysis was able to discover the ARE sequences 
(turquoise box) in the (a) scbR - scbA (sco6265 - sco6266) intergenic region and (b) 
the promoter of cpkO (sco6280). The experimentally confirmed ScbR binding sites 
are underlined in black. 
 
MEME enrichment analysis of AHFCA-dependent signalling systems identified ARE 
sequences located upstream of both TetR repressors; however, in the 
SCB/ScbR/ScbR2 system, MEME enrichment analysis could not find any binding 
sites upstream of scbR2 and suggests the TetR repressors do not directly regulate 
expression of scbR2 repressor. Interestingly, temporal expression analysis have 
shown that the production of ScbR2 is delayed and is expressed after ScbR; the delay 
SiteA
SiteR
SiteOA
SiteOB
a) scbR - scbA (sco6265 – sco6266)
b) Upstream of cpkO (sco6280)
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in expression implies other transcriptional factors are regulating expression of 
scbR2. 140  
 
Although the MEME enrichment analysis has proven to be an incredibly powerful 
approach to discover TetR binding sites, the bioinformatic analysis alone cannot 
deduce which repressor can bind to the ARE sequences. MEME enrichment analysis 
was only able to identify SiteOB within the cpkO promoter and results from EMSA 
experiments have also shown ScbR2 repressor can bind to SiteOB and not 
SiteOA.  120,140 The MEME enrichment analysis might be bias towards the prediction 
of ScbR2 binding sites; this is further supported by the experimentally confirmed 
binding of ScbR2 to the cpkN promoter, which was reported by Li and co-workers, 
and the successful identification of the ARE sequence located in the cpkN 
promoter.  117,140  
 
As for the AHFCA-dependent signalling systems, early experimental results have 
demonstrated the MmfR-like repressors can bind to the ARE sequences within their 
respective cryptic biosynthetic gene clusters (Harrison, P., Malet, N., Zhou, S., 
Styles, K. and Fullwood, A. Personal communication) and the analogous MmyR 
repressor exhibited very weak or no binding to the same ARE sequences (Fullwood, 
A. and Styles, K. Personal communication); these observations suggests the MEME 
enrichment analysis might also be bias towards predicting MmfR-like binding sites. 
 
Half palindromic sequences within the mmr - mmyJ (scp1.237c - scp1.238) 
intergenic region and upstream of mmyQ (scp1.231) and mmyT (scp1.241c) (Table 
4-1) were observed within the methylenomycin biosynthetic gene cluster. 57 The 
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binding of MmfR or MmyR repressors to the half palindromic sites have not been 
investigated; however, the homodimeric repressors are speculated to bind loosly 
with the half palindromic sequences. Alternatively, the half-palindromic sequences 
could be the binding sites for the MmyR repressor. 
 
Table 4-1 – Half palindromic sequences in the methylenomycin gene cluster. 
Start End 
Half 
palindrome 
ARE sequence 
bp upstream 
of start codon 
Gene 
downstream of 
sequence 
3756 3764 ATACCTGCG 33 scp1.231 (mmyQ) 
12349 12357 GTCGGGTAT 187 scp1.238 (mmyJ) 
12349 12357 ATACCCGAC 20 scp1.237c (mmr) 
16127 16135 TTACGTTCT 58 scp1.241c (mmyT) 
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Figure 4-2 – MEME enrichment analysis of the SCB/ScbR/ScbR2 system identified 
(a) highly conserved ARE sequences and (b) are location upstream of sco6265, 
sco6266, sco6280 and sco6288 genes, which encode for the TetR repressor (blue), 
ScbA biosynthetic enzyme (red) and the CpkO and CpkN SARP transcriptional 
activators (green) respectively. 
 
A combination of ChIP-seq, transcriptome and EMSA analysis carried out by Li and 
co-workers discovered several additional ScbR and ScbR2 binding sites within the 
cpk gene cluster. 140 Both ScbR and ScbR2 repressors bound upstream of cpkM 
(sco6268) and only the ScbR2 repressor was confirmed to bind to the accA1 - scF 
(sco6271 - sco6272), cpkA - cpkD (sco6275 - sco6276) and cpkI - cpkJ 
(sco6282 - sco6283) intergenic regions; demonstrating that ScbR2 has different 
binding specificities to ScbR repressor. 140 The SCB/ScbR/ScbR2 system appears to 
be incredibly complicated and the TetR repressors were discovered to bind to 
several targets across the genome including other specialised metabolite 
biosynthetic gene clusters. 140  
(6884138 to 6952430 bps)
6900000 6920000 6940000
ARE ARE AREARE
a)
b)
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FIMO results for the SCB/ScbR/ScbR2 system, which contained a total of 785 
individual hits, were analysed in detail to discover potential binding sites across the 
S. coelicolor genome (Electronic Supplementary Material). Binding sites located 
within the promoters of genes (300 bp from start codon) were investigated 
(Electronic Supplementary Material); it should be noted that some binding sites 
would have been missed because individual hits were located more than 300 bp 
away from the predicted ORF's start codon. From the 785 individual hits, 202 
binding sites were located in the promoters of ORFs; however, the MEME 
enrichment analysis was only able to identify two binding sites, which were 
consistent with published experimental results (sco4921 and sco6312) (Table 
4-2). 140 
 
The sco4921 and sco6312 genes encodes for AccA2 acetyl-Coenzyme A (CoA) 
carboxylase and CprA TetR transcriptional repressor respectively. The AccA2 
enzyme is an essential enzyme in S. coelicolor and is involved in the carboxylation of 
acetyl-CoA to malonyl-CoA, which are precursors for fatty acid biosynthesis and 
polyketide biosynthesis, such as actinorhodin and coelimycin. 146 CprA is an 
ArpA-like transcriptional repressor and the exact biological role of CprA is not clear, 
but CprA is known to regulate metabolite production and morphological 
differentiation. 147 The direct regulation of accA2 and cprA is proposed to alter the 
production of other metabolites in S. coelicolor and redirect the metabolix flux of 
primary precursors. 
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Table 4-2 – Predicted ScbR/ScbR2 binding sites upstream of cprA and accA2. 
Start End ARE sequence 
bp upstream 
of start 
codon 
Gene 
downstream of 
ARE sequence 
5357259 5357280 AAAGAAACCGCGTGGCCCGCAG 203 sco4921 (accA2) 
6972702 6972723 AAAACAGGCACACGGTCTGTTG 26 sco6312 (cprA) 
 
The failure to find the other experimentally confirmed ScbR and ScbR2 binding sites 
is suspected to be due to the strict nature of the algorithm. The FIMO program 
searches for individual hits according to the initial motif (positional weight matrix) 
and consequently does not account for gap sequences. Many of the experimentally 
confirmed binding sites contained different length of “variable” spacers and in some 
binding sequences, only one half of the palindrome sequence were present; these 
sequences would have been significantly different to the initial motif and would not 
have been picked up by FIMO. 140 Nevertheless, the MEME enrichment analysis was 
successful at identifying binding sequences upstream of the key regulatory genes 
within the coelimycin biosynthetic gene cluster. 
 
4.2. MEME enrichment analysis of putative GBL-dependent signalling 
systems in Streptomyces bacteria 
As of July 2014, the NCBI database contained 20 completely sequenced Streptomyces 
genomes and from these genomes, 679 cryptic specialised metabolites were 
predicted by AntiSMASH (Table 4-3). 133 Based on the identification of the afsA-like 
gene, 36 of these cryptic biosynthetic gene clusters are proposed to be under the 
control of regulation systems dependent on butenolide-derived signalling 
molecules (Table 4-3 and Electronic Supplementary Material). 94 The predicted 
GBL-dependent signalling systems were further investigated using MEME 
Chapter 4: GBL-dependent Signalling Systems 
89 
 
enrichment analysis, not only to determine the binding sites for the TetR repressors, 
but also to examine the effectiveness of the bioinformatic approach at predicting 
other regulation systems (Electronic Supplementary Material). 
 
Table 4-3 – Genome information of sequenced Streptomyces bacteria. 
Streptomyces Organism 
Size 
(Mb) 
GC % ORF 
Metabolite 
clusters 
Butyrolactone-like 
clusters 
S. albulus NK660 9.37 72.3 8,238 40 5 
S. albulus NK660 
(pNKL plasmid) 
0.01 71.2 22 0 0 
S. albus J1074 6.84 73.3 5,937 23 0 
S. avermitilis MA-4680 9.12 70.7 7,765 23 2 
S. avermitilis MA-4680  
(SAP1 plasmid) 
0.09 69.2 96 0 0 
S. bingchenggensis BCW-1 11.94 70.8 10,107 49 1 
S. cattleya NRRL 8057 8.09 73.0 7,580 27 3 
S. cattleya NRRL 8057  
(pSCATT plasmid) 
1.81 73.3 1,714 15 1 
S. coelicolor A3(2) 9.05 72.0 8,299 23 1 
S. coelicolor A3(2)  
(SCP1 plasmid) 
0.36 69.1 355 2 1 
S. coelicolor A3(2)  
(SCP2 plasmid) 
0.03 72.1 34 0 0 
S. collinus Tu 365 8.38 72.6 7,207 32 0 
S. collinus Tu 365  
(pSCO1 plasmid) 
0.09 68.3 78 0 0 
S. collinus Tu 365  
(pSCO2 plasmid) 
0.02 69.9 30 0 0 
S. davawensis JCM 4913 9.56 70.6 8,697 35 1 
S. davawensis JCM 4913  
(pSDA1 plasmid) 
0.09 69.9 113 0 0 
S. fulvissimus DSM 40593 7.91 71.5 7,027 35 1 
S. hygroscopicus subsp. Jinggangensis 
5008 
10.38 71.9 9,194 39 3 
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S. hygroscopicus subsp. Jinggangensis 
5008 (pSHJG1 plasmid) 
0.16 69.0 183 0 0 
S. hygroscopicus subsp. Jinggangensis 
5008 (pSHJG2 plasmid) 
0.07 70.9 75 0 0 
S. niveus NCIMB 11891 8.73 70.3 7,679 28 1 
S. niveus NCIMB 11891  
(pSniv1 plasmid) 
0.12 68.6 101 1 0 
S. niveus NCIMB 11891  
(pSniv2 plasmid) 
0.05 71.4 53 0 0 
S. niveus NCIMB 11891  
(pSniv3 plasmid) 
0.01 69.0 18 0 0 
S. niveus NCIMB 11891  
(pSniv4 plasmid) 
0.02 67.4 17 0 0 
S. pratensis ATCC 33331 7.66 71.0 6,857 27 2 
S. pratensis ATCC 33331  
(pSFLA01 plasmid) 
0.19 67.8 200 0 0 
S. pratensis ATCC 33331  
(pSFLA01 plasmid) 
0.13 67.2 126 0 0 
S. pristinaespiralis ATCC 25386 8.13 69.7 7,077 20 0 
S. rapamycinicus NRRL 5491 12.70 70.6 10,144 48 2 
S. roseochromogenes subsp. Oscitans 
DS 12.976 
9.77 70.6 8,808 43 2 
S. roseochromogenes subsp. Oscitans 
DS 12.976 (pSros1 plasmid) 
0.20 69.2 134 0 0 
S. scabiei 87.22 10.15 71.5 8,901 34 2 
S. griseus subsp. Griseus NBRC 13350 8.55 72.2 7,224 39 1 
S. sviceus ATCC 29083 9.31 69.8 8,464 25 2 
S. venezuelae ATCC 10712 8.23 72.4 7,536 31 3 
S. violaceusniger Tu 4113 11.14 70.9 9,610 39 1 
S. violaceusniger Tu 4113  
(pSTRVI01 plasmid) 
0.29 68.2 298 1 1 
S. violaceusniger Tu 4113  
(pSTRVI02 plasmid) 
0.19 69.7 250 0 0 
   Total 679 36 
 
The 36 putative GBL-dependent signalling systems also include the five previously 
analysed AHFCA-dependent signallng systems in S. avermitilis, S. coelicolor, 
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S. hygroscopicus, S. roseochromogenes and S. venezuelae (Figure 3-8, Figure 3-10 and 
Figure 3-11) as well as the SCB/ScbR/ScbR2 system (Figure 4-2). For the remaining 
30 putative GBL-dependent signalling systems, MEME enrichment analysis 
successfully discovered conserved semi-palindromic ARE sequences in 12 gene 
clusters (Figure 4-3 and Figure 4-4). The consensus ARE motifs are listed in Figure 
4-3 and correspond to the gene clusters in Figure 4-4 (Electronic Supplementary 
Material). 
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Figure 4-3 – Motifs for putative GBL-dependent signalling systems; the TetR 
repressors are proposed to bind to ARE sequences to regulate biosynthetic genes. 
Consensus motifs correspond to cryptic biosynthetic gene clusters listed in Figure 
4-4.  
 
E-value 4.6e-004
Streptomyces albulus NK660
E-value 1.1e-002
Streptomyces davawensis JCM 4913
E-value 1.2e-002 E-value 5.4e+001
Streptomyces fulvissimus DSM 40593
E-value 5.8e-010
Streptomyces hygroscopicus subsp. Jinggangensis 5008
E-value 2.8e-006 E-value 5.1e-023
Streptomyces pratensis ATCC 33331
E-value 3.2e-010
Streptomyces rapamycinicus NRRL 5491 
E-value 1.2e+000
Streptomyces roseochromogenes subsp. Oscitans DS 12.976 
E-value 2.1e-005
E-value 9.8e-007 E-value 5.8e-003
a) b)
a) b)
a)
a) b)
a) a)
a)
a) a)
Streptomyces sviceus ATCC 29083 Streptomyces scabiei 87.22 
Chapter 4: GBL-dependent Signalling Systems 
93 
 
 
Figure 4-4 – Putative GBL signalling gene clusters are adjacent to cryptic 
biosynthetic gene clusters. Analogous regulatory genes are colour-coded; TetR 
repressors (blue); A-factor biosynthesis enzyme (red); transcriptional activator 
(green). Predicted TetR binding sites (ARE) are highlighted as a turquoise box and 
black lines represent 1 kb in length. 
 
The GBL consensus motifs (Figure 4-3) share characteristic patterns with the 
AHFCA consensus motifs (Figure 3-8 and Figure 3-11); the highly conserved 
extremities of the consensus motifs primarily consists of As and Ts, whilst the 
"variable" spacer region consists of Cs and Gs. In addition, the ARE sequences are 
always found in the intergenic region between the TetR repressor and afsA-like gene 
(Figure 4-4 and Table 4-4); however, in Streptomyces sviceus ATCC 29083, the ARE 
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sequence could not be identified upstream of the afsA-like gene, but was found in 
the promoters of putative transcriptional activators and biosynthetic genes (Figure 
4-4). The failure to identify ARE sequence may be due to sequencing errors of the 
genome or alternatively, the putative GBL-dependent signalling system in S. sviceus 
may have a novel transcriptional regulation mechanism to control the neighbouring 
cryptic biosynthetic gene cluster. 
 
Unlike the GBL consensus motifs, the ARE sequences in AHFCA-dependent 
signalling systems are conserved across the Streptomyces bacteria (Figure 4-3), and 
implies the GBL-dependent signalling systems have likely evolved for a longer 
period of time and novel regulations systems may have branched off and developed. 
Furthermore, the organisation of putative GBL signalling gene clusters (Figure 4-4) 
are not as well conserved and clustered as the AHFCA signalling genes (Figure 3-10); 
however, in both regulation systems, the TetR repressor gene is always divergent 
and adjacent to the afsA-like gene (Figure 3-10 and Figure 4-4).  
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Table 4-4 – ARE sequences identified in GBL-dependent signalling systems. 
Organism (cluster) 
Gene downstream 
of ARE sequence 
ARE sequence 
bp 
upstream 
of start 
codon 
Proposed function 
S. albulus (a) 
dc74_7607 
ATAAATAACGTTCTCTAT 85 
A-factor 
biosynthesis 
enzyme 
S. albulus (a) 
dc74_7608 
ATAGAGAACGTTATTTAT 27 
TetR family 
transcriptional 
repressor 
S. albulus (a) 
dc74_7615 
AAAGATAGCGCTCTTTAT 138 
Short-chain 
dehydrogenase/ 
reductase 
S. albulus (a) 
dc74_7616 
ATAAAGAGCGCTATCTTT 249 
Nitrate/nitrite 
sensor protein 
S. albulus (b) 
dc74_7317 
CGTGATCTCACCCGGATGGTTGGGATCCCG 97 
Hypothetical 
protein 
S. albulus (b) 
dc74_7317 
CGGGATCCCAACCATCCGGGTGAGATCACG 100 
Hypothetical 
protein 
S. albulus (b) 
dc74_7322 
TAAGATACGTACCATCCGGTTTTCTTTTCA 136 
TetR family 
transcriptional 
repressor 
S. albulus (b) 
dc74_7321 
TGAAAAGAAAACCGGATGGTACGTATCTTA 43 
A-factor 
biosynthesis 
enzyme 
S. davawensis (a) 
bn159_4439 
AAGATACAAGCATGCGGGTATGTT 76 
TetR family 
transcriptional 
repressor 
S. davawensis (a) 
bn159_4440 
AACATACCCGCATGCTTGTATCTT 59 
A-factor 
biosynthesis 
enzyme 
S. davawensis (a) 
bn159_4436 
AGAAAACCCGCATGCGGGTATGTT -5 
AraC family 
transcriptional 
regulator 
S. davawensis (b) 
bn159_2279 
TTGAAAACAAACCGGTCGGCTCGTACTCTA 60 
A-factor 
biosynthesis 
enzyme 
S. davawensis (b) 
bn159_2280 
TAGAGTACGAGCCGACCGGTTTGTTTTCAA 86 
TetR family 
transcriptional 
repressor 
S. davawensis (b) 
bn159_2278 
TGAAAAACAAACGGCATGACCCGTTCGTTT 19 
TetR family 
transcriptional 
repressor 
S. fulvissimus (a) 
sful_260 
AAACCACACCCACTAAGTGGTTAGTAAG 116 
TetR family 
transcriptional 
repressor 
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S. fulvissimus (a) 
sful_261 
CTTACTAACCACTTAGTGGGTGTGGTTT 71 
Glucan endo-1,6-
beta-glucosidase 
S. fulvissimus (a) 
sful_269 
AAATCAAACCGGTAAGTTGGTTTGATAT 121 
TetR family 
transcriptional 
repressor 
S. fulvissimus (a) 
sful_271 
AAAAAAAACCGCTTAGTCTGTATCTTAT 56 
A-factor 
biosynthesis 
enzyme 
S. fulvissimus (a) 
sful_272 
ATAAGATACAGACTAAGCGGTTTTTTTT 61 
TetR family 
transcriptional 
repressor 
S. hygroscopicus (a) 
shjg_4003 
AAGATAGAGATAGTTCTTTTTT 75 
TetR family 
transcriptional 
repressor 
S. hygroscopicus (a) 
shjg_4004 
AAAAAAGAACTATCTCTATCTT 79 
A-factor 
biosynthesis 
enzyme 
S. hygroscopicus (a) 
shjg_4000 
AAGAGAGTAATATTTTTTATTT 182 
TetR family 
transcriptional 
repressor 
S. hygroscopicus (a) 
shjg_3999 
AAATAAAAAATATTACTCTCTT 132 
DNA-binding 
protein 
S. hygroscopicus (b) 
shjg_8650 
ACATAGATAGCGTCATTTATGT 49 
A-factor 
biosynthesis 
enzyme 
S. hygroscopicus (b) 
shjg_8651 
ACATAAATGACGCTATCTATGT 20 
TetR family 
transcriptional 
repressor 
S. hygroscopicus (b) 
shjg_8657 
GCATAAATAGCGTTATCTATCT 747 
StrR-like regulatory 
protein 
S. hygroscopicus (b) 
shjg_8656 
AGATAGATAACGCTATTTATGC 98 
StrR-like regulatory 
protein 
S. hygroscopicus (b) 
shjg_8656 
GCATAAAGAGCGCTATTCATGT 269 
StrR-like regulatory 
protein 
S. hygroscopicus (b) 
shjg_8657 
ACATGAATAGCGCTCTTTATGC 576 
StrR-like regulatory 
protein 
S. pratensis (a) 
sfla_6322 
AAGTAACATAGGGATTACTATTTTAATT 22 
TetR family 
transcriptional 
repressor 
S. pratensis (a) 
sfla_6323 
AATTAAAATAGTAATCCCTATGTTACTT 71 
A-factor 
biosynthesis 
enzyme 
S. pratensis (a) 
sfla_6320 
ATAAAAAATAGCGAACTCTATTATTCTT 33 
TylR-like regulatory 
protein 
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S. pratensis (a) 
sfla_6319 
AAGAATAATAGAGTTCGCTATTTTTTAT 363 
TetR family 
transcriptional 
repressor 
S. rapamycinicus (a) 
m271_07485 
TCAAACATTATTAGTATTTTA 2 
A-factor 
biosynthesis 
enzyme 
S. rapamycinicus (a) 
m271_07490 
TAAAATACTAATAATGTTTGA 82 
TetR family 
transcriptional 
repressor 
S. rapamycinicus (a) 
m271_07475 
ACAACCACTACTTTTGGTCCA 66 
Hypothetical 
protein 
S. rapamycinicus (a) 
m271_07480 
TCAAACTAACGTAGTGATCGT 155 Hydrolase 
S. roseochromogenes 
(a) m878_11420 
AAAACCGATCAGTCAGTTTT 58 
A-factor 
biosynthesis 
enzyme 
S. roseochromogenes 
(a) m878_11425 
AAAACTGACTGATCGGTTTT 175 
A-factor 
biosynthesis 
enzyme 
S. roseochromogenes 
(a) m878_11395 
CAAACCAGACGATCGGTTTT 223 
TetR family 
transcriptional 
repressor 
S. roseochromogenes 
(a) m878_11390 
AAAACCGATCGTCTGGTTTG 57 
StrR-like regulatory 
protein 
S. roseochromogenes 
(a) m878_11425 
CAAACAAACCATCCAGTTGT 95 
A-factor 
biosynthesis 
enzyme 
S. roseochromogenes 
(a) m878_11420 
ACAACTGGATGGTTTGTTTG 138 
A-factor 
biosynthesis 
enzyme 
S. scabiei (a) 
scab_12101 
AATAAACCAACCGTGCGGTATATT 68 
TetR family 
transcriptional 
repressor 
S. scabiei (a) 
scab_12111 
AATATACCGCACGGTTGGTTTATT 74 Transposase 
S. scabiei (a) 
scab_12081 
ACAATACAGGTCAGCCGGTTTTTT 53 
A-factor 
biosynthesis 
enzyme 
S. scabiei (a) 
scab_12091 
AAAAAACCGGCTGACCTGTATTGT 100 
TetR family 
transcriptional 
repressor 
S. scabiei (a) 
scab_12101 
AGAAAACCAACCGTCCGGTATTGT 142 
TetR family 
transcriptional 
repressor 
S. scabiei (a) 
scab_12111 
ACAATACCGGACGGTTGGTTTTCT 0 Transposase 
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S. sviceus (a) 
sseg_05943 
AAAAAGATGACATAGGTTT 122 
DNA-binding 
protein 
S. sviceus (a) 
sseg_05944 
AAACCTATGTCATCTTTTT -56 
Hypothetical 
protein 
S. sviceus (a) 
sseg_11168 
AAACGGATGTGATCGTTGT 22 
Monooxygenase, 
FAD-binding 
S. sviceus (a) 
sseg_02730 
AAACCGATGAGTAGGTTTT 37 
Phosphate regulon 
regulatory protein 
S. sviceus (a) 
sseg_02731 
AAAACCTACTCATCGGTTT 521 
TetR family 
transcriptional 
repressor 
S. sviceus (a) 
sseg_02728 
ACACCCATGTCAGCAGTCT 612 
Acetyl-CoA 
carboxylase, biotin 
carboxylase 
S. sviceus (a) 
sseg_02730 
ACACCCATGTCAGCAGTCT 677 
Phosphate regulon 
regulatory protein 
Putative transcriptional activators are highlighted in green. 
 
4.3. Exploitation of putative signalling systems 
To our current knowledge, the putative GBL-dependent signalling systems have not 
been investigated and the exploitation of regulation systems is expected to unlock 
the production of novel natural compounds.  
 
In 7 of the GBL-dependent gene clusters, the MEME enrichment analysis successfully 
identified ARE sequences upstream of putative transcriptional activators 
(highlighted in green in Table 4-4). The specific overexpression of pathway-specific 
transcriptional activator is expected to increase expression of neighbouring cryptic 
biosynthetic gene clusters. Furthermore, in the partially characterised 
GBL-dependent regulatory systems of SCB/ScbR/ScbR2 in S. coelicolor and 
SVB/JadR3/JadR2 in S. venezuelae, the deletion of specific transcriptional 
repressors have resulted in the production of compounds from cryptic biosynthetic 
Chapter 4: GBL-dependent Signalling Systems 
99 
 
gene clusters; for instance, the deletion of scbR2 and jadR2 "pseudo" GBL receptors 
in S. coelicolor and S. venezuelae unlocked the production of coelimycin and 
jadomycin respectively. 121,148 To identify specific TetR repressor to inactivate, a 
phylogenetic analysis of all of the TetR repressors in the AHFCA/GBL dependent 
signalling systems were carried out (Figure 4-5).  
 
The phylogenetic tree reveals 4 main clades of receptors (Figure 4-5). Other 
“smaller” clades were also observed in the phylogenetic tree (Figure 4-5) and were 
primary found divergently adjacent to biosynthetic genes; the exact biological 
function or the cognate ligand for these TetR repressors are not known.  
 
The “cognate AHFCA binding receptor” clade consists of the analogous MmfR 
repressors and have been experimentally confirmed to bind to AHFCA signalling 
molecules (Malet, N. Zhou, S., Styles, K. and Fullwood, A. Personal communication). 
In the ““pseudo” AHFCA binding receptor” clade, which includes the paralogous 
MmyR repressors, in silico analysis and early investigations have shown the MmyR 
repressors do not bind to the same AHFCA signalling molecules (Styles, K. Personal 
communication).  
 
The deletion of "psuedo" AHFCA binding receptors in S. coelicolor and S. venezuelae 
resulted in the overproduction of methylenomycin and gaburedins respectively and 
hence, the deletion of MmyR orthologues is also expected to result in a similar 
phenotype in other cryptic biosynthetic gene clusters (Figure 4-5). 57,62  
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Figure 4-5 – Phylogenetic analysis reveals the TetR repressors are clustering into 
four clades. TetR repressor protein sequences were aligned using MUSCLE and 
phylogenetic tree was generated using maximum likelihood method. Bootstrap 
consensus tree was inferred from 1000 iterations.  
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Intriguingly, the M271_07490 repressor from S. rapamycinicus also falls into the 
“cognate AHFCA binding receptor” clade (Figure 4-5); this implies that the 
M271_07490 repressor share similar properties with MmfR and may interact with 
AHFCA-like signalling molecules. To determine whether M271_07490 could bind to 
AHFCA-like signalling molecules, the key amino acid residues required for binding 
with the cognate ligand were compared with analogous MmfR repressors. 
Co-crystallisation of MmfR with MMF2 has revealed Y85 and Y144 are directly 
involved in hydrogen bonding with the cognate ligand (Figure 4-6) and these amino 
acid residues are not present in the analogous MmyR repressors (Dean., R. et al. 
Manuscript in preparation).  
 
All of the MmfR analogues contain the conserved Y85 and Y144 residue, except for 
SHJG_7318, which has a phenylalanine residue instead of tyrosine at position 144. 
The M271_07490 repressor contains phenylalanine in both of the key amino acid 
positions and suggests M271_07490 may also bind to AHFCA-like signalling 
molecules. Of particular interest is that the cryptic biosynthetic gene cluster in 
S. rapamycinicus does not contain analogous mmfH or mmfP genes; therefore, the 
signalling system in S. rapamycinicus is proposed to be dependent on a novel class 
of signalling molecule. Alternatively, the cryptic biosynthetic gene cluster could 
cross-talk with other Streptomyces bacteria that produce AHFCA signalling 
molecules to coordinate the biosynthesis of specialised metabolites. 
 
Chapter 4: GBL-dependent Signalling Systems 
102 
 
 
Figure 4-6 – Clustal Omega alignment of the cognate AHFCA binding receptor clade. 
Residues proposed to be involved in hydrogen bond with the cognate AHFCA ligand 
are highlighted in pale red. 
 
There are also two separate clades for the GBL binding receptors (Figure 4-5). Based 
on the TetR repressors in jadomycin and coelimycin biosynthetic gene clusters, the 
““real” GBL binding receptor” were reported to bind to GBL signalling molecules, 
whilst the ““pseudo” GBL binding receptor” do not bind to the same GBL molecules, 
but to structurally diverse metabolites, such as actinorhodin, undecylprodigiosin 
and jadomycin. 98,99,117,139 In addition, the deletion of sco6286, which encodes for the 
ScbR2 “pseudo” binding receptor, resulted in the production of coelimycin in 
S. coelicolor. 115,121 Therefore, the deletion of these specific “pseudo” GBL receptors 
in putative GBL-dependent regulatory systems is expected to unlock the production 
of compounds from cryptic biosynthetic gene clusters. 
 
Some of the putative GBL-dependent signalling systems contain a varied number of 
TetR repressor genes; for example, the putative GBL-dependent signalling systems 
in S. albulus, S. davawensis and S. rapamycinicus appears to be under the control of a 
single TetR repressor whilst S. fulvissimus contains five TetR repressors. From the 
predictions of ARE sequences, the transcriptional regulation of these cryptic 
biosynthetic gene clusters could function differently and novel mechanisms could 
have evolved. 
M271_07490            VVEEHFATWPPLIERF-20-AFRDDIVVRAGARLWAERTLIEAPMPPPFVGWID
KCH_13230             VVEALYATWPRTLEAV-20-AFLNDPIMQAGTRLQNERDVIDVELPLPYVDWTT
SCP1.242c             VVEEHYARWPAAMEEI-20-AFRDDPVMQAGARLQSERAFIDAELPLPYVDWTH
M878_26345            VVEAHYSRWPELLEGI-20-AFATDIVVQAGARLQLERSLIDAQLPQPYVGWTQ
SAV_2270              VLEEFYRRMQEAVNGA-21-AFHEDVFIHAGARLQIERPYIKAELPVPYVGTLK
SHJG_7318             VTTEFYKRLPAISDTV-20-ALRDEPMMKAGARLQIERGLIDADLPIPFQDYTE
HMPREF1211_06613      VAEEFYHVLGVIGQEV-20-AFRDDTMVQAGARLQIERSLIGAEMPMPYLGYTE
IG96_RS0135495        VIMEHYARWEPLVSEV-20-AFRDDVMVQAGARLQIERSLIKADLPVPYVGWQE
SVEN_4182             VVQEHYARWPEILKGA-20-AFARDIVVQAGARLQIERALIDAELPEPYVGWED
*    : .      *:  : .::**:**  **  * . :* *: 
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4.4. Conclusions 
The GBL-dependent signalling systems are widely distributed in Streptomyces 
bacteria; in fact, the genome analysis of 20 sequenced Streptomyces bacteria 
identified 36 cryptic biosynthetic gene clusters proposed to be under the control of 
putative GBL-dependent signalling systems. To test the effectiveness of the MEME 
enrichment analysis at discovering TetR binding sites, the bioinformatic analysis 
was performed on 36 gene clusters. 
 
From the 36 gene clusters, the MEME enrichment analysis was successful at 
discovering the ARE sequences for 18 biosynthetic gene clusters. The ARE 
sequences were identified in the promoters of putative transcriptional activators 
and TetR repressors; the deletion of specific “pseudo” ArpA-like transcriptional 
repressors or overexpression of pathway-specific transcriptional activators is 
expected to unlock the production of novel compounds from cryptic biosynthetic 
gene clusters. 
 
The SCB/ScbR/ScbR2 system, which is involved in regulating coelimycin 
biosynthesis, has been extensively studied by global transcriptomic analysis and 
ChIP-seq. MEME enrichment analysis was unable to identify all of the 
experimentally confirmed binding sites and is speculated to be due to the strict 
nature of the searching algorithm.  
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5. Prediction and Identification of Azoxy Compounds from S. avermitilis 
From genome mining analyses, a number of cryptic biosynthetic gene clusters that 
appear to be under the control of putative AHFCA-dependent regulatory systems 
were identified (Figure 3-10, Appendix D to Appendix K). To our knowledge, the 
neighbouring 50 kb cryptic biosynthetic gene cluster in S. avermitilis has not been 
investigated (cluster #15 in Table 1-2) and exploitation of the AHFCA-dependent 
signalling system is expected to result in the discovery of novel natural compounds. 
The 50 kb cryptic biosynthetic gene cluster contains approximately 45 genes in total 
including 6 genes involved in regulation; the cassette of 5 genes (sav_2266 to 
sav_2270) that forms an AHFCA signalling gene cluster and sav_2301, which encodes 
for a SARP transcriptional activator (Appendix F).  
 
Structural prediction of cryptic metabolites would assist their identification and 
characterisation. Detailed gene annotations of the 50 kb cryptic biosynthetic gene 
cluster in S. avermitilis reveals several biosynthetic genes including polyketide 
synthases, which code for large family of multi-domain enzymes involved in 
producing polyketide natural products (Figure 6-1). 149 
5.1. Seryl-tRNA synthetase involved in natural product biosynthesis 
The sav_2294 gene product encodes for a putative seryl-tRNA synthetase (serRS). 
Aminoacyl-tRNA synthetases (aaRS) are enzymes that catalyse esterification of a 
specific amino acid to their cognate tRNA to produce an aminoacyl-tRNA and are 
essential substrates for protein translation. Aminoacyl-tRNAs are also substrates for 
the bridge formation in peptidoglycan biosynthesis of bacterial cell walls. 150 The 
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presence of a serRS in biosynthetic gene clusters is not common, however a few 
biosynthetic gene clusters with serRS orthologues have recently been identified, 
such as albomycin and valanimycin from S. sp. ATCC 700974 and 
S. viridifaciens MG456-hF10 respectively (Figure 5-1). 151,152  
 
 
Figure 5-1 – Structure of albomycin and valanimycin. The albomycin antibiotic 
consists of a serRS inhibitor linked to hydroxamate siderophore through a serine 
residue. VlmL serRS is actively involved in the biosynthesis of valanimycin natural 
compound and provides charged serine. 
 
The genome of S. avermitilis, S. sp. ATCC 700974 and S. viridifaciens contains two 
serRS paralogs. 151,152 One of the serRS paralogs in S. sp. ATCC 700974 and 
S. viridifaciens encodes for a housekeeping serRS, and has high similarity and kinetic 
parameters with other Streptomyces housekeeping aaRS. 151,153 In S. avermitilis, both 
sav_2294 and sav_4244 genes encode for serRS and from phylogenetic analysis, the 
sav_4244 is most likely the housekeeping serRS (Figure 5-2). 
 
Paralogous serRS in S. sp. ATCC 700974 and S. viridifaciens are suggested to have 
different biological functions. In S. sp. ATCC 700974, the alb10 gene product, which 
encodes for a paralogous serRS, is located within the albomycin biosynthetic gene 
cluster. 151 The albomycin antibiotic has a thioribosyl nucleoside linked to a 
siderophore through a serine residue and the thioribosyl nucleoside is proposed to 
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mimic a serine substrate to inhibit serRS (Figure 5-1). 154 Biochemical investigations 
confirmed albomycin inhibited the activity of housekeeping serRS in 
S. sp. ATCC 700974, but not of Alb10 serRS, which is proposed to confer albomycin 
resistance in the natural producer. 151  
 
 
Figure 5-2 – Phylogenetic analysis of seryl-tRNA synthetases in Streptomyces 
bacteria reveals housekeeping serRS (SerRS1) clusters separately to paralogous 
serRS (SerRS2). SerRS were aligned with MUSCLE and a consensus bootstrap 
phylogenetic tree was generated using the maximum likelihood method from 1000 
iterations.  
 
Valanimycin, which has been extensively investigated by Garg and co-workers, is 
derived from L-valine and L-serine via the intermediacy of isobutylamine and 
isobutylhydroxylamine (Figure 5-3). 155,156 The biological functions of 6 genes 
involved in valanimycin biosynthesis have been established (Figure 5-3). VlmD 
catalyses the decarboxylation of L-valine into isobutylamine while the 
flavin-dependent VlmH/VlmR two-component system reduces isobutylamine to 
isobutylhydroxylamine (Figure 5-3). 157,158,159 The unusual involvement of VlmL 
serRS was found to charge L-serine to the cognate tRNA and the seryl residue is then 
transferred to the hydroxyl group of isobutylhydroxylamine by VlmA (Figure 
5-3).  152 Currently, the mechanism for the formation of the azoxy moiety remains 
unclear and possible mechanisms are discussed in reference 152. The final 
VlmL
KSE 27300
SSFG 07823
SAV 2294
FM21 20610
B446 27905 
SAV 4244 
SCO3961
SvsR
80
100
86
100
76
100
100
SerRS1
SerRS2
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biosynthetic step involves the dehydration of valanimycin hydrate to yield 
valanimycin. Two enzymes are responsible for catalysing the phosphorylation 
(VlmJ), which then favours the elimination reaction (VlmK) (Figure 5-3). 160  
 
VlmL serRS is therefore directly involved in the biosynthesis of a specialised 
metabolite (Figure 5-3). Interestingly, the Alb10 serRS, which has demonstrated to 
confer resistance to albomycin, is also speculated to be involved in peptide 
formation between the serRS inhibitor moiety and hydroxamate siderophore 
(Figure 5-1). 151,152,153 The SAV_2294 serRS in S. avermitilis, which shares 59% 
identity and 70% similarity over 427 amino acids with VlmL, is also predicted to 
participate in the biosynthesis of cryptic metabolite(s). 
 
 
Figure 5-3 – Proposed valanimycin biosynthetic pathway. Valine is converted into 
valanimycin through the intermediacy of isobutylamine and isobutylhydroxamine 
intermediates. VlmL provides charged serine substrate for valanimycin 
biosynthesis. Adapted from reference 161. 
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5.2. Prediction of novel azoxy natural compound produced by the 
S. avermitilis cryptic biosynthetic gene cluster 
The valanimycin biosynthetic gene cluster contains a total of 14 genes including 
resistance and regulatory genes (Figure 5-4). 162 The vlmE gene encodes for a TetR 
transcriptional repressor and vlmI encodes for a SARP transcriptional activator. 162 
The vlmE gene is divergently adjacent to the vlmF valanimycin resistance 
transporter (Figure 5-4) and similar to the tetracycline resistance system in E. coli, 
VlmE, most likely, regulates the expression of vlmF. From genetic and 
complementation studies, VlmI is essential for valanimycin biosynthesis and 
expression of valanimycin biosynthetic genes are under the positive control of 
VlmI.  161 
 
The biological functions of 7 biosynthetic genes in the valanimycin gene cluster have 
been experimentally validated (Figure 5-3 and Figure 5-4). All of these genes except 
vlmD were also identified in the S. avermitilis 50 kb cryptic biosynthetic gene cluster 
(Figure 5-3 and Figure 5-4), suggesting this cluster directs the biosynthesis of 
azoxy-containing compound derivatives. No orthologues of VlmD, which provides 
the isobutylamine precursor in valanimycin biosynthesis, is present in S. avermitilis 
(Figure 5-3). A different precursor is therefore proposed to be incorporated into the 
S. avermitilis azoxy compounds. In addition, the S. avermitilis biosynthetic gene 
cluster is significantly larger than that of valanimycin and contains a number of 
genes involved in polyketide biosynthesis (Figure 5-4). A polyketide precursor (or 
possibly another amino acid) could therefore be incorporated into the azoxy 
metabolites in S. avermitilis (Figure 5-5). Homologues of all of the key enzymes 
involved in formation of the dehydroalanine moiety in valanimycin are present in 
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S. avermitilis and is expected to be intact in the final predicted azoxy compounds 
(Figure 5-5). 
 
 
 
Figure 5-4 – The valanimycin biosynthetic gene cluster contains 14 genes involved 
in biosynthesis, regulation and resistance. (a) The functions of valanimycin 
biosynthetic genes have been established through biochemical studies are 
highlighted in bold. (b) Nearly all of the valanimycin biosynthetic genes are 
present in the S. avermitilis biosynthetic gene cluster. Analogous genes are 
colour-coded. 
 
 
Streptomyces viridifaciens MG456-hF10 
Valanimycin biosynthetic gene cluster (17,496 bp)
Gene in 
S. viridifaciens
Analogous gene in 
S. avermitilis Proposed Function
vlmA sav_2300 O-seryl acyltransferase
vlmH sav_2284 Isobutylamine N-hydroxylase
vlmO sav_2287 Putative integral membrane protein
vlmR sav_2288 NADPH-flavin oxidoreductase
vlmB sav_2289 Hypothetical protein
vlmC sav_2293 Amino acid permease
vlmD Valine decarboxylase
vlmE TetR family transcriptional repressor
vlmF Valanimycin resistance
vlmG Hypothetical protein
vlmI sav_2301 SARP family transcriptional regulator
vlmJ sav_2272 Diacylglycerol kinase
vlmK sav_2272 MmgE/PrpD family protein
vlmL sav_2294 Seryl-tRNA synthetase
2kb
1kb
1kb
a)
b)
AHFCA
Regulatory system
Streptomyces avermitilis MA-4680
(50, 462 bp)
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Figure 5-5 – Proposed core azoxy structure produced by the predicted azoxy 
biosynthetic gene cluster in S. avermitilis. Due to absence of valine decarboxylase 
enzyme in S. avermitilis, azoxy natural compounds in S. avermitilis are speculated 
to incorporate a different precursor, possibly of polyketide origin. 
 
5.3. Capture of the entire azoxy biosynthetic gene cluster into PAC vectors 
Compared to the model organism, S. coelicolor A3(2), genetic manipulations in 
S. avermitilis are relatively more difficult. For instance, transformation is primarily 
carried out via protoplast rather than intergenic conjugation. 163 Cloning entire 
biosynthetic gene clusters into well characterised heterologous hosts or superhost, 
such as S. lividans TK24 or S. coelicolor M1152 respectively, does not only make the 
genetic work easier but also improves yield and facilitate identification/ purification 
processes. 164,165,166 Genomic DNA libraries, which are a collection of DNA fragments 
captured onto a specific vector, have been routinely used to acquire biosynthetic 
gene clusters for heterologous expression. 167 Several cloning vector systems are 
available depending on the size of DNA fragment required and cloning purpose 
(Table 5-1). 
 
Table 5-1 – Cloning vectors for genomic DNA library. 
Vector Host 
Typical insert 
size (kb) 
Plasmids E. coli Up to 10 
Cosmids/ Fosmids E. coli Up to 45 
Bacterial artificial chromosome E. coli 100 to 300 
P1-derived artificial chromosome E. coli 100 to 300 
Yeast artificial chromosome Saccharomyces cerevisiae 100 to 2,000 
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It is difficult to determine the boundaries of the predicted azoxy biosynthetic gene 
cluster in S. avermitilis. With the identification of ARE sequences on the opposite 
ends of the biosynthetic gene cluster, the azoxy biosynthetic gene cluster is 
proposed to be at least 50 kb (Appendix F). Therefore, plasmid or modified λ phage 
vectors, such as cosmid or fosmids, are not appropriate to capture the 50 kb gene 
cluster and artifical chromosomes are more suitable. Examples of artificial 
chromosomes include the bacterial artificial chromosomes (BAC) and P1-derived 
artificial chromosomes (PAC), which are based on the replicon of the F factor 
fertility plasmid and bacteriophage P1 respectively. 168,169 Sosio and co-workers 
were able to produce an E. coli - Streptomyces artificial chromosomes (ESAC) shuttle 
vector by introducing the ΦC31 attP-int system into pCYPAC2 to generate a non-
conjugative pPAC-S1 vector. 170 The pPAC-S1 vector could replicate autonomously 
in E. coli, as well as allow direct site-specific integration into Streptomyces bacterial 
genome. The pPAC-S1 vector was further developed by introducing oriT, from RK2 
replicon, to create a conjugative pESAC13 vector (Figure 5-6), which is currently 
licensed to Bio S&T, and is able to produce pESAC13A PAC genomic libraries with 
insert sizes of approximately 130 kb. 171 
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Figure 5-6 – The pESAC13 and pESAC13A PAC vector. Kanamycin resistance gene 
in (a) pESAC13 was replaced with an apramycin resistance gene to generate the 
(b) pESAC13A PAC vector. Image obtained from Bio S&T (www.biost.com). 
 
The S. avermitilis pESAC13A PAC genomic DNA library was used to capture the 
putative azoxy gene cluster. An apramycin resistant pESAC13A PAC genomic library 
of S. avermitilis MA-4680 was constructed for the project by Bio S&T and a total of 
1,920 individual clones of E. coli DH10B each containing a single pESAC13A were 
obtained (Figure 5-6). Bio S&T also screened the pESAC13A genomic library for the 
biosynthetic gene cluster of interest (Figure 5-7). 
 
Three pairs of primers were designed to bind to the left, center and right of the 
predicted azoxy biosynthetic gene cluster (for_pESAC_SAV2283a and 
rev_pESAC_SAV2283a; for_pESAC13_sav2266a and rev_pESAC13_sav2266a; 
for_pESAC_sav2301a and rev_pESAC_sav2301a, see Table 2-3). The primers were 
first tested on genomic DNA and then the pESAC13A constructs for the predicted 
azoxy biosynthetic gene cluster. Two individual constructs, named pESAC13A-2H 
and pESAC13A-19K, were positive for all three pairs of primers (Figure 5-7). The 
predicted azoxy biosynthetic gene cluster is present in pESAC13A-2H and 
a) b)
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pESAC13A-19K constructs and contains approximately 130 kb and 135 kb insert 
sizes respectively as determined by restriction digests (Figure 5-7); however, the 
extremities of the cloned DNA fragment were not determined and sequencing of 
pESAC13A constructs would be required to define the fragment ends. 
 
 
 
Figure 5-7 – PCR identified two pESAC13A constructs containing the entire 
predicted azoxy biosynthetic gene cluster. (a) The pESAC13A-2H (Lane 1) and 
pESAC13A-19K (Lane 2) contain an approximate insert size of 130 kb and 135 kb 
respectively. (b) The pESAC13A-2H (Lanes 1, 4 and 7) and pESAC13A-19K (Lanes 
2, 5, 8) constructs were positive for left (sav_2283), center (sav_2266) and right 
(sav_2301) primers. S. avermitilis genomic DNA (Lane 3, 6 and 9) was used as a 
positive control. Isolation and screening of colonies containing the pESAC13A 
construct of interest was performed by Bio S&T. 
 
From bioinformatic and genome analysis, the genome of S. avermitilis is predicted 
to produce 38 specialised metabolites and as of 2014, 16 compounds have been 
detected (Table 1-2). 35 Putative biosynthetic gene clusters in S. avermitilis are all 
under 130 kb (Table 1-2) and the pESAC13A PAC genomic library could be further 
exploited to find other cryptic biosynthetic gene clusters in S. avermitilis; 
identification of products from these cryptic biosynthetic gene clusters could be 
a)                       b)
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carried out using a heterologous expression/comparative metabolic profiling 
approach. 
5.4. Heterologous expression of the predicted azoxy biosynthetic gene 
cluster from S. avermitilis 
The positive pESAC13A constructs were introduced into two different Streptomyces 
heterologous hosts; S. coelicolor M1152 and S. lividans TK24. S. coelicolor M1152 
(Δact, Δred, Δcpk, Δcda, rpoB[C1298T]) is an engineered strain designed for 
heterologous expression of metabolite gene clusters. Most importantly, S. coelicolor 
M1152 is based on S. coelicolor M145 (SCP1-, SCP2-) and the actinorhodin, 
prodiginines, coelimycin and CDA biosynthetic pathways have been deleted; in 
consequence primary precursors and more energy are available for heterologous 
metabolic pathways. 166 S. coelicolor M1152 also contains a single amino acid 
mutation in RpoB, which encodes for a RNA polymerase β-subunit, and mutations 
in RpoB were shown to enhance the level of metabolite production. 166,172 
S. lividans TK24 (SLP2-, SLP3-) is a derivative of S. lividans 66, which had its genome 
sequenced in 2013, and is a closely related species to S. coelicolor. 173  
5.4.1. Introduction of pESAC13A-2H and pESAC13A-19K into S. lividans TK24 
by tri-parental conjugation 
The advantage of using S. lividans as a heterologous hosts is that it does not contain 
a methyl-sensing restriction system; therefore, methylated DNA from E. coli can be 
directly introduced into S. lividans TK24 without the need to passage the vector 
through a non-methylating E. coli host (Figure 5-8). 21 
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Figure 5-8 – Schematic of tri-parental conjugation in S. lividans TK24. The pUB307 
helper plasmid from E. coli DH5α is mobilised into E. coli DH10B containing 
pESAC13A and transfers the pESAC13A constructs into S. lividans TK24. 
 
Tri-parental conjugation was carried out between E. coli DH5α/pUB307, 
E. coli DH10B containing pESAC13A constructs and S. lividans TK24 to mobilise 
pESAC13A-2H and pESAC13A-19K into S. lividans heterologous hosts; two colonies 
of S. lividans TK24/pESAC13A-2H and S. lividans TK24/pESAC13A-19K were 
obtained (Figure 5-9). The successful integration of pESAC13A-2H and 
pESAC13A-19K in S. lividans heterologous host strains were confirmed by PCR using 
the same primer pairs that were used to identify pESAC13A-2H and pESAC13A-19K 
(Figure 5-10). 
 
 
 
Figure 5-9 – Successful integration of apramycin resistant pESAC13A-2H (left) and 
pESAC13A-19K (right) constructs in S. lividans TK24. 
Streptomyces lividans TK24
E. coli DH10B/pESAC13A
Apra
Helper plasmid
pUB307
pESAC13A
E. coli DH5α/pUB307
Kan, Chl
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Figure 5-10 – PCR confirmed the integration of pESAC13A-2H and pESAC13A-19K 
constructs in S. lividans heterologous host strains. The primers pairs (sav_2266, 
sav_2283 and sav_2301) were used and a band corresponding to the expected 
product of 0.4 - 0.5 kb were obtained in all colonies. S. lividans TK24 genomic DNA 
was used as a negative control (Lane A) and S. avermitilis genomic DNA was used 
as a positive control (Lane B). 
 
5.4.2. Introduction of pESAC13A-2H and pESAC13A-19K into S. coelicolor 
M1152 by tri-parental conjugation 
To introduce DNA into S. coelicolor, DNA needs to be passaged into a 
non-methylating DNA host, such as E. coli ET12567. 21 Firstly, tri-parental 
conjugation was carried out between E. coli DH5α/pR9604, E. coli ET12567 and the 
E. coli DH10B containing the pESAC13A constructs to introduce the self 
transmissible pR9604 plasmid and pESAC13A constructs into non-methylating 
E. coli ET12567 hosts (Figure 5-11). E. coli ET12567/pR9604/pESAC13A-2H and 
E. coli ET12567/pR9604/pESAC13A-19K exconjugants were screened by PCR using 
the same three primer pairs as in the previous section (Figure 5-12). 
 
bp
850
400
sav_2266 sav_2283 sav_2301
L      A     B     1    2     1     2     A    B     1    2    1     2    A     B   1    2     1     2    L
2H 2H 2H19K 19K 19K
0.4kb 0.5kb 0.4kb
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Figure 5-11 – Schematic of tri-parental conjugation in S. coelicolor M1152. The 
pR9604 helper plasmid is transferred into E. coli DH10B containing the pESAC13A 
constructs. The pR9604 plasmid mobilises the pESAC13A constructs into E. coli 
ET12567 resulting in a kanamycin, carbenicillin and apramycin resistant strain. 
Standard E. coli/ Streptomyces conjugation is carried out to transfer the pESAC13A 
constructs into S. coelicolor M1152. 
 
After transfer of pESAC13A construct and pR9604 plasmid into non-methylating 
E. coli ET12567, intergenic conjugation was successfully carried out between 
S. coelicolor M1152 and E. coli ET12567/pR9604 transformants containing the 
pESAC13A constructs; two colonies of S. coelicolor M1152/pESAC13A-2H and 
S. coelicolor M1152/pESAC13A-19K were obtained. Successful integration of 
pESAC13A-2H and pESAC13A-19K constructs into S. coelicolor heterologous hosts 
were confirmed by PCR screening (Figure 5-13). No noticeable phenotype change 
was observed in S. coelicolor heterologous host strains when compared to the wild 
type S. coelicolor M1152. 
 
Streptomyces coelicolor M1152
E. coli DH10B/pESAC13A
Apra
Helper plasmid
pR9604
pESAC13A
E. coli DH5α/pR9604
Carb
E. coli ET12567
Kan
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Figure 5-12 – PCR confirmed the transfer of pESAC13A-2H and pESAC13A-19K 
constructs into E. coli ET12567. The 3 primer pairs (sav_2266, sav_2283 and 
sav_2301) were used and the band corresponding to the expected product of 
0.4 - 0.5 kb were obtained in all of the colonies. S. avermitilis genomic DNA was 
used as a positive control (Lane A). 
 
 
Figure 5-13 – PCR confirmed the integration of pESAC13A-2H and pESAC13A-19K 
constructs in S. coelicolor heterologous host strains. The 3 primers pairs (sav_2266, 
sav_2283 and sav_2301) were used and the band corresponding to the expected 
product of 0.4 - 0.5 kb were obtained in all of the colonies. S. avermitilis genomic 
DNA was used as a positive control (Lane A) and S. coelicolor M1152 genomic DNA 
was used as a negative control (Lane B). 
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5.5. Comparitive metabolic profiling of Streptomyces heterologous hosts 
grown on SMMS agar 
Comparative metabolic profiling of S. coelicolor and S. lividans heterologous host 
strains by LC-MS analysis was expected to reveal the presence of novel metabolites 
resulting from the integration of pESAC13A-2H or pESAC13A-19K into the 
chromosome. 166 
5.5.1. Comparative metabolic profiling of S. lividans heterologous hosts 
Metabolites from S. lividans heterologous host strains containing the pESAC13A 
constructs were compared against metabolites produced by the wild type 
S. lividans TK24 by LC-MS. LC-MS analysis of both the neutral and acidified organic 
extraction did not reveal any compounds produced due to the introduction of the 
pESAC13A constructs. Absence of compounds of interest may be due to poor 
precursor supply in S. lividans TK24 or active transcriptional regulation of 
biosynthetic genes in S. lividans heterologous hosts.  
5.5.2. Identification of predicted azoxy compounds in S. coelicolor 
heterologous hosts 
Similarly, metabolites between the S. coelicolor heterologous host strains and wild 
type S. coelicolor M1152 were compared by LC-MS. Three new compounds (1 - 3) 
were identified in the acidified S. coelicolor organic extracts (Figure 5-14). The m/z 
values for compounds 1 - 3 were 219.0, 201.1 and 201.1 respectively and were only 
present in S. coelicolor strains containing pESAC13A-2H or pESAC13A-19K and 
were absent in S. coelicolor M1152 control.  
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Due to the nitrogen rule, molecular ion masses of compounds 1 - 3 indicates they 
contain an even number of nitrogen atoms, which was confirmed from the molecular 
formulae generated by UHPLC-ESI-TOF-MS data (Table 5-2); compound 1 has a 
molecular formula of C9H19N2O4 and both compounds 2 and 3 have a molecular 
formula of C9H17N2O3.  
 
The molecular formulae therefore imply that the observed compounds 1 - 3 are 
related and similar to the valanimycin compound, which has a molecular formula of 
C7H12N2O3 and an m/z value of 173.1 (Figure 5-15). 155,161 Compared to valanimycin, 
compound 1 has an additional C2H6O whilst compounds 2 and 3 have an extra C2H4. 
Of particular interest are compounds 2 and 3, which have the exact same molecular 
formulae and are likely to be isomers (Table 5-2). A mass difference of 18 Da, which 
corresponds to a loss of water, was also observed from 1 to 2 and 3. 
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Figure 5-14 – Predicted azoxy compounds (1 - 3) were identified in the acidified 
S. coelicolor organic extracts by LC-MS. Extracted ion chromatograms (m/z = 219.0 
and 201.0) detected compounds 1 - 3 only in S. coelicolor M1152 containing 
pESAC13A-2H or pESAC13A-19K and not in S. coelicolor M1152 control or blank. 
 
Table 5-2 – Compounds detected in the acidified organic extraction of S. coelicolor 
heterologous host strains grown on SMMS agar. 
# 
Retention 
Time 
(min) 
[M+H]+ [M+Na]+ 
Formula Observed Calculated Formula Observed Calculated 
1 20.0 C9H19N2O
4 
219.1336 219.1345 C9H18N2O4Na 241.1154 241.1164 
2 23.3 C9H17N2O
3 
201.1226 201.1239 C9H16N2O3Na 223.1042 223.1059 
3 23.7 C9H17N2O
3 
201.1231 201.1239 C9H16N2O3Na 223.1045 223.1059 
 
With the hypothesis that the dehydroalanine moiety is still intact in the predicted 
azoxy compounds, the branched isobutyl moiety in valanimycin is expected to be 
extended by two CH2 units and the proposed structures of possible azoxy 
compounds (2 and 3) are shown in Figure 5-15.  
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Due to the absence of valine decarboxylase in S. avermitilis, a different precursor 
was predicted to be incorporated in the azoxy compounds. Another amino acid 
could participate in the biosynthesis of the azoxy compounds; however, there are no 
amino acids that are larger than valine by two units of CH2. Therefore, an amino acid 
is unlikely to be incorporated in the predicted azoxy compounds, but a precursor of 
polyketide origin as proposed earlier.  
 
 
Figure 5-15 – Structure of valanimycin and proposed structures for the predicted 
azoxy compounds (2 and 3), which contain two extra units of CH2. 
 
5.5.3. Identification of predicted aromatic amine compounds in S. coelicolor 
heterologous hosts 
In addition to the acidified organic extraction, metabolites from S. coelicolor strains 
were extracted with ethyl acetate at neutral pH and analysed by LC-MS. Three new 
compounds (4 - 6) were detected in the neutral S. coelicolor organic extracts, and 
were only observed in S. coelicolor strains containing pESAC13A-2H or 
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pESAC13A-19K (Figure 5-16). The aromatic amine compounds (4 - 6), and not the 
predicted azoxy compounds (1 - 3), were found in the neutral extracts, and vice 
versa for the acidified extracts.  
 
 
Figure 5-16 – Aromatic amine compounds (4 - 6) were identified in the neutral 
S. coelicolor organic extracts by LC-MS. Extracted ion chromatograms (m/z = 262.0, 
278.0 and 276.0) detected the compounds 4 - 6 only in S. coelicolor M1152 
containing pESAC13A-2H or pESAC13A-19K and not in S. coelicolor M1152 control 
or blank. 
 
The molecular ion masses for these three new compounds (where m/z for 4 is 
262.06, for 5 is 278.06 and for 6 is 276.06) indicate they contain an odd number of 
nitrogens and are most likely not related to the predicted azoxy compounds (1 - 3). 
This was confirmed by molecular formulae generated from UHPLC-ESI-TOF-MS 
data. The molecular formulae for compounds 4 - 6 are speculated to be aromatic 
amine compounds containing at least 3 aromatic rings; this is implied from the ratio 
of carbons and hydrogens (Table 5-3).  
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Table 5-3 – Compounds detected in the neutral organic extraction of S. coelicolor 
heterologous host strains grown on SMMS agar. 
# 
Retention 
Time  
(min) 
[M+H]+ [M+Na]+ 
Formula Observed Calculated Formula Observed Calculated 
4 22.0 C19H20N 262.1591 262.1596 C19H19NNa 284.1410 284.1415 
5 22.2 C19H20NO 278.1540 278.1545 C19H19NONa 300.1359 300.1364 
6 23.0 C19H22NO 276.1745 276.1752 C20H21NNa  298.1566 298.1572 
 
The predicted aromatic amine compounds (4 - 6) were only observed when 
pESAC13A-2H or pESAC13A-19K constructs were introduced in S. coelicolor 
heterologous hosts and are likely products of the metabolic pathway introduced via 
the pESAC13A. Both of the pESAC13A constructs contain an insert size of 
approximately 130 - 135 kb (Figure 5-7); therefore, including the 50 kb predicted 
azoxy biosynthetic gene cluster (sav_2266 to sav_2301), there are an additional 
80 - 85 kb of DNA in the inserts of these pESAC13A constructs. The theoretical DNA 
insert could span between sav_2202 to sav_2378, and from the predicted metabolite 
gene clusters published by Ikeda and co-workers, the polyketide 
(sav_2367 - sav_2369; cluster #16 in Table 1-2) and half of the aromatic polyketide 
(sav_2372 - sav_2388; cluster #17 in Table 1-2) biosynthetic gene clusters could 
have been captured along with the predicted azoxy biosynthetic gene cluster. 35 The 
aromatic amine 4 - 6 may be products of the polyketide or aromatic polyketide 
biosynthetic gene cluster.  
 
Alternatively, introduction of pESAC13A constructs in S. coelicolor M1152 may have 
activated expression of cryptic biosynthetic gene clusters or modified endogenous 
metabolites produced by S. coelicolor M1152. 174 More importantly, the observed 
compounds (1 - 6) were detected in strains containing either pESAC13A-2H and 
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pESAC13A-19K, and implies that the two pESAC13A constructs are similar. 
Sequencing of pESAC13A-2H and pESAC13A-19K constructs would allow the insert 
ends to be determined and these interpretations to be validated. 
 
5.6. Incorporation of isotope labelled L-serine in the predicted azoxy 
compounds  
Incorporation experiments using isotopically-labelled precursors, carried out by 
Ronald and co-workers, established that valanimycin is derived from L-valine and 
L-serine (Figure 5-3). 155,156 The seryl residue, from seryl-tRNA, is transferred onto 
the hydroxyl group of isobutylhydroxylamine to form an intermediate, which is 
subsequently converted into valanimycin hydrate (Figure 5-3). 152 The seryl residue 
in valanimycin hydrate is dehydrated to form valanimycin (Figure 5-3). 160 Since 
serine and threonine amino acids only differ by a single methyl group, L-threonine 
may be incorporated into the predicted azoxy compounds, instead of L-serine. Thus, 
dehydration of the threonyl residue would result in the expected cis/trans isomers 
(2 and 3) (Figure 5-17); however, if serine was the precursor no configurational 
isomers would result from the dehydration. The feeding of isotope-labelled 
L-serine-13C3-15N and L-threonine-13C4-15N was carried out to determine whether 
they are incorporated into the predicted azoxy compounds (1 - 3).  
 
The mass spectra of azoxy compounds (1 - 3) resulting from isotope-labelled 
feeding experiments revealed incorporation of L-serine-13C3-15N and not 
L-threonine-13C4-15N (Figure 5-18). In the feeding of L-serine-13C3-15N, the expected 
increase of 4 Da for the [M+H]+ and [M+Na]+ molecular ion mass were observed for 
all of the azoxy compounds (1 - 3) (Figure 5-18). The 4 Da increase implies intact 
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incorporation of L-serine into the azoxy compounds (1 - 3), which is consistent with 
the proposed valanimycin biosynthesis pathway (Figure 5-3). 160 Incorporation of 
isotope-labelled serine in all of the predicted azoxy compounds further supports the 
predictions that compounds 1 - 3 are structurally related and are the novel azoxy 
compounds of interest. 
 
For the feeding of L-threonine-13C4-15N, the molecular mass increase of 5 Da was not 
observed for the predicted azoxy compounds (1 - 3) (Figure 5-18), which indicates 
that L-threonine is not incorporated into the azoxy compounds (1 - 3). Dehydration 
of the seryl residue of compounds 1 is therefore not responsible for generating the 
cis/trans isomers, compound 2 and 3 are different type of isomers. The molecular 
formulae for the S. avermitilis azoxy compounds are highly similar to that of 
valanimycin and indicate they contain an additional two CH2 groups extending the 
isobutyl moiety in valanimycin. Depending on the chain branching, different 
structural isomers may be envisaged for 1 - 3 (Figure 5-15).  
 
For the aromatic amine compounds (4 - 6), isotope-labelled feeding experiments 
revealed these compounds do not incorporate either L-serine-13C3-15N or 
L-threonine-13C4-15N and further supports their unrelatedness with the identified 
azoxy compounds (1 - 3). 
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Figure 5-17 – Proposed incorporation of L-serine or L-threonine into the 
predicted azoxy compound and subsequent dehydration of the seryl and threonyl 
residues. In the case of threonyl dehydration cis/trans isomers could be expected.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-18 – (Next Page) The predicted azoxy compounds (1 - 3) are 
incorporating L-serine-13C3-15N and not L-threonine-13C4-15N; water was used as a 
negative control. Extracted ion chromatograms (m/z = 201.0 and 219.0) detected 
the predicted azoxy compounds (1 - 3) and their respective mass spectra are 
shown; molecular ion mass of [M+H]+ and [M+Na]+ are highlighted. 
Chapter 5: Prediction and Identification of Azoxy Compounds from S. avermitilis 
128 
 
 
1
2
3
W
a
te
r
Se
ri
n
e
T
h
re
o
n
in
e
2
1
9
.1
1
2
4
1
.0
4
V
P
1
2
3
_
46
_
01
_
16
8
73
.d
: +
M
S,
 2
0.
4-
2
0.
6m
in
 #
3
39
7
-3
4
35
0247
x
1
0
In
te
n
s
.
2
2
0
2
3
0
2
4
0
m
/z
2
2
3
.1
1
2
4
5
.0
6
2
0
5
.1
4
2
2
3
.0
7
V
P
1
2
1
_
44
_
01
_
16
8
71
.d
: +
M
S,
 2
2.
9-
2
3.
1m
in
 #
3
84
3
-3
8
83
0
.0
0
.5
8
x
1
0
In
te
n
s
.
2
0
0
2
1
0
2
2
0
m
/z
2
0
1
.1
4
2
2
7
.0
8
2
0
1
.1
3
2
2
3
.0
7
V
P
1
2
3
_
46
_
01
_
16
8
73
.d
: +
M
S,
 2
2.
9-
2
3.
2m
in
 #
3
85
1
-3
8
93
0
.0
0
.5
8
x
1
0
In
te
n
s
.
2
0
0
2
1
0
2
2
0
m
/z
2
0
5
.1
3
2
2
3
.0
92
2
7
.1
1
V
P
1
2
1
_
44
_
01
_
16
8
71
.d
: +
M
S,
 2
3.
4-
2
3.
5m
in
 #
3
93
2
-3
9
56
0127
x
1
0
In
te
n
s
.
2
0
0
2
1
0
2
2
0
m
/z
2
0
1
.1
4
2
2
3
.0
8
V
P
1
1
9
_
42
_
01
_
16
8
69
.d
: +
M
S,
 2
3.
2-
2
3.
3m
in
 #
3
89
9
-3
9
23
0127
x
1
0
In
te
n
s
.
2
0
0
2
1
0
2
2
0
m
/z
2
0
1
.1
5
2
0
1
.1
4
2
2
3
.0
8
V
P
1
2
3
_
46
_
01
_
16
8
73
.d
: +
M
S,
 2
3.
4-
2
3.
6m
in
 #
3
93
6
-3
9
62
0127
x
1
0
In
te
n
s
.
2
0
0
2
1
0
2
2
0
m
/z
2
1
9
.1
0
2
4
1
.0
4
V
P
1
1
9
_
42
_
01
_
16
8
69
.d
: +
M
S,
 2
0.
4-
2
0.
7m
in
 #
3
39
2
-3
4
45
0247
x
1
0
In
te
n
s
.
2
2
0
2
3
0
2
4
0
m
/z
2
1
9
.1
1
2
4
1
.0
5
V
P
1
2
1
_
44
_
01
_
16
8
71
.d
: +
M
S,
 2
0.
4-
2
0.
6m
in
 #
3
38
2
-3
4
27
0247
x
1
0
In
te
n
s
.
2
2
0
2
3
0
2
4
0
m
/z
2
0
1
.1
3
2
2
3
.0
6
V
P
1
1
9
_
42
_
01
_
16
8
69
.d
: +
M
S,
 2
2.
7-
2
3.
0m
in
 #
3
81
3
-3
8
57
0
.0
0
.5
8
x
1
0
In
te
n
s
.
2
0
0
2
1
0
2
2
0
m
/z
Chapter 5: Prediction and Identification of Azoxy Compounds from S. avermitilis 
129 
 
5.7. Purification of azoxy compounds for structure determination by NMR 
spectroscopy 
To obtain enough product for the structure elucidation of compounds 1 - 3, the 
growth of S. coelicolor M1152/pESAC13A-2H was scaled up to 750 mL on SMMS 
agar (30 x 25 mL plates). Organic extraction was performed with ethyl acetate and 
solvent was evaporated in vacuo. The residual crude extract was dissolved in 
methanol and water before LC-MS analysis. Once the presence of compounds of 
interest was confirmed, purification using semi-preparative HPLC was initiated. The 
predicted azoxy compounds (1 - 3) were previously shown to strongly absorb 
wavelengths of 220 nm and 230 nm (Figure 5-19), which is also consistent with 
previously isolated azoxy metabolites. 155,175 For semi-preparative HPLC, the UV 
chromatogram at 230 nm was used to guide their purification.  
 
 
Figure 5-19 – UV chromatogram of the predicted azoxy compounds (1 - 3). 
Extracted ion chromatograms (blue trace - m/z = 201.0 and m/z = 219.0) detected 
the azoxy compounds (1 - 3) that strongly absorb wavelengths of 220 nm (green 
trace) and 230 nm (orange trace). 
 
Fractions collected by semi-preparative HPLC were further analysed by mass 
spectroscopy to confirm the presence of the compounds of interest and pooled 
together. The samples were concentrated by evaporating the methanol in vacuo and 
1
2
3
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remaining water was removed by freeze drying. The resulting dried residue sample 
was dissolved in deuterated chloroform and analysed by NMR spectroscopy. 
Compound 1 (7.3mg) and 3 (17.7mg) were analysed by 1H-NMR (700 Mhz), and 
compound 2 (6.6mg) was analysed by a combination of 1- and 2-D NMR 
spectroscopy (1H, 13C, COSY, HSQC and HMBC) (Figure 5-20). 
 
The signals on the 1H-NMR spectra obtained for 1 and 3 were not intense enough 
for determining their structure. For compound 2, analysis of the NMR spectra 
(performed by Corre, C. and Song, L.) was discovered to be consistent with NMR 
spectroscopy data of the SCB1 signalling molecule, which was previously 
characterised by Takano and co-workers in 2008. 119 The SCB1 signalling molecule 
has a characteristic mass spectrum pattern with molecular ion peaks for [M+Na]+ 
(m/z = 267.07), [M+H]+ (m/z = 245.11), [M+H-H2O]+ (m/z = 227.14) and 
[M+H-2H2O]+ (m/z = 209.17) and detailed analysis of mass spectra obtained for the 
purified compounds, undeniably, revealed SCB1 signalling molecules were 
co-purified with compounds 2 and 3 (Figure 5-21). Purification of predicted azoxy 
compounds would need to be further optimised to remove SCB1 signalling 
molecules. Interestingly, extracted ion chromatogram of the scaled up extract 
revealed that SCB1 was overproduced in S. coelicolor M1152 co-eluate with 
compound 2 and 3 (Figure 5-21). Optimisation of the purification of 2 and 3 to 
remove SCB1 signalling molecules would be difficult and an alternative solution 
would be to genetically inactivate the scbA gene, which encodes for the key enzyme 
involved in the assembly of SCBs. 176 Inactivation of scbA in S. coelicolor M1152 is 
expected to abolish the production of SCB signalling molecules and would generate 
a “cleaner” S. coelicolor superhost. For compound 1, only small amounts of SCBs 
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were co-eluating (Figure 5-21). Therefore, purification of the proposed hydrated 
azoxy compounds (1) could be further optimised for establishing its structure. The 
amount of purified material from 750 mL of SMMS agar was too low to obtain signals 
intense enough by NMR spectroscopy, and would need to be further scaled up to 
obtain more product. Production of predicted azoxy compounds (1 - 3) were still 
detectable in 50 mL of liquid SMM at 30 ⁰C, shaking at 220 rpm for 6 days and 
compounds 1 - 3 could be further scaled up in liquid culture. Furthermore, previous 
attempts to scale up the production of the predicted azoxy compounds (1 - 3) were 
carried out in S. coelicolor M1152/pESAC13A-2H1 strain and genetic manipulations, 
such as overexpression of the sav_2301 activator or inactivation of the sav_2268 
repressor, is expected to over produce the compounds of interest. In addition, a 
significant decrease in valanimycin was observed in S. viridifaciens after 40 hours of 
incubation; growth conditions of S. coelicolor heterologous hosts could be further 
optimised to obtain the maximum yield of azoxy compounds. 155 
 
With greater production of the compounds of interest, the samples could be further 
analysed by infra-red (IR) spectroscopy to confirm the azoxy moiety, which has a 
characteristic IR spectrum at ~1540 cm-1. 177 
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Figure 5-20 – (a) Proton NMR (700 Mhz) and (b) 2-D COSY spectrum of 
compound 2 dissolved in deuterated chloroform. The NMR data for compound 2 
matched the structure of the SCB1 signalling molecule published by Takano and 
co-workers (See reference 117). 
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Figure 5-21 – (a) Extracted ion chromatogram (m/z = 219.0, 201.0 and 201.0 
traces are coloured blue, red and black respectively) and (b) mass spectra of 
compounds 1 - 3 reveal the predicted azoxy compounds are co-purified with SCB 
signalling molecules, which are overproduced in S. coelicolor M1152 
(m/z = 209.17, 227.14, 245.11 and 267.07, grey trace). 
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5.8. Conclusions 
To our knowledge, the cryptic biosynthetic gene cluster in S. avermitilis, which is 
proposed to be under the control of the neighbouring putative AHFCA-dependent 
signalling system, has not been investigated. Genome mining analyses have revealed 
a set of genes that are shared between the valanimycin biosynthetic gene cluster 
from S. viridifaciens and the cryptic biosynthetic gene cluster from S. avermitilis; 
therefore, the cryptic biosynthetic gene cluster is predicted to be involved in the 
biosynthesis of novel azoxy natural compounds. 
 
A S. avermitilis pESAC13A PAC genomic library was constructed for the project by 
Bio S&T. The pESAC13A-2H and pESAC13A-19K constructs were confirmed to have 
captured the predicted azoxy biosynthetic gene cluster. The pESAC13A constructs 
were successfully introduced into S. coelicolor M1152 and S. lividans TK24 by 
tri-parental conjugation and comparative metabolic profiling identified 6 new 
compounds (1 - 6). The molecular formulae, generated through the analysis of 
UHPLC-ESI-TOF-MS data, confirmed compounds 1 - 3 are the predicted azoxy 
compounds of interest and compounds 4 - 6 are aromatic amines. 
 
To further support the identification of the predicted azoxy compounds, compounds 
1 - 3 were demonstrated to incorporate isotope-labelled L-serine-13C3-15N. 
Production of compound 1 - 3 were further scaled up and purified by semi-
preparative HPLC in order to determine the structure of compounds by a 
combination of 1- and 2-D NMR spectroscopy; however, the structure of compounds 
1 - 3 could not be solved and purification needs to be optimised by further scale up 
and removal of SCB signalling molecules. 
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6. Exploitation of AHFCA-dependent Signalling Systems 
The MEME enrichment analysis has proven to be an efficient tool for gaining insights 
into complex regulatory networks and was successful at revealing TetR binding sites 
for all of the putative AHFCA-dependent signalling systems. In the S. avermitilis 
AHFCA-dependent signalling system, TetR binding sites were identified in 
promoters of genes involved in the assembly of AHFCA signalling molecules, TetR 
repressors and upstream of sav_2301 SARP transcriptional activator (Figure 6-1); 
hence, the signalling system is proposed to regulate expression of sav_2301 and 
control the biosynthesis of the predicted azoxy compounds. The SARP family of 
transcriptional activators are commonly found in Streptomyces biosynthetic gene 
clusters and are involved in pathway-specific regulation of biosynthetic gene 
clusters by binding to direct heptameric DNA repeats located in promoter 
regions.  116  
6.1. Predictions of SAV_2301 SARP transcriptional activator binding sites  
Organisation of the predicted azoxy biosynthetic gene cluster suggests there are 
four possible operons; sav_2282 - sav_2272 operon that is divergently adjacent to 
sav_2283 - sav_2294 operon and sav_2300 - sav_2295 operon is divergently adjacent 
to sav_2301 - sav_2304 operon (Coloured in pale red, blue, green and yellow 
respectively in Figure 6-1). Bioinformatic analysis identified SARP-like 
transcriptional activator binding sites in the intergenic regions between these 
divergently adjacent putative operons (Figure 6-1 and Figure 6-2).  
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Figure 6-1 – The 50 kb cryptic biosynthetic gene cluster appears to be under the 
control of an AHFCA-dependent signalling system. MEME enrichment analysis 
identified ARE sequences upstream of sav_2301 (highlighted in green). The 
SAV_2301 transcriptional activator is proposed to bind to SARP binding sites 
(S1 and S2) to regulate expression of the four operons (highlighted in pale red, 
blue, green and yellow). *contains TTA codon. 
 
The predicted SARP-like binding sites are similar to other experimentally confirmed 
SARP binding sites; SAV_2301 is proposed to bind to these 2 specific sequences to 
recruit RNA polymerase and activate the 4 divergently adjacent operons (Figure 6-1 
and Figure 6-2). 161  
ARE ARE ARE
S. avermitilis MA-4680 (50,462 bp)
1kb
Name Proposed Function
SAV_2263 TetR family transcriptional regulator
SAV_2264 Transmembrane efflux protein
SAV_2265 Hypothetical protein
SAV_2266 MmfP homologue
SAV_2267 MmfH homologue
SAV_2268 MmyR homologue
SAV_2269 MmfL homologue
SAV_2270 MmfR homologue
SAV_2272 MmgE/PrpD family protein
SAV_2273 Isomerase
SAV_2274 Diacylglycerol kinase
SAV_2275 Transmembrane efflux protein
SAV_2276 3-oxoacyl-ACP synthase
SAV_2277 Thioesterase
SAV_2278 F420-dependent dehydrogenase
SAV_2279 Long-chain-fatty-acid-CoA ligase
SAV_2280 Modular polyketide synthase
SAV_2281 Modular polyketide synthase
SAV_2282 ACP
SAV_2283 Aldehyde dehydrogenase
SAV_2284 Isobutylamine N-hydroxylase
SAV_2285 Ornithine aminotransferase
SAV_2286 Cyclase
Name Proposed Function
SAV_2287 Integral membrane protein
SAV_2288 NADPH-flavin oxidoreductase
SAV_2289 Hypothetical protein
SAV_2290 3-oxoacyl-ACP synthase
SAV_2291 ACP
SAV_2292 3-oxoacyl-ACP synthase
SAV_2293 Amino acid permease
SAV_2294 Seryl-tRNA synthetase
SAV_2295 Enoyl-ACP reductase
SAV_2296 Ferredoxin
SAV_2297 MFS transporter
SAV_2298 Fatty acid desaturase
SAV_2299 Hypothetical protein
SAV_2300 Integral membrane lysyl-tRNA synthetase
SAV_2301* SARP family transcriptional regulator *
SAV_2302 Membrane protein
SAV_2303 Methylmalonyl-CoA carboxyltransferase
SAV_2304 Hypothetical protein
SAV_2305 Enamine deaminase
SAV_2306 Acyl-CoA dehydrogenase
SAV_2307 Acyl-CoA synthetase
SAV_2308 PaaX family transcriptional regulator
S1S2
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Figure 6-2 – Conserved direct heptameric repeats were identified in the 
promoters of divergently adjacent putative operons. SARP-like binding sequences 
are similar to other experimentally confirmed SARP binding sites identified in 
Streptomyces bacteria. SAV_2301 activator is proposed to bind to the sequences to 
activate expression of downstream genes. Image adapted from reference 161. 
 
From earlier MEME enrichment analysis, one of the TetR binding sites was found in 
the sav_2301 promoter. The ARE sequence was discovered to overlap 
the -10 and -35 boxes; this implies the binding of TetR repressors to the specific ARE 
sequence is expected to prevent expression of sav_2301 (Figure 6-1 and Figure 6-3). 
The predicted SARP binding sequence is located upstream of the promoter elements 
of sav_2301 and binding of SAV_2301 activator to the SARP binding sequence is 
expected to drive expression of itself and further amplify signals for the azoxy 
biosynthetic genes (Figure 6-3). Intriguingly, the ARE sequence is located 
downstream of the predicted SARP binding sequence and there is a 2 bp nucleotide 
overlap between the two sequences; binding of TetR repressors is speculated to 
block binding of SARP activator and/or RNA polymerase (Figure 6-3). Therefore, 
overexpression of sav_2301 transcriptional activator alone may not result in the 
activation and expression of the silent biosynthetic gene cluster, genetic inactivation 
of TetR repressors or addition of a specific amount of AHFCA signalling molecules is 
proposed to be required for the overproduction of compounds of interest. Another 
TCCCGCC- -TCGCAAC- -TCAACAG    sav_2300-sav_2301
TCAGGCC- -TCAGCGG- -TCAGATT    sav_2283-sav_2282
TCACGTG-15-TCAGGTG- –TCAGGGA vlmA-vlmH
TCACAGG-15-TCAGAAA- -TCAGGAA    vlmJ
TCGAAGT- -TCGAGCC- -TCGAGTG    actVI-ORF1
TCGAACC- -TCGAGGG- -TCGAGGC    actVI-ORFA
TCGACCC-15-TGGAGTG- -TCGAGGC    dnrD
TCGAGCT- -TGGACCG- -TCAAGCC    fdmD
TCCAGCC-15-TCGAGTC               fdmR2
4
4
4
4
4
4
4
4
4
4
4
4
4
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conserved SARP-like binding sequence was also identified within the 
sav_2282 - sav_2283 intergenic region and SAV_2301 activator is expected to drive 
expression of the two divergently adjacent operons. Additionally, MEME enrichment 
analysis did not reveal any ARE sequence within the sav_2282 - sav_2283 intergenic 
region; therefore, overexpression of sav_2301 is expected to increase expression of 
divergently adjacent sav_2282 - sav_2272 and sav_2283 - sav_2294 operons (Figure 
6-1). 
 
 
Figure 6-3 – Binding of TetR repressors to the ARE sequence (turquoise line), 
which overlaps the -35 and -10 boxes for sav_2301 (black line), is expected to 
prevent expression of sav_2301. SAV_2301 activator is predicted to bind to 
heptameric repeats (green line) located upstream of the promoter elements to 
drive expression of itself. The -10 and -35 boxes were predicted using BPROM. 
 
6.2. Cross-talk with other specialised metabolite biosynthetic gene clusters 
in S. avermitilis 
FIMO analysis of the S. avermitilis putative AHFCA-dependent signalling system 
reveals a total of 246 TetR binding sites across the S. avermitilis genome. Of these 
246 predicted TetR binding sites, 81 binding sites were located in promoter of ORFs 
(within 300 bp of an ORF start codon) and 8 of these binding sites were located 
within specialised metabolite biosynthetic gene clusters (Table 6-1 and Electronic 
Supplementary Material). The S. avermitilis AHFCA-dependent signalling system 
-35                                              -10
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may cross-talk and regulate (activating or repressing) other biosynthetic gene 
clusters, such as filipin or oligomycin clusters (Table 6-1). Furthermore, detailed 
analysis of FIMO results revealed a binding site upstream of aco gene (sav_3706), 
which encodes for a key enzyme involved in the biosynthesis of avenolides (Table 
6-1). 40 
 
Table 6-1 – Proposed SAV_2268/SAV_2270 binding sites in S. avermitilis 
specialised metabolite biosynthetic gene clusters. 
Start End ARE Sequence 
Gene downstream 
of ARE sequence 
Gene 
Cluster 
527141 527164 AAGCCGCCTTCGCGCACGTACGTG sav_416 Filipin 
2766276 2766299 AGAATTCGTTCACGAACGTATCTT sav_2267 AHFCA 
2766276 2766299 AAGATACGTTCGTGAACGAATTCT sav_2268 AHFCA 
2768078 2768101 AATATACCTGCGCGAAGGTATATT sav_2269 AHFCA 
2803762 2803762 AAAATACCTTCTCAAAGGAATTAT sav_2301 Azoxy 
2910600 2910623 AGAACTCGTCCATGATGGACTTCT sav_2385 Aromatic 
PK 3536473 3536496 AAACTTCGGCCGAGCAGGAATTCA sav_2892 Oligomycin 
3536473 3536496 TGAATTCCTGCTCGGCCGAAGTTT sav_2891 Oligomycin 
4585568 4585591 AAGATACGTACTAGACGGTTTTGT sav_3706 Avenolide 
8790017 8790040 ACTCATCCTGCGCGTACGTGTCCT sav_7362 PK 
 
The avenolide signalling molecules represents a structually distinct family of 
signalling molecules compared to the AHFCAs (Figure 6-4); it is a small diffusible 
butenolide molecule produced in S. avermitilis and their mechanism of action is 
proposed to be analogous to that of GBL and AHFCA signalling molecules. 40 The 
avenolides have been shown to be essential for avermectin production and deletion 
of the aco gene results in the abolished production of both avermectins and 
avenolides. 40  
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Figure 6-4 – Avenolide signalling molecules in S. avermitilis are essential for 
avermectin biosynthesis. 
 
The avenolide signalling gene cluster contains a total of 5 genes (Figure 6-5), which 
consists of 3 TetR repressor genes, avaR1 (sav_3705), avaR2 (sav_3703) and avaR3 
(sav_3702), and 2 biosynthetic genes, aco and cyp17 (sav_3704); aco and cyp17 gene 
products encodes for a putative acyl-CoA oxidase and cytochrome P450 
respectively. 40 AvaR1 and AvaR3 are negative regulators of the avermectin 
biosynthetic gene cluster as deletion of avaR1 and avaR3 resulted in increased 
production of avermectins; the biological role and activity of AvaR2 has yet to be 
investigated. 178,179  
 
MEME enrichment analysis was performed on the avenolide-dependent signalling 
system to determine AvaR1, AvaR2 and AvaR3 binding sites across the S. avermitilis 
genome. Highly conserved semi-palindromic sequences in promoters of TetR 
repressor genes and upstream of aco gene were successfully identified (Figure 6-5). 
Previously published EMSA and DNase I footprinting analyses established that 
AvaR1 repressor can bind upstream of the aco promoter region (126 bp upstream 
of aco start codon) and protected a 30 bp sequence. 40,178 However, MEME 
enrichment analysis could not identify this specific DNA sequence, but a different 
ARE sequence was found in the aco promoter (Figure 6-5). The experimentally 
confirmed AvaR1 binding sequence (AAGACAAAACCGTCTAGTACGTATCTTTGA; 
palindromic sequences are highlighted in red) contains a longer variable spacer 
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compared to other ARE sequences and is most likely the reason why the MEME 
enrichment analysis failed to find this specific sequence (Figure 6-5); these 
observations suggests AvaR1, AvaR2 and AvaR3 may have different binding 
specificities and the MEME enrichment analysis may be bias towards the prediction 
of AvaR2 and/or AvaR3 repressors assuming that AvaR1 recognises a different 
sequences. 
 
 
Figure 6-5 – The avenolide signalling system (a) is proposed to regulate 
avermectin biosynthetic gene cluster by controlling expression of aveR.  
MEME enrichment analysis (b) revealed conserved semi-palindromic ARE 
sequences in the avenolide-dependent signalling system and promoter of aveR. 
 
The predicted ARE sequences for the AHFCA-dependent and avenolide-dependent 
signalling system in S. avermitilis were found to overlap avaR1 and aco promoter 
Name
bp upstream
of start codon
p-value Sites
SAV_3706 250 1.23e-11 GACCGGGACG ATAAAACCAGCTGAACGGTTTTTC AATGCTCCCC
SAV_3705 170 1.23e-11 GGGGAGCATT GAAAAACCGTTCAGCTGGTTTTAT CGTCCCGGTC
SAV_3703 36 1.29e-10 CTGATGCGCG AGAAAACCGCACAAGCGGTTTGTT AAAGTTGCTG
SAV_3702 41 1.42e-10 GGGCGCCACA AACAAACCGCTATGCTGGTTTCTT GCAGGGCCCT
SAV_935 24 3.08e-7 TCAAGCAATC GAAATCCCCGAGACACGCTTTCTT GGAAAAAGGA
E-value : 2.0e-001
Avenolide biosynthetic gene cluster
Avermectin biosynthetic gene cluster
1kb
aco
ARE
avaR1cyp17
ARE
avaR3avaR2
ARE
10kb aveR
ARE
a)
b)
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elements respectively (Figure 6-6), and binding of TetR repressors are expected to 
repress the expression of avaR1 and aco. Most significantly, the ARE sequence, 
which was predicted for the AHFCA-dependent signalling system, is consistent with 
the experimentally confirmed AvaR1 binding site (Figure 6-6); 
SAV_2268/SAV_2270 repressors may have similar binding specificities as 
AvaR1.  40,178 
  
 
Figure 6-6 – MEME enrichment analysis predicted a TetR binding sites (underlined 
in turquoise) for AHFCA-dependent (ARE1) and avenolide-dependent (ARE2) 
signalling system within the avaR1 - aco intergenic region; both ARE sequences 
overlap the -10 and -35 boxes of avaR1 and aco respectively. The experimentally 
confirmed avaR1 binding is highlighted in a purple box. 
 
Detailed analysis of the avenolide-dependent signalling system reveals a total of 253 
individual binding sites across the S. avermitilis genome and 58 binding sites were 
found in promoters of ORFs (within 300 bp of the start codon) (Electronic 
Supplementary Material). One binding site of interest was located upstream of the 
aveR promoter, also known as sav_935 (Figure 6-5 and Table 6-2). AveR encodes for 
ARE1
-10-35
-10 -35
ARE2
ARE1
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a transcriptional activator that belongs to the LAL family of transcriptional regulator 
and has been found to be essential for the production of avermectins and also 
appears to negatively regulate oligomycin biosynthesis. 180,181 EMSA and in vivo 
assays have also confirmed the binding of AvaR1 repressor to the promoter of aveR 
(Wang, W. Personal communication).  
 
Table 6-2 – Proposed AvaR1/AvaR2/AvaR3 binding sites in S. avermitilis 
specialised metabolite biosynthetic gene clusters. 
Start End ARE Sequence 
Gene downstream 
of ARE sequence 
Biosynthetic 
gene cluster 
1131715 1131735 AATACCGGGTGACCGGTATGT sav_935 (aveR) Avermectin 
3930109 3930129 CACAACCGTCCGGCGGGTGTT sav_3155 NRP 
4581364 4581384 ACAAACCGCTATGCTGGTTTC sav_3702 (avaR2) Avenolide 
4583028 4583048 AAAACCGCACAAGCGGTTTGT sav_3703 (avaR3) Avenolide 
4585448 4585468 AAAAACCGTTCAGCTGGTTTT sav_3705 (avaR1) Avenolide 
4585448 4585468 AAAAACCGTTCAGCTGGTTTT sav_3706 (aco) Avenolide 
 
Bioinformatic analysis of TetR repressor binding sites in the S. avermitilis avenolide-
dependent signalling system has therefore provided unprecedented information of 
the complex regulatory network. The avenolide-dependent signalling system 
appears to be very complicated and does not specifically regulate any neighbouring 
biosynthetic gene cluster, but controls expression of several biosynthetic gene 
clusters across the genome. Binding of AvaR1/AvaR2/AvaR3 and 
SAV_2268/SAV_2270 to the predicted ARE sequence needs to be further 
investigated in order determine their exact biological roles and functions. From 
genome mining analysis, analogous avenolide signalling gene clusters have been 
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identified in S. fradiae, S. ghanaensis and S. griseoauranticus and investigations into 
these clusters may result in the discovery of avenolide-like signalling molecules. 40 
 
Inactivation of sav_2268 or sav_2270 repressors in the AHFCA-dependent signalling 
system may indirectly affect regulation of several other gene clusters, such as those 
for avenolide, avermectin, oligomycin and filipin biosynthesis. Furthermore, global 
transcriptional regulators may regulate the azoxy biosynthetic gene cluster and 
deletion of sav_2270 may not result in the unlocked production of the predicted 
azoxy compounds. Using heterologous hosts would prevent the cross-talk between 
diverse biosynthetic gene clusters from S. avermitilis; although cross-
communication with another set of gene clusters may still occur in heterologous 
hosts. The azoxy-containing metabolites (1 - 3) were not detected in S. lividans 
heterologous hosts containing the pESAC13A constructs, which could be explained 
by the fact that this cluster may still be tightly regulated. 
 
 
6.3. Inactivation of sav_2268 to unlock the production of azoxy compounds 
and AHFCA signalling molecules 
In our previous studies of AHFCA-dependent signalling systems in S. coelicolor and 
S. venezuelae, inactivation of mmyR and gbnR repressor led to the overproduction of 
specialised metabolites (methylenomycins and gaburedins respectively), as well as 
overproduction of AHFCAs (Sidda, J. D. Manuscript in preparation). 57,62 Inactivation 
of sav_2268 (mmyR orthologue) in the azoxy gene cluster was therefore expected to 
result in the constitutive production of azoxy compounds (1 - 3) and AHFCAs 
(Figure 3-12).  
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Various approaches and methodologies have been attempted to exploit regulatory 
systems that controls production of metabolites, including the deletion of 
transcriptional repressors and overexpression of transcriptional activators. 131,182  
 
The pER2 plasmid, which was previously constructed by separately cloning 
sav_2267 and sav_2269 into the pCC4 vector, was used to delete the entire sav_2268 
repressor gene in S. lividans heterologous host strains by double homologous 
recombination (Figure 6-7 and Figure 6-8). The pER2 plasmid, which is based on the 
pCC4 vector, contains the integrative element of pSAM2 that is needed to be deleted 
to prevent prevent site-specific recombination (Figure 6-8). 183 The pER2 plasmid 
was digested with AclI restriction enzyme, and the 8.3 kb DNA fragment was 
recovered by gel extraction and re-ligated to generate a pER2Δint construct (Figure 
6-9).  
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Figure 6-7 – Homologous recombination strategy to delete the sav_2268 repressor 
gene in pESAC13A-2H and pESAC13A-19K. 
 
 
 
 
Figure 6-8 – The sav_2269 and sav_2267 genes were separately cloned into the 
integrative pCC4 vector to produce the pER2 plasmid. 
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Deletion of the integrative system in pER2 plasmid was screened by AclI restriction 
enzyme digestion, PCR, and DNA sequencing. For the restriction enzyme digestion 
screening, a single product of 8,309 bp was expected and a band consistent with this 
size was observed for the digested pER2Δint; confirming the deletion of the 
integrase system (Figure 6-9 and Figure 6-10). To further support the deletion of 
the integration system, primers (for_integrase_screen and rev_integrase_screen, see 
Table 2-3) were designed to anneal upstream and downstream of the AclI restriction 
enzyme site and a band consistent with the expected PCR product of 3,214 bp for 
pER2 and 552 bp for pER2Δint were obtained by PCR (Figure 6-10). The 552 bp PCR 
product for pER2Δint was sent for DNA sequencing and results further confirmed 
the successful deletion of the integrase system. 
 
 
Figure 6-9 – The pER2 plasmid was digested with AclI restriction enzyme to delete 
the integrase system. The resulting 8.3 kb digested fragment was re-ligated to 
generate the pER2Δint construct. 
 
 
pER2Δint
8,309 bps
AclI
hygR
SAV_2267
SAV_2269
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pER2
10,971 bps
AclI
AclI
int_pSAM2
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SAV_2267
SAV_2269
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Figure 6-10 – The integrase element was confirmed to be deleted in the pER2Δint 
construct by (a) AclI restriction enzyme digestion and (b) PCR. For the AclI 
restriction enzyme digestion, bands corresponding to the expected product of 
8,303 bp was obtained in the pER2Δint plasmid (c) Primers (purple arrows) were 
designed to flank the AclI restriction enzyme site and (b) a band consistent the 
expected PCR product of 552 bp was obtained in the pER2Δint plasmid. 
 
The pER2Δint construct was successfully introduced into conjugative E. coli 
ET12567/pUZ8002 host by electroporation and intergenic conjugation was 
successfully carried out between E. coli ET12567/pUZ8002/pER2Δint and 
S. lividans heterologous host strains containing pESAC13A-2H and pESAC13A-19K; 
exconjugants were selected with apramycin and hygromycin. Since the integrative 
system of pER2 were deleted in pER2Δint construct, the first recombination event 
was expected to occur in the sav_2269 or sav_2267 arms with homologous DNA 
sequence to those in the azoxy gene cluster integrated into the chromosome (Figure 
6-7 and Figure 6-11). The first recombination event would integrate the entire 
pER2Δint construct, which contains the hygromycin resistance gene, into S. lividans 
TK24/pESAC13A-2H and S. lividans TK24/pESAC13A-19K to generate hygromycin 
resistant S. lividans colonies (Figure 6-7 and Figure 6-11). The second 
recombination event was obtained after passaging S. lividans colonies on SFM agar 
L
bp
5000
20002.7kb
8.3kb
3.2kb
0.5kb
bp
500
La)                                           b)                                         c)
pER2Δint
8,309 bps
AclI
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with apramycin and nalidixic acid but no hygromycin. After each passage, S. lividans 
colonies were streaked for single colonies and selected for hygromycin sensitivity 
(Figure 6-11). The second recombination event where the pER2Δint backbone was 
lost resulting in hygromycin sensitive S. lividans mutant strains (Figure 6-7 and 
Figure 6-11) was desired and importantly deletion of the sav_2268 repressor gene 
was expected in some of these new mutants. A total of 4 hygromycin sensitive 
S. lividans TK24/pESAC13A-2H Δsav_2268 mutant strains were obtained and 
deletion of sav_2268 repressor gene was assessed by a series of PCR and DNA 
sequencing.  
 
 
Figure 6-11 – S. lividans TK24/pESAC13A-2H/pER2Δint were passaged on SFM 
agar to obtain double cross-over mutations. Hygromycin sensitive 
S. lividan TK24/pESAC13A-2H Δsav_2268 mutant colonies were obtained after 4 
passages. 
 
- Hygromycin + Hygromycin
- Hygromycin + Hygromycin Streak for single colonies
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Primers (for_integrase_screen and rev_integrase_screen, see Table 2-3), which 
annealed to the pER2Δint backbone, were used to confirm the absence of the 
pER2Δint construct and hence that double-cross over had occured in S. lividans 
mutant strains. A band corresponding to the expected PCR product of 552 bp was 
only observed in positive controls of pER2Δint and 
S. lividans/pESAC13A-2H/pER2Δint (Figure 6-12) and were absent in negative 
controls of pESAC13A-2H and S. lividans TK24/pESAC13A-2H. Most significantly, 
the expected PCR product of 552 bp was absent in all of the four S. lividans mutant 
strains, which confirms the deletion of the pER2Δint backbone and hence, double 
homologous recombination has occurred in the 4 hygromycin sensitive mutant 
strains. 
 
 
Figure 6-12 – PCR confirmed the removal of pER2Δint backbone in S. lividans 
mutant strains. A band corresponding to the expected PCR product of 552 bp was 
obtained in the positive control pER2Δint (Lane P) and hygromycin resistant 
S. lividans TK24/pESAC13A-2H/pER2Δint (Lane C), but is absent in the 4 double 
cross-over S. lividans mutant strains (Lane 1 - 4); thus confirming the successful 
removal of the pER2Δint backbone. DNA of pESAC13A-2H (Lane A) and 
S. lividans TK24/pESAC13A-2H (Lane B), which do not have the pER2Δint 
construct, were used as negative controls. 
 
 
L    P   A  B   C   1    2    3    4   L
0.5kb0.5kb
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700
400
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Primers (for_sav_2268_deletion_screen and rev_sav2268_deletion_screen, see Table 
2-3) were designed to confirm the deletion of sav_2268 repressor by annealing to 
sav_2266 and sav_2270 gene (Figure 6-13). A band corresponding to the expected 
PCR product of 2,536 bp was observed in the 4 S. lividans mutant strains; thus, 
further confirming the successful deletion of sav_2268 gene (Figure 6-13). The 
negative controls, pESAC13A-2H and S. lividans TK24/pESAC13A-2H do not have 
the sav_2268 repressor deleted and a band corresponding to the expected product 
of 3,235 bp was obtained by PCR (Figure 6-13).  
 
 
 
Figure 6-13 – PCR confirmed the deletion of sav_2268 gene in the 4 S. lividans 
mutants strains. (A) Primers were designed to anneal to sav_2266 and sav_2270 
gene. (B) A band consistent with the expected product of 2,536 bp was observed in 
the 4 S. lividans mutant strains (Lane 1 – 4). As expected, no PCR products was 
observed in the pER2Δint (Lane P) and the expected band corresponding to 
3,235 bp was obtained in pESAC13A-2H and S. lividans TK24/pESAC13A-2H 
negative controls.  
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Finally, the DNA region between sav_2267 and sav_2269 was sequenced to confirm 
the correct deletion of sav_2268. Primers (for_avaA-B_screen and 
rev_avaA-B_screen, see Table 2-3), which flanked sav_2268, were used to amplify the 
sav_2267 - sav_2269 intergenic region. PCR product was analysed by DNA 
sequencing and results confirmed the successful deletion of sav_2268 in all 4 of the 
mutant strains (Figure 6-14); errors were observed near the ends of sequencing 
reads, but were corrected by sequencing of the reverse strand (Figure 6-14). 
 
 
Figure 6-14 – DNA sequencing confirmed the successful deletion of sav_2268 gene 
in the 4 repressor mutant strains. Sequencing reads of for_avaA-B_screen (54JG71, 
54JG73, 54JG75 and 54JG77) and rev_avaA-B_screen (54JG72, 54JG74, 54JG76 and 
54JG78) were aligned against the Δsav_2268 mutant template. Nucleotide positions 
of sav_2267 and sav_2269 reading frames are highlighted as black arrows and 
nucleotide matches are highlighted in green. 
 
6.3.1. Additional attempts to inactivate the sav_2268 repressor gene 
6.3.1.1. Double homologous recombination in S. avermitilis 
The same double homologous recombination strategy was attempted in the native 
organism, S. avermitilis (Figure 6-7); however, intergenic conjugations between 
E. coli ET12567/pER2Δint and S. avermitilis were unsuccessful in our hands. The 
deletion of sav_2268 could therefore not be carried out using the same approach as 
in the S. lividans heterologous host strains. An alternative solution would be to 
sav_2269sav_2267
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introduce the pER2Δint construct into S. avermitilis through polyethylene glycol 
assisted protoplast transformation, which involves removing the Streptomyces 
bacteria’s cell wall and introducing the DNA material through the cell membrane 
directly by electroporation. 184,185,186  
6.3.1.2. Double homologous recombination in S. coelicolor heterologous 
host strains 
While the predicted azoxy compounds 1 - 3 were produced in S. coelicolor host 
containing the azoxy pathway, deletion of sav_2268 was expected to result in the 
overproduction of these metabolites. As with S. lividans hosts, the same double 
homologous recombination strategy (Figure 6-7) was attempted with S. coelicolor 
hosts containing the azoxy pathway. Conjugation between 
E. coli/ET12567/pER2Δint and S. coelicolor was successful, and after the 8th 
passage, one S. coelicolor M1152/pESAC13A-2H and two S. coelicolor 
M1152/pESAC13A-19K hygromycin sensitive colonies were obtained. Deletion of 
sav_2268 gene in hygromycin sensitive S. coelicolor mutant strains remains to be 
confirmed by PCR and DNA sequencing. 
6.3.1.3. PCR targeting approach 
Due to the slow growth of Streptomyces bacteria, deletion of genes via double 
homologous recombination can take a considerable amount of time to accomplish. 
Therefore, deletion of genes within E. coli hosts can provide a quicker approach to 
producing mutants. The PCR targeting system, which takes advantage of the λ-RED 
recombination system, has been successful in generating thousands of mutants in 
E. coli K12, as well as creating knock-outs in gene clusters. 56,131,187 The “PCR 
targeting system in Streptomyces coelicolor A3(2)” protocol was followed in an 
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attempt to replace the sav_2268 repressor gene with a kanamycin disruption 
cassette in E. coli (Figure 6-15). 131,182  
 
Due to the temperature sensitive pKD20 plasmid, introduction of low copy 
pESAC13A constructs in E. coli BW25113/pKD20 by electroporation needed to be 
carried out at 30 ⁰C; however, electroporation of the pESAC13A constructs into an 
E. coli BW25113/pKD20 host were unsuccessful and is most likely due to the 
inefficiency of introducing large fragile pESAC13A-2H and pESAC13A-19K DNA into 
the slow growing E. coli bacteria. To overcome this problem, pESAC13A-2H and 
pESAC13A-19K were successfully introduced in empty E. coli BW25113 by 
electroporation performed at 37 ⁰C. The pKD20 plasmid, which contains the λ-RED 
recombination system, was later reintroduced into E. coli BW25113/pESAC13A-2H 
and E. coli BW25113/pESAC13A-19K by electroporation and confirmed by PCR 
(for_PKD20_screen and rev_pKD20_screen, see Table 2-3). 
 
The kanamycin disruption cassette, which was cloned from pIJ777 
(for_Target_SAV_2268 and rev_Target_SAV_2268, see Table 2-3), was introduced 
into arabinose induced E. coli BW25113/pKD20/pESAC13A-2H and 
E. coli BW25113/pKD20/pESAC13A-19K by electroporation; however, no 
kanamycin resistant colonies were obtained and deletion of the sav_2268 gene was 
unsuccessful. Alternative kanamycin disruption cassettes were amplified with 
different primers (for_Target_SAV_2268_2 and rev_Target_SAV_2268_2, see Table 
2-3) and had also failed to produce kanamycin resistant colonies. Unsuccessful 
attempts to delete sav_2268 via PCR targeting may be due to the resulting 
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overexpression of the azoxy biosynthetic genes, which could cause a toxic 
environment and hence may kill the E. coli bacteria.  
 
 
Figure 6-15 – PCR targeting approach to replacing sav_2268 gene with a 
kanamycin disruption cassette. E. coli BW25113/pKD20 contains a temperature 
sensitive and arabinose inducible λ-RED recombination system, which increases 
recombination probability between extremities of the kanamycin resistance gene 
and sav_2268 gene. 
 
6.3.2. Attempts to overexpress the sav_2301 transcriptional activator  
Overexpression of sav_2301 cluster-situated pathway-specific transcriptional 
activators in the predicted azoxy biosynthetic gene cluster provides an alternative 
strategy to overproduce the azoxy compounds. Cloning of sav_2301 gene 
(for_SAV_2301_2 and rev_SAV_2301_2, see Table 2-3), with appropriate ribosome 
binding site and flanking restriction sites, was successful; however, the cloned 
sav_2301 DNA fragment could not be introduced downstream of ermE* promoter of 
pCC4 and pOSV556 vectors via HindIII and PstI sites (Figure 6-16). 
E. coli BW25113/pKD20
amp, 30  C
pESAC13A
Disruption 
cassette
E. coli
BW25113/pKD20/pESAC13A
apra, kan 37  C
E. coli BW25113/pESAC13A
apra, kan 37  C
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amp, apra 30  C
L-arabinose
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Figure 6-16 – The pCC4 plasmid is a derivative of the pOSV556 plasmid where the 
ampicillin resistance gene was replaced with an apramycin resistance gene. HindIII 
and PstI sites are located downstream of the ermE* constitutive promoter. 
 
A synthetic sav_2301 gene was also ordered and subcloning into pOSV556 was 
requested (Life Technologies). The sav_2301 transcriptional activator gene contains 
TTA codon between position 46 to 48. BldA encodes for the rare UUA leucine tRNA 
and regulates many biological processes in Streptomyces bacteria including 
morphological differentiation and antibiotic production. This leucine tRNA is known 
to be functional only in specific growth phases; 130 hence, the TTA codon was 
changed to GAG to prevent the BldA-dependent regulation of  
sav_2301. 57  
 
The altered sav_2301 transcriptional activator gene was successfully synthesised 
into pMK-RQ vector and introduced into E. coli K12 by Life Technologies (Figure 
6-17). However, Life Technologies were also unsuccessful in subcloning the 
synthetic sav_2301 gene into pOSV556 vector and suggests there might be toxicity 
issues with overexpression of the SARP transcriptional activator in E. coli hosts; this 
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may explain why the deletion of sav_2268 repressor, which is expected to result in 
sav_2301 expression, in E. coli BW25113 hosts was unsuccessful. To overcome 
toxicity issues, inducible vectors may provide an alternative approach in controlling 
toxic effects of the transcriptional activator.  
 
 
Figure 6-17 – The altered sav_2301 gene was synthesised and introduced into the 
kanamycin resistant pMK-RQ vector by Life Technologies. 
 
6.4. Comparitive metabolic profiling of S. lividans mutant strains grown in 
SMMS agar 
Comparative metabolic profiling of S. lividans mutant strains were carried out to 
determine whether the production of the predicted azoxy compounds (1 - 3) were 
overproduced. 
 
Different phenotypes were observed when the S. lividans mutant strains were 
grown on SMMS agar (Figure 6-18); the repressor mutants were a significantly 
darker red in colour when compared with wild type S. lividans TK24. 
pMK-RQ_SAV_2301
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S. lividans TK24 also contains the prodiginine gene cluster and the repressor mutant 
is speculated to have altered production of the prodigines. However, base peak 
chromatogram (m/z = 392.0 - 396.0) was unable to detect the red-pigmented 
prodiginine compounds. 188  
 
 
Figure 6-18 – Different phenotypes were observed in the S. lividans heterologous 
host strains when grown on SMMS agar for 6 days. 
 
Productions of the predicted azoxy compounds (1 - 3) was expected to be unlocked 
in the repressor mutant. Extracted ion chromatograms could not detect either the 
predicted azoxy compounds (1 - 3) (m/z = 201.0 and 219.0) or aromatic amine 
compounds (4 - 6) (m/z = 268.0, 278.0 and 272.0) in S. lividans mutant strains. This 
suggests the predicted azoxy biosynthetic gene cluster is still tightly regulated at the 
transcriptional level or specific precursor supply is required for production of azoxy 
compounds. 
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Whilst the previously observed compounds (1 - 6) were not detected in S. lividans 
mutant strains, LC-MS analysis of the acidified and neutral extracts revealed a series 
of compounds (7 - 16) that were unlocked and overproduced in mutant strains 
(Figure 6-19). UHPLC-ESI-TOF-MS analyses of compounds 7 - 14 (m/z = 270.2) and 
compounds 15 and 16 (m/z = 254.2) suggest that compounds 7 - 16 are related 
polyunsaturated fatty acid amines (PUFAA) (Table 6-3) and confirms that 
compounds 7 - 14 and compounds 15 and 16 are isomers. 
 
The exact biological relevance of the observed PUFAA compounds remains unclear; 
however, it is interesting to note that the production of the predicted PUFAA 
compounds (7 - 14) were only observed in the deletion of sav_2268 repressor gene 
in S. lividans TK24/pESAC13A-2H heterologous hosts and hence, the predicted 
PUFAA compounds (7 - 14) are speculated to be intermediates or products of the 
predicted azoxy biosynthetic gene cluster. However one cannot exclude at this stage 
that deletion of the repressor gene may have unlocked the production of novel 
cryptic compounds, alternatively, the azoxy biosynthetic genes could be modifying 
endogenous metabolites produced by S. lividans TK24. 
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Figure 6-19 – Comparative metabolic profiling of S. lividans mutant strains 
identified a series of PUFAA compounds (7 - 16). Extracted ion chromatograms 
(m/z = 254.0 and 270.0) detected compounds (7 - 16) only in the mutant strains 
grown on SMMS agar. 
 
Detailed analysis of UHPLC-ESI-TOF-MS traces revealed the predicted PUFAA 
compounds (7 - 16), which were overproduced in mutant strains, were almost 
undetectable in S. lividans heterologous host strains (Figure 6-20) and deletion of 
the sav_2268 gene in S. lividans heterologous host strains has been essential to 
identify these metabolites (7 - 16). 
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Table 6-3 – Compounds detected in acidified and neutral organic extraction of 
S. lividans mutant strains grown on SMMS agar. 
# 
Retent. 
Time 
(min) 
[M+H]+ [M+Na]+ 
Formula Observ. Calc. Formula Observ. Calc. 
7 22.3 C15H28NO3 270.2070 270.2069 C15H27NO3Na 292.1886 292.1889 
8 22.6 C15H28NO3 270.2071 270.2069 C15H27NO3Na 292.1887 292.1889 
9 22.8 C15H28NO3 270.2067 270.2069 C15H27NO3Na 292.1884 292.1889 
10 23.9 C15H28NO3 270.2073 270.2069 C15H27NO3Na 292.1886 292.1889 
11 24.1 C15H28NO3 270.2073 270.2069 C15H27NO3Na 292.1885 292.1889 
12 24.5 C15H28NO3 270.2062 270.2069 C15H27NO3Na 292.1884 292.1889 
13 24.8 C15H28NO3 270.2068 270.2069 C15H27NO3Na 292.1895 292.1889 
14 25.6 C15H28NO3 270.2067 270.2069 C15H27NO3Na 292.1885 292.1889 
15 26.5 C15H28NO2 254.2124 254.2120 C15H27NO2Na 276.1941 276.1939 
16 25.7 C15H28NO2 254.2125 254.2120 C15H27NO2Na 276.1941 276.1939 
 
 
 
Figure 6-20 – Extracted ion chromatogram (m/z = 270.2067 and 254.2124) of 
UHPLC-ESI-TOF-MS traces revealed the predicted PUFAA compounds (7 - 16) are 
produced in minute quantities in S. lividans TK24/pESAC13A-2H (blue trace). 
Compounds 7 - 16 were overproduced in S. lividans mutant strains (black trace) 
and were absent in the wild type S. lividans TK24 (red trace). 
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6.5. Comparitive metabolic profiling of S. lividans mutant strains in VPM 
Previous work on molecular characterisation and analysis of the valanimycin 
biosynthetic gene cluster by Garg and co-workers had similarly captured the 
valanimycin biosynthetic gene cluster from S. viridifaciens on a cosmid and 
subsequently introduced the cosmid construct into S. lividans TK24 as a 
heterologous hosts. To determine whether low precursor supply was responsible 
for the absence of azoxy compounds in SMMS, comparative metabolic profiling of 
S. lividans mutant strains grown in VPM was performed. 162 
 
The predicted azoxy compounds (1 - 3) were finally detected in S. lividans mutant 
strains grown in VPM by LC-MS (Figure 6-21). In addition to the predicted azoxy 
compounds (1 - 3), base peak chromatogram (m/z = 200 - 300) also detected 
AHFCA signalling molecules (17 and 18); the identification of the predicted azoxy 
compounds (1 - 3) and AHFCA signalling molecules (17 and 18) were confirmed by 
UHPLC-ESI-TOF-MS analysis (Table 6-4).  
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Figure 6-21 – Production of the predicted azoxy compounds (1 - 3) and AHFCAs 
(17 - 18) were unlocked in S. lividans mutant strains (black trace), and are absent 
in wild type S. lividans TK24 (red trace), S. lividans TK24/pESAC13A-2H1 (blue 
trace) and blank (green trace). Base peak chromatogram (m/z = 200 - 300) 
detected AHFCA signalling molecules (17 and 18); the high resolution mass 
spectra data are shown for these AHFCA compounds. 
 
 
Table 6-4 – AHFCA compounds detected in acidified organic extracts of S. lividans 
mutant strains grown in VPM. 
# 
Retention 
Time 
(min) 
[M+H]+ [M+Na]+ 
Formula Observed Calculated Formula Observed Calculated 
17 24.0 C11H17O4 213.1138 213.1127 C11H16O4Na 235.0953 235.0946 
18 25.0 C12H19O4 227.1294 227.1283 C12H17O4Na 249.1103 248.1025 
 
10 15 20 25 30 Time [min]
0.0
0.2
0.4
0.6
0.8
1.0
1.2
8x10
Intens.
1
2
3
17 18
17 18
C11H15O3
[M+H-H2O]
195.1043
C11H17O4
[M+H]
213.1139
C11H16O4Na
[M+Na]
235.0953
VP111_GA4_01_73.d: +MS, 16.5-16.6min #993-999
0
2
4
6
8
4x10
Intens.
190 200 210 220 230 240 m/z
VP111_GA4_01_73.d: +MS, 17.4-17.5min #1044-1052
0.0
0.5
1.0
1.5
2.0
2.5
5x10
Intens.
200 210 220 230 240 250 m/z
C12H17O3
[M+H-H2O]
209.1192
C12H19O4
[M+H]
227.1295
C12H18O4Na
[M+Na]
249.1103
Chapter 6: Exploitation of AHFCA-dependent Signalling Systems 
164 
 
6.5.1. Characterisation of S. avermitilis AHFCA signalling molecules  
The presence of AHFCAs were further supported by their mass spectra. Indeed these 
molecules present a characteristic mass spectrum pattern. Intense molecular ion 
peaks for [M+H-H2O]+ and [M+Na]+, but very weak peak for [M+H]+ patterns were 
obtained for compounds 17 and 18 (Figure 6-21 and Table 6-4). 56 
  
Two main structural isomers could be envisaged for each of the predicted AHFCAs 
(17 and 18), which have m/z value for [M+H]+ of 213.1 and 227.1 respectively 
(Figure 6-22). To determine their precise structure, authentic standard of AHFCAs 
consistent with the m/z values observed, i.e. AHFCA3, AHFCA5, AHFCA6 and 
AHFCA7 (obtained from Zhou, S., Challis Group - Warwick) were analysed by LC-MS 
in parallel with organic extracts.  
 
 
Figure 6-22 – Structural isomers of AHFCA3, AHFCA5, AHFCA6 and AHFCA7 
signalling molecules. 
 
Extracted ion chromatogram for AHFCA signalling molecules (m/z = 195.0, 209.0, 
235.0 and 249.0) in diluted organic extracts revealed an unexpected small shoulder 
peak for compounds 17 and 18 and line up with the authentic standards (Figure 
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6-23); this implies compounds 17-1, 17-2, 18-1 and 18-2 are AHFCA3, AHFCA5, 
AHFCA6 and AHFCA7 respectively.  
 
 
Figure 6-23 – S. lividans organic extracts were compared with AHFCA3, AHFCA5, 
AHFCA6 and AHFCA7 authentic standards. Extracted ion chromatogram 
(m/z = 195.0, 209.0, 235.0 and 249.0) showing AHFCA3, AHFCA5, AHFCA6 and 
AHFCA7 were overproduced in S. lividans mutant strains.  
 
Due to high concentration of authentic standards and the use of low resolution 
LC-MS, the retention time of the AHFCA standards did not line up exactly with that 
observed for S. avermitilis AHFCAs (17-1, 17-2, 18-1 and 18-2) (Figure 6-23). 
Co-injection of authentic standards with organic extracts would confirm the nature 
of S. avermitilis AHFCA compounds. In addition UHPLC-MS instead of LC-MS analysis 
would provide a greater retention time resolution. Finally, comparison of 
tandem MS fragmentation patterns would also further confirm the identity of the 
observed compounds (17-1, 17-2, 18-1 and 18-2).  
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6.5.2. Identification of predicted polyunsaturated fatty acid amine 
compounds 
Different phenotypes between S. lividans strains were also observed when grown in 
liquid VPM for 6 days (Figure 6-24). The culture of wild type S. lividans TK24 and 
S. lividans TK24/pESAC13A-2H1 were deep blue and red in colour (Figure 6-24) and 
implies actinorhodin and undecylprogiosin are overproduced respectively. The 
base peak chromatogram was able to detect the overproduction of prodigiosins 
(m/z = 392 - 396) in S. lividans TK24/pESAC13A-2H1; however, the base peak 
chromatogram for actinorhodin (m/z = 632 - 636) could not identify the specific 
compounds. The mutant strains were neither blue or red and implies production of 
actinorhodin and prodigiosins were abolished; the abolished production of 
prodigosin (m/z = 392 for streptorubin B and 394 for undecylprodigiosin) was 
confirmed by UHPLC-ESI-TOF-MS analysis. 
 
 
Figure 6-24 – Different phenotypes were observed when S. lividans strains were 
grown in VPM for 6 days.  
 
Comparative metabolic profiling of acidified organic extracts revealed a series of 
compounds (19 - 45) that were only produced in S. lividans heterologous host and 
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mutant strains (Figure 6-25 and Figure 6-26) using VPM culture medium but not 
SMM. The molecular formulae generated by UHPLC-ESI-TOF-MS analysis for 
compounds 19 - 45 suggests they are related PUFAA compounds (Table 6-5). For 
each m/z value corresponding to PUFAAs, a number of isomers were detected by 
UHPLC-ESI-TOF-MS analysis; for instance, compound 22 has a molecular formula of 
C16H27NO2 and the extracted ion chromatogram (m/z = 266.2113 and 288.1939) 
highlighted another 10 compounds (23 - 33) with the same molecular formula 
eluating at different retention times (Figure 6-25 and Table 6-5). 
 
Surprisingly, the production of the PUFAA compounds (19 - 45) were altered in 
S. lividans mutant strains; compounds 19 - 38 were abolished and compounds 
39 - 45 were significantly reduced in mutant strains (Figure 6-25 and Figure 6-26). 
It is difficult to rationalise why the production of some of the PUFAA compounds 
(39 - 45) are abolished in the repressor mutants.  
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Figure 6-25 – From UHPLC-ESI-TOF-MS traces, extracted ion chromatogram 
detected compounds 19 - 38 from S. lividans TK24/pESAC13A-2H1 (blue trace). 
Compounds 19 - 38 were absent in wild type S. lividans TK24 (red trace), blank 
(green trace) and mutant strains (black trace). Arrows are colour-coded according 
to Table 6-5. 
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Figure 6-26 – From UHPLC-ESI-TOF-MS traces, extracted ion chromatogram 
detected the compounds (39 - 45) in S. lividans TK24/pESAC13A 2H1 (blue trace) 
and were significantly reduced in S. lividans mutant strains (black trace). 
Compounds (19 - 38) were absent in wild type S. lividans TK24 (red trace) and 
blank (green trace). Arrows are colour-coded according to Table 6-5. 
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Table 6-5 – Compounds detected in acidified organic extraction of S. lividans 
heterologous host strains grown in VPM for 6 days. 
# 
Retent. 
Time 
(min) 
[M+H]+ [M+Na]+ 
Formula Observed Calculated Formula Observed Calculated 
19 24.9 C16H28NO 250.2168 250.2171 C16H27NONa 272.1954 272.1990 
20 25.1 C16H28NO 250.2168 250.2171 C16H27NONa 272.1981 272.1990 
21 28.2 C16H28NO 250.2174 250.2171 C16H27NONa 272.1990 272.1990 
22 24.6 C16H28NO2 266.2113 266.2120 C16H27NO2Na 288.1934 288.1939 
23 25.1 C16H28NO2 266.2114 266.2120 C16H27NO2Na 288.1935 288.1939 
24 25.8 C16H28NO2 266.2116 266.2120 C16H27NO2Na 288.1933 288.1939 
25 26.1 C16H28NO2 266.2113 266.2120 C16H27NO2Na 288.1935 288.1939 
26 26.4 C16H28NO2 266.2117 266.2120 C16H27NO2Na 288.1935 288.1939 
27 26.7 C16H28NO2 266.2118 266.2120 C16H27NO2Na 288.1935 288.1939 
28 27.4 C16H28NO2 266.2119 266.2120 C16H27NO2Na 288.1936 288.1939 
29 27.6 C16H28NO2 266.2118 266.2120 C16H27NO2Na 288.1944 288.1939 
30 27.9 C16H28NO2 266.2120 266.2120 C16H27NO2Na 288.1948 288.1939 
31 28.6 C16H28NO2 266.2118 266.2120 C16H27NO2Na 288.1948 288.1939 
32 28.9 C16H28NO2 266.2188 266.2120 C16H27NO2Na 288.1938 288.1939 
33 29.1 C16H28NO2 266.2116 266.2120 C16H27NO2Na 288.1939 288.1939 
34 22.9 C16H26NO 248.2021 248.2014 C16H25NONa 270.1826 270.1834 
35 28.7 C16H26NO 248.2019 248.2014 C16H25NONa 270.1836 270.1834 
36 29.0 C16H26NO 248.2015 248.2014 C16H25NONa 270.1828 270.1834 
37 27.2 C17H30NO2 280.2274 280.2277 C17H29NO2Na 302.2100 302.2096 
38 28.8 C17H30NO2 280.2275 280.2277 C17H29NO2Na 302.2098 302.2096 
39 26.7 C15H26NO 236.2014 236.2014 C15H25NONa 258.1832 258.1834 
40 27.1 C15H26NO 236.2014 236.2014 C15H25NONa 258.1830 258.1834 
41 27.6 C15H26NO 236.2015 236.2014 C15H25NONa 258.1836 260.1990 
42 28.3 C15H26NO 236.2017 236.2014 C15H25NONa 258.1833 258.1834 
43 29.1 C15H26NO 236.2018 236.2014 C15H25NONa 258.1834 258.1834 
44 29.6 C15H26NO 236.2018 236.2014 C15H25NONa 258.1835 258.1834 
45 29.1 C16H30NO2 268.2279 268.2277 C16H29NO2Na 290.2096 290.2096 
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6.6. Prediction of precursors for the azoxy compounds 
From genome mining analyses discussed in Chapter 5.2, the azoxy compounds 
produced in S. avermitilis were proposed to incorporate precursor of polyketide 
origin (Figure 5-5). Detailed annotation of the azoxy biosynthetic genes in 
S. avermitilis show sav_2282 to sav_2280 encodes for polyketide synthase enzymes 
and appears to only contain a single extension module with ketoreductase and 
dehydratase domains (Figure 6-27). 
 
With the detection of polyunsaturated fatty acid amine and aromatic amine 
compounds (4 - 16 and 19 - 45) in S. lividans heterologous host and mutant strains, 
the 3 PKS enzymes are proposed to act in an iterative manner to reuse domains and 
assemble a long fatty acid-like polyketide chain. Presence of a nitrogen atom on the 
predicted PUFAA compounds (7 – 16 and 19 - 45) and aromatic amine compounds 
(4 - 6) could be explained by sav_2279 and sav_2307 gene products, which are 
proposed to encode for a long chain fatty acid-CoA ligase and acyl-CoA synthetase 
respectively; both contain adenylation domains (Figure 6-27). Adenylation domains 
often activates amino acids using ATP, the activated amino acid could be condensed 
to the polyketide derived precursor. The sequence analysis of SAV_2279 and 
SAV_2307 adenylation domains were unable to predict the substrate specificity. 51 
After the assembly of the polyketide chain, SAV_2277 thioesterase is proposed to 
cleave the PUFAA compounds from the ACP.  
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Figure 6-27 – Detailed antiSMASH annotation of biosynthetic genes from the 
predicted azoxy biosynthetic gene cluster in S. avermitilis. Abbreviations are as 
follows: A – adenylation; KS – ketosynthase; AT – acyltransferase; 
DH – dehydrogenase; KR – ketoreductase; TE – thioesterase. Blue circles are acyl 
carrier proteins. 
 
Furthermore, elaiomycins, which are azoxy compounds produced by S. sp. strain 
HKI0708, were shown to incorporate isotope-labelled N-octylamine. 175 In addition, 
azoxyalkenes, produced by S. rochei 7434AN4, were also reported to incorporate 
N-hexylamine. 189 With the idea that the predicted PUFAA compounds might be 
involved in the biosynthesis of the predicted azoxy compounds, the expected 
molecular formula and molecular weight from the incorporation of the observed 
compounds (4 - 16 and 19 - 45) in the biosynthesis of the final azoxy compounds 
are detailed in Table 6-6; however, azoxy compounds consistent with these 
molecular formulae could not be identified by LC-MS. 
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Table 6-6 – Expected azoxy compounds generated from incorporation of the 
observed compounds as precursors 
Compound R group Expected Formula Expected MW 
1 C6H15O C9H18N2O4 218 
2 - 3 C6H13 C9H16N2O3 200 
4 - 5 C19H16 C21H19N2O3 347 
6 C19H18 C21H21N2O3 349 
7 - 14 C15H24O2 C18H27N2O5 351 
15 - 16 C15H24O C18H27N2O4 335 
19 - 21 C16H24 C19H27N2O3 331 
22 - 33 C16H24O C19H27N2O4 347 
34 - 36 C16H22 C19H25N2O3 329 
37 - 38 C17H26O C20H29N2O4 361 
39 - 44 C15H22 C18H25N2O3 317 
45 C16H26O C19H29N2O3 333 
 
The valanimycin compounds were reported to be extremely unstable and structural 
determination of valanimycin was impossible without the formation of stable 
derivatives. A valanimycin ammonia adduct was found to be the most stable and MS 
analysis and structure elucidation by NMR spectroscopy were subsequently 
performed on this stable derivative. 155 The azoxy compounds in S. avermitilis, which 
were proposed to incorporate the PUFAA compounds (4 - 16 and 19 - 45), may be 
unstable and undetectable by LC-MS (Table 6-6). Organic extracts from S. coelicolor, 
S. lividans heterologous host or mutant strains could be treated similarly to the 
valanimycin isolation procedures by Yamato and co-workers to obtain stable 
derivatives and they could then be characterised by MS and NMR spectrum 
analysis.  155  The predicted azoxy compounds are known to incorporate L-serine and 
a genomisotopic guided approach could be used to detect our azoxy compounds of 
interest. 55 
 
The predicted azoxy biosynthetic gene cluster in S. avermitilis also contains other 
enzymes including an intriguing ornithine aminotransferase, which is encoded by 
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sav_2285 (Figure 6-1). The exact biological role of the ornithine aminotransferase 
enzyme in S. avermitilis is unclear in the biosynthesis of the novel azoxy compounds. 
Ornithine aminotransferase is involved in creating ornithine from amino acid 
precursor (Figure 6-28); hence, feeding of isotope-labelled ornithine would provide 
insights into the biosynthesis of the azoxy compounds. 
 
 
Figure 6-28 – Orf6 ornithine aminotransferase enzyme from S. clavuligerus is 
involved in one of the key steps in the biosynthesis of arginine by catalysing the 
conversion of glutamate to ornithine via N-acetylglutamate semialdehyde. Image 
adapted from reference 190. 
 
The azoxy compounds (1 - 3), which were detected in S. coelicolor heterologous host 
and S. lividans mutant strains, may not be the true metabolic product of the 
S. avermitilis azoxy biosynthetic gene cluster; this is supported by the size of the 
gene cluster as well as the nature of some of the genes present in the silent and 
cryptic azoxy biosynthetic gene cluster.  
6.7. Antimicrobial assays to determine the biological activity of the 
predicted azoxy compounds 
The family of azoxy compounds have demonstrated a broad range of biological 
activities including antifungal, antibacterial and antitumour 
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properties.  155,175,191,192,193 The azoxy compounds are highly cytotoxic and 
carcinogenic, and are proposed to act as alkylating agents by specifically reacting 
with DNA and resulting in strand breaks. Valanimycin was reported to be active 
against both Gram-positive and Gram-negative bacteria, but was also shown to be 
more effective against DNA-repair deficient bacteria, which further supports the 
hypothesis that the azoxy compounds primarily targets DNA. 194 To determine the 
biological activity of the observed azoxy compounds (1 - 3), crude organic extracts 
were tested against E. coli, B. subtilis, S. aureus, S. coelicolor and S. lividans. 
 
Crude extract of S. coelicolor heterologous host strains grown on SMM agar or VPM 
did not exhibit any differences in antimicrobial activity when compared to the 
wild type S. coelicolor M1152 crude extracts. This implies that the predicted azoxy 
compounds (1 - 3) and aromatic amine compounds (4 - 6) are not active against the 
Gram-positive and Gram-negative bacteria tested at the concentration of extract 
used. Scaled up production and purification of specific compounds, rather than 
crude extracts, could be used to investigate the biological activities of the 
compounds of interest. 
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Figure 6-29 – Zone of inhibition assays to determine antimicrobial activity of crude 
extract of S. lividans mutant strains grown in VPM. Crude extract of 
S. lividans TK24/pESAC13A-2H1 (2H) and mutant strains (1 - 4) were active against 
B. subtilis, S. aureus, and S. lividans and weakly active against E. coli. Apramycin (+), 
methanol (-), wild type S. lividans TK24 crude extract (c) were used as controls.  
 
Of significant interest, crude organic extracts of S. lividans TK24/pESAC13A-2H 
grown in VPM showed significant antimicrobial activity against both Gram-positive 
and Gram-negative bacteria when compared to extracts from S. lividans TK24 wild 
type (Figure 6-29). The same area of inhibition were observed in S. lividans 
heterologous host and mutant strains, suggesting compounds with antimicrobial 
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activity are produced when pESAC13A-2H is introduced into S. lividans TK24. From 
LC-MS analysis, the production levels of specific compounds are not under the 
control of the SAV_2268 repressor. Comparative metabolic profiling did not reveal 
any compound absent from S. lividans TK24 and produced in similar amounts 
between S. lividans containing the pESAC13A-2H or mutated version of 
pESAC13A-2H. 
 
Interestingly, crude extract from S. lividans heterologous host and mutant strains 
were active against wild type S. lividans TK24 implying pESAC13A-2H also contains 
the resistance genes against these antimicrobial compounds. It should be noted that 
the wild type S. lividans TK24 crude extract were also active against itself and the 
resistance genes may not be expressed. The antimicrobial assays needs to be 
repeated to confirm the antimicrobial activity of the crude organic extracts. 
6.8. Potential cross-talk in S. coelicolor and S. lividans heterologous hosts 
The production of the azoxy compounds (1 - 3) were observed in S. coelicolor 
heterologous hosts grown on SMMS agar; however in the case of S. lividans, the 
azoxy compounds (1 - 3) were still not produced in rich media and deletion of the 
sav_2268 repressor was required to unlock the production of 1 - 3. These 
observations suggest there are two components to the regulation of the predicted 
azoxy biosynthetic gene cluster; firstly, the sav_2268 repressor needs to be deleted 
to allow expression of biosynthetic genes and secondly, there needs to be 
appropriate precursors. 
 
The azoxy compounds (1 - 3) were detected in S. coelicolor heterologous host strains 
grown on SMMS agar and appears to be greatly affected by the availability of 
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nutrients. Indeed the production of 1 - 3 were abolished when S. coelicolor 
heterologous host strains were grown in VPM; nutrient-sensing pleiotropic 
transcription factors may play a role in regulating the azoxy compounds. The 
predicted azoxy compounds (1 - 3) were not detected when S. lividans heterologous 
host strains were grown on SMMS agar and implies either nutrient supply is 
insufficient or other nutrient-sensing transcriptional repressors may still be 
regulating the predicted azoxy biosynthetic gene cluster. 
 
S. coelicolor M1152 and S. lividans TK24 are highly similar species; however, many 
endogenous biosynthetic gene clusters were deleted in S. coelicolor, including the 
ScbR2 "pseudo" GBL-binding receptor (the role of ScbR2 repressor in S. coelicolor is 
discussed in Section 1.5.2). 166 SLIV_06715 repressor in S. lividans TK24, which 
shares 99% identity and 99% similarity with ScbR2 repressor, may regulate 
expression of the predicted azoxy biosynthetic gene cluster; this is supported by 
detection of 1 - 3 in S. coelicolor, but not in S. lividans, when grown on SMMS. Using 
MEME enrichment analysis, only one ScbR binding site 
(GGACGGCTGGCGCTGGCTGTTC) was discovered within sav_2297 (582 bp 
downstream of sav_2297 start codon), which encodes for a major facilitator 
superfamily transporter; the binding of the SLIV_06715 repressor to the specific 
ARE sequence may regulate expression of the operon (Figure 6-1). 
 
Using MEME enrichment analysis, SAV_2268/SAV_2270 repressor binding sites 
were also revealed across the S. lividans TK24 genome. From FIMO analysis, 
14 unique individual hits were discovered and 10 hits were found in the promoters 
of ORFs (within 300 bp of start codon) (Table 6-7 and Electronic Supplementary 
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Material). Surprisingly, some of the SAV_2268/SAV_2270 binding sites were 
discovered in promoters of transcriptional regulators involved in nutrient-
response, such as the PhoU family transcriptional regulator (sliv_rs17285). The 
PhoU family transcriptional regulator is essential in E. coli for the repression of the 
pho regulon in high phosphate concentrations and in S. coelicolor, PhoU regulator 
has been implicated to be involved in regulating the pho regulon. 92,195 MEME 
enrichment analysis was successful at revealing ARE sequences in S. lividans TK24 
hosts and suggests potential cross-activity between the heterologous host and 
predicted azoxy biosynthetic gene cluster. The predicted ARE sites needs to be 
further confirmed to determine cross-talk between pathways of heterologous hosts 
and that contained in the integrated pESAC13A. Introduction of pESAC13A-2H and 
pESAC13A-19K constructs in other heterologous hosts, such as S. albus J1074, which 
does not contain any AHFCA-dependent or GBL-dependent signalling systems, 
might provide a better solution to prevent cross-talk between ArpA-like repressors. 
 
In S. coelicolor heterologous hosts, production of the AHFCA signalling molecules 
(17-1, 17-2, 18-1, 18-2) could not be detected. The AHFCA-dependent signalling 
system in S. coelicolor heterologous host strains could have been rearranged and 
this may explain why the predicted azoxy compounds (1 - 3) were detected in the 
S. coelicolor heterologous host strains when grown on SMMS agar. Although, the 
assembly of AHFCA signalling molecules could still be tightly regulated by 
SAV_2268, the deletion of sav_2268 gene in S. coelicolor heterologous host strains is 
expected to unlock production of AHFCA signalling molecules. Sequencing of 
S. coelicolor and S. lividans heterologous host and mutant strains would confirm if 
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any rearrangements of the azoxy biosynthetic gene cluster have occured and may 
provide insights into the compounds observed by LC-MS.  
 
Table 6-7 – Predicted SAV_2268/SAV_2270 binding sites in S. lividans TK24. 
Matched Sequence 
bp 
upstream 
of gene 
Gene 
downstream 
of sequence 
Proposed 
function of gene 
CGAAGGACTTCATCGAGAAGGACTACTACA -37 SLIV_RS19960 
DnaJ Molecular 
Chaperone 
TGATAGATGACTCTGGAAAGGAATCATTCA 24 SLIV_RS36610 Oxidoreductase 
TGAATGATTCCTTTCCAGAGTCATCTATCA 16 SLIV_RS36605 
TetR family 
transcriptional 
regulator 
CGACGCGTACGTCCGTGACCGTATCCTGCT -95 SLIV_RS20910 
N-acetylglutamate 
synthase 
CGAAACGGACGTACGAGAGGGAATCCTGAT -2 SLIV_RS17285 
PhoU family 
transcriptional  
Regulator 
ATCAGGATTCCCTCTCGTACGTCCGTTTCG 186 SLIV_RS17280 
Two-component 
sensor histidine 
kinase 
TGCAGAAGGGCTTCGAGGAGGTCGACTTCT -70 SLIV_RS21110 Hydrolase 
AGAAGTCGACCTCCTCGAAGCCCTTCTGCA 114 SLIV_RS21115 
AraC family 
transcriptional 
regulator 
TGTACAAGACCTTCTTCAAGCTCGTCTTCT -31 SLIV_RS30350 
Dihydroorotate 
dehydrogenase 
ACTTGAACACCTTCGCGAAGGTGCCGTTGA -73 SLIV_RS19075 
Hypothetical 
protein 
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6.9. Conclusions 
Deletion of the sav_2268 repressor, as well as overexpression of the sav_2301 
activator was expected to unlock the production of predicted azoxy compounds 
(1 - 3) and AHFCA signalling molecules. The sav_2268 repressor was inactivated in 
S. lividans heterologous host strains by double homologous recombination and 
LC-MS analysis of mutant strains grown in VPM revealed the production of azoxy 
compounds (1 - 3) and AHFCA signalling molecules (17-1, 17-2, 18-1 and 18-2); 
identification of these specific compounds were confirmed by UHPLC-ESI-TOF-MS. 
 
In addition to the observed compounds, a series of PUFAA compounds (4 - 16 and 
19 – 45) were also detected in S. lividans heterologous host strains and were 
significantly reduced or abolished in mutant strains. From genome mining analyses, 
the azoxy compounds were proposed to derive from a precursor of polyketide origin 
and the observed PUFAA compounds were speculated to be involved in the 
biosynthesis of the azoxy compounds; however, such compounds could not be 
detected by LC-MS due to possible instability of these specific azoxy compounds and 
their isolation could be further optimised by converting them into stable ammonia 
adduct derivatives. The azoxy biosynthetic gene cluster appears to be regulated 
differently between S. lividans TK24 and S. coelicolor M1152; further investigations 
are required to determine whether there are possible cross-talks between different 
specialised metabolite gene clusters or rearrangements of the azoxy biosynthetic 
gene cluster. 
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7. Conclusions, Summary and Future Work 
7.1. MEME enrichment analysis 
Due to the rise in multi-drug resistance microorganism, there is an urgent need for 
novel antimicrobial agents. Two-thirds of antibiotics approved for use in the clinic 
today originate from the Streptomyces genus of bacteria and each Streptomyces 
bacteria is predicted to contain dozens of gene clusters involved in the direct 
biosynthesis of specialised metabolites. 21 Production of these specific bioactive 
molecules are sometimes not produced or produced in very small quantities in 
laboratory conditions and most often, these cryptic biosynthetic gene clusters are 
tightly regulated at the transcriptional level and are under the control of 
DNA-binding transcription factors. 116 
 
AHFCA-dependent and GBL-dependent signalling systems are widespread in 
Streptomyces bacteria and represent examples of complex regulatory networks 
involved in controlling cryptic biosynthetic gene clusters. Genome mining analysis 
has identified other putative AHFCA-dependent signalling systems and TetR 
repressor binding sites could be predicted using MEME enrichment analysis. This 
information provides unprecedented insights into the complex regulatory networks 
and genetic manipulation targets to unlock the production of novel compounds from 
silent and cryptic biosynthetic gene clusters. To our knowledge, the specific natural 
product assembled by cryptic biosynthetic gene clusters are not known and 
exploitation of these signalling systems, through the deletion of specific 
transcriptional repressors and overexpression of transcriptional activators, are 
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expected to lead to the discovery of novel natural compounds. In our previous 
studies, exploitation of AHFCA-dependent signalling system in S. coelicolor and 
S. venezuelae (published in reference 62) unlocked the production of 
methylenomycins and gaburedins respectively. 57,62 In this project, the exploitation 
of the AHFCA-dependent signalling system in S. avermitilis resulted in the discovery 
of azoxy compounds and AHFCAs.  
 
7.2. Azoxy natural compounds 
The first azoxy compound that was discovered was the antifungal compound, 
macrozamin, from the plant cycad, Macrozamia spiralis (Figure 7-1). 191,196 Since the 
discovery of macrozamin in 1940, which was also the first naturally occurring 
compound isolated to contain an N-N bond, a series of other azoxy compounds have 
been isolated, including cycasin from Cycas revoluta Thunb, azoxybacillins from 
bacillus cereus and more recently, azoxyalkenes from S. rochei 7434AN4 (Figure 
7-1). 189,192,197  
 
 
Figure 7-1 – Azoxy compounds isolated from other organisms. 
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Azoxy compounds exhibit a broad range of biological activities, including 
antimicrobial, antifungal and anticancer properties (Figure 7-1 and Figure 7-2). 
Most interestingly, modifications of the aliphatic chain or seryl residue of elaiomycin 
compounds significantly altered the biological properties; for instance, amidation in 
elaiomycin H displayed activity against Aspergillus (Figure 7-2). 175,193,198  
 
 
Figure 7-2 – Elaiomycin compounds isolated from Streptomyces bacteria. 
 
To date, the only sequenced azoxy biosynthetic gene cluster is the valanimycin gene 
cluster from S. viridifaciens. Sequencing of the gene cluster has proved to be greatly 
beneficial in the investigation of valanimycin biosynthesis, which has led to the 
establishment of the unusual involvement of seryl-tRNA synthetase in valanimycin 
biosynthesis. Despite extensive investigations, formation of the key azoxy moiety 
still remains unclear. 152,162 Biosynthesis of other specialised metabolites that utilise 
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aminoacyl-tRNA synthetase are widespread and have been found to participate in 
the biosynthesis of pacidamycins and cyclodipeptides. 199,200  
 
Most significantly, sequencing of the valanimycin biosynthetic gene cluster has 
assisted with genome mining analysis of the S. avermitilis cryptic biosynthetic gene 
cluster, which is proposed to be under the control of an AHFCA-dependent signalling 
system. Since nearly all of the key valanimycin biosynthetic genes were also 
identified in the S. avermitilis cryptic biosynthetic gene cluster, the cryptic 
biosynthetic gene cluster is predicted to direct biosynthesis of novel azoxy natural 
compounds.  
7.3. Identification of the predicted azoxy compounds 
Due to the relatively poor tractability of S. avermitilis, a heterologous expression/ 
comparative metabolic profiling approach was used to identify the compounds of 
interest. The predicted azoxy biosynthetic gene cluster was captured using 
pESAC13A PAC technologies (pESAC13A-2H and pESAC13A-19K) by Bio S&T. In the 
first instance, pESAC13A-2H and pESAC13A-19K, which contains the predicted 
azoxy biosynthetic gene cluster, were successfully introduced into 
S. coelicolor M1152 and S. lividans TK24 heterologous hosts via tri-parental 
conjugation. Comparative metabolic profiling of S. coelicolor heterologous host 
strains grown on SMMS agar successfully detected the predicted azoxy compounds 
(1 – 3). Identification of the azoxy compounds were further supported by 
UHPLC-ESI-TOF-MS data and incorporation of isotope-labelled L-serine-13C3-15N. 
 
As of May 2014, the products of 16 cryptic biosynthetic gene clusters in S. avermitilis 
are known and the pESAC13A PAC genomic library can be further exploited to 
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screen for the remaining 22 cryptic biosynthetic gene clusters. 35 Similar 
heterologous expression/ comparative metabolic profiling can be applied to identify 
these specific natural compounds. 
7.4. Genetic manipulations of the S. avermitilis AHFCA-dependent signalling 
system 
The predicted azoxy compounds (1 - 3) were not detected in S. lividans heterologous 
host strains by LC-MS, which implies that the biosynthetic gene cluster is still tightly 
regulated. MEME enrichment analysis successfully revealed TetR binding sites in 
the promoter of sav_2301 transcriptional activator. The neighbouring 
AHFCA-dependent signalling system is speculated to tightly regulate expression of 
sav_2301, which is predicted to control expression of the azoxy biosynthetic genes. 
Therefore, deletion of TetR repressor, sav_2268, is expected to unlock the 
production of azoxy compounds (1 - 3) and AHFCAs.  
 
The sav_2268 repressor was successfully deleted in S. lividans heterologous host 
strains by double homologous recombination. Comparative metabolic profiling of 
S. lividans mutant strains by LC-MS revealed the predicted production of azoxy 
compounds (1 - 3) and AHFCA 3, 5, 6 and 7 signalling molecules (17-1, 17-2, 18-1 
and 18-2); identification of AHFCA signalling molecules were established using 
AHFCA synthetic standards and UHPLC-ESI-TOF-MS analysis. 
 
The presence of AHFCA signalling molecules needs to be further confirmed by 
tandem MS and co-injection of S. avermitilis AHFCAs and authentic standards on 
LC-MS. In addition, the activity of these AHFCAs will need to be tested to determine 
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whether the specific signalling molecules can abolish binding of the TetR repressors 
to ARE sequences. 
7.5. Identification of other metabolites 
Detailed analysis of LC-MS results revealed a series of compounds that were, not 
only produced in heterologous host strains containing the pESAC13A constructs, but 
were also significantly reduced or abolished in repressor mutant strains. Molecular 
formulae, generated by UHPLC-ESI-TOF-MS data, implies these compounds are 
aromatic amines (4 - 6) and polyunsaturated fatty acid amines (7 - 16 and 19 - 45). 
The exact biological roles and functions of these compounds remains unclear; 
however, the predicted azoxy compounds are proposed to incorporate a precursor 
of polyketide origin. The S. avermitilis azoxy biosynthetic gene cluster contains a few 
genes that encode for PKS enzymes and the biosynthetic machinaries are speculated 
to be involved in the assembly of PUFAA compounds (7 - 16 and 19 - 45). The 
PUFAA compounds (7 - 16 and 19 - 45) are hypothesised to be incorporated in the 
final azoxy compounds; however, LC-MS was unable to detect these specific azoxy 
compounds, which could be due to possible instability of the azoxy compounds.  
 
Isolation of the predicted azoxy compounds needs to be further optimised to 
produce stable derivatives that could be characterised by MS and NMR spectroscopy 
analyses. Since the azoxy compounds should incorporate L-serine, a genomisotopic 
approach can be used to identify these specific azoxy compounds and also aid in 
isolation for structure determination by NMR spectroscopy. 55 
 
Furthermore, DNA sequencing of heterologous host strains and pESAC13A 
constructs to determine insert ends and possible rearrangements of the azoxy 
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biosynthetic gene cluster would provide insights and explanations to observations 
from comparative metabolic profiling. 
7.6. Structure determination of the predicted azoxy compounds 
To determine the structure of compounds 1 - 3, production of compounds were 
scaled up, purified by semi-preparative HPLC and analysed by a combination of 
1- and 2-D NMR spectroscopy. Analyses of the NMR spectra revealed the main 
compound was the signalling molecule, SCB1, and not the azoxy metabolite. 
Furthermore, detailed analysis of mass spectra data, undoubtedly, showed 
compounds 1 - 3 were co-purified with SCB signalling molecules. 
 
Isolation of 1 - 3 will therefore require further optimisation by determining optimal 
growth conditions for the maximum yield of product and through genetic 
manipulations of the AHFCA-dependent signalling system to overproduce the azoxy 
compounds. The SCB1 signalling molecules, which are overproduced in S. coelicolor 
M1152, needs to be removed for structure determination of compounds 1 - 3 and 
deletion of the scbA gene, which is involved in assembly of SCB signalling molecules, 
would abolish the production of SCB signalling molecules in S. coelicolor M1152. 
Alternatively, introduction of the pESAC13A constructs in other "cleaner" 
heterologous hosts could help with the purification of the specific azoxy compounds. 
An increased availability of purified compound material would facilitate structure 
determination by NMR spectroscopy and permit the use of other analytical 
chemistry techniques, such as IR spectroscopy. 
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7.7. Cross-talks between Streptomyces heterologous host and the predicted 
azoxy biosynthetic gene cluster  
The conditions required to detect the predicted azoxy compounds (1 - 3) implies 
that the predicted azoxy biosynthetic gene cluster is regulated differently between 
S. coelicolor and S. lividans heterologous hosts. MEME enrichment analysis was used 
to determine cross-talk between different specialised metabolite biosynthetic gene 
clusters and revealed one ScbR/ScbR2 repressor binding site located within the 
predicted azoxy biosynthetic gene cluster. The analogous ScbR2 repressor in 
S. lividans may affect expression of the azoxy biosynthetic gene cluster. In addition, 
several SAV_2268/SAV_2270 repressor binding sites were discovered across 
S. lividans TK24 including nutrient-sensing transcription factors, such as the PhoU 
transcriptional regulator. 92,195  
 
Nutrient-sensing transcriptional repressors and analogous ArpA-like repressors are 
speculated to tightly regulate the azoxy biosynthetic gene cluster and possible 
cross-activity needs to be confirmed through binding assays. Alternatively, 
introduction of the pESAC13A constructs into different heterologous hosts, such as 
S. albus, which does not produce GBLs, is expected to abolish cross-activity with 
other ArpA-like transcription factors. 
7.8. Genome mining analysis of other putative azoxy biosynthetic gene 
clusters 
Azoxy compounds are a rare class of N-N bond-containing compounds; in fact, to 
date, there are only 18 compounds, containing the azoxy moiety, within the 
Dictionary of Natural Products. 201 Genome mining analyses have identified putative 
biosynthetic gene clusters that are proposed to direct the biosynthesis of distinct 
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novel azoxy natural compounds, all sharing key valanimycin biosynthetic genes 
(Figure 7-3). Intriguingly, no AHFCA-dependent signalling systems are present in 
these gene clusters and all putative azoxy biosynthetic gene clusters are suggested 
to be unique. Experimental investigations of these systems are expected to result in 
the discovery of further azoxy compounds (Figure 7-3). 
 
 
Figure 7-3 – Other specialised metabolite biosynthetic gene clusters proposed to 
direct the biosynthesis of novel azoxy compounds. Analogous genes are 
colour-coded.
Streptomyces viridifaciens MG456-hF10
Streptomyces collinus Tu 365
Streptomyces hygroscopicus subsp. Jinggangensis 5008
Kitasatospora setae KM-6054
1kb
Streptomyces avermitilis MA-4680
2kb
Frankia sp. EAN1pec
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9. Appendices 
9.1. Appendix A – Initial consensus ARE motif for S. coelicolor, S. venezuelae, 
S. avermitilis and S. hygroscopicus AHFCA-dependent signalling systems 
Streptomyces coelicolor A3(2)  
 
E-value: 5.9e-005 
Name 
Bp 
Upstream 
of start 
codon 
p-value Sites 
SCP1.243 94 2.10e-14 AACCCATTGC ATAATACCTTCCCGCAGGTATATT  TCTCTCGGTC 
SCP1.242c 76 2.44e-14 GACCGAGAGA AATATACCTGCGGGAAGGTATTAT  GCAATGGGTT 
SCP1.246 44 1.27e-13 CGCCCCCACT AACATACCTTCCCGAGGGTATGTT  TTCCGGGCCC 
 
Streptomyces venezuelae ATCC 10712 
 
E- value: 3.2e-010 
Name 
Bp 
Upstream 
of start 
codon 
p-value Sites 
SVEN_4183 65 2.15e-15 TATGCCTTGC AATATACATTCTCGAAGGTATATT  TCTTGCTGCC 
SVEN_4182 32 2.15e-15 GGCAGCAAGA AATATACCTTCGAGAATGTATATT  GCAAGGCATA 
SVEN_4188 41 8.82e-13 GGCCCCACAG AAAATACCTTCCAGACCGAATCTT  TTTCTACTCG 
SVEN_4187 69 1.25e-12 CGAGTAGAAA AAGATTCGGTCTGGAAGGTATTTT  CTGTGGGGCC 
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Streptomyces avermitilis MA-4680 
 
E-value: 5.7e-008 
Name 
Bp 
Upstream 
of start 
codon 
p-value Sites 
SAV_2270 95 1.41e-14 AGGCATCATT AATATACCTGCGCGAAGGTATATT  GCAAGGCTCG 
SAV_2269 72 1.41e-14 CGAGCCTTGC AATATACCTTCGCGCAGGTATATT  AATGATGCCT 
SAV_2268 19 8.44e-13 CTCGATGATT AGAATTCGTTCACGAACGTATCTT  TTATGCTTCG 
SAV_2267 25 8.44e-13 CGAAGCATAA AAGATACGTTCGTGAACGAATTCT  AATCATCGAG 
 
Streptomyces hygroscopicus subsp. Jinggangensis 5008 
 
E-value: 1.2e-008 
Name 
Bp 
Upstream of 
start codon 
p-value Sites 
SHJG_7319 163 1.28e-12 GCCAGGGAAT AAACCTTCCCAAAGGTAGGTTT  GACGTGGGGG 
SHJG_7322 30 1.45e-12 TCCGCTGATA AAAAATTCCGTAATGATGGTTT  GCTCTTCGTT 
SHJG_7318 68 1.45e-12 CCCCCACGTC AAACCTACCTTTGGGAAGGTTT  ATTCCCTGGC 
SHJG_7323 214 1.62e-12 AACGAAGAGC AAACCATCATTACGGAATTTTT  TATCAGCGGA 
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9.2. Appendix B – Refined consensus ARE motif for S. coelicolor, 
S. venezuelae, S. avermitilis and S. hygroscopicus AHFCA-dependent signalling 
systems 
Streptomyces coelicolor A3(2)  
 
E-value: 2.0e-013 
Name 
Bp 
Upstream 
of start 
codon 
p-value Sites 
SCP1.243 94 2.40e-13 AACCCATTGC ATAATACCTTCCCGCAGGTATATT  TCTCTCGGTC 
SCP1.242c 76 2.66e-13 GACCGAGAGA AATATACCTGCGGGAAGGTATTAT  GCAATGGGTT 
SCP1.230 13 5.55e-13 TACGAGTCAT AAAAAACCTTCGGGAAGGTTTGAC  ACTGTGAGGC 
SCP1.229c 193 6.62e-13 GCCTCACAGT GTCAAACCTTCCCGAAGGTTTTTT  ATGACTCGTA 
SCP1.246 44 7.82e-13 CGCCCCCACT AACATACCTTCCCGAGGGTATGTT  TTCCGGGCCC 
 
 
Streptomyces venezuelae ATCC 10712 
 
E-value: 5.3e-018 
Name 
Bp 
Upstream 
of start 
codon 
p-value Sites 
SVEN_4182 30 3.31e-16 CGGCAGCAA GAAATATACCTTCGAGAATGTATATTGC  AAGGCATAC 
SVEN_4183 63 4.67e-16 GTATGCCTT GCAATATACATTCTCGAAGGTATATTTC  TTGCTGCCG 
SVEN_4188 39 1.88e-14 CGGCCCCAC AGAAAATACCTTCCAGACCGAATCTTTT  TCTACTCGC 
SVEN_4187 67 2.21e-14 GCGAGTAGA AAAAGATTCGGTCTGGAAGGTATTTTCT  GTGGGGCCG 
SVEN_4179 10 5.01e-13 CCTGATTAC AGTTGATACCTTCGTGAAGGTTTTTATT  TCATGGGTC 
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Streptomyces avermitilis MA-4680 
 
E-value: 1.3e-011 
Name 
Bp 
Upstream 
of start 
codon 
p-value Sites 
SAV_2270 92 1.55e-15 TAGGCATC ATTAATATACCTGCGCGAAGGTATATTGCA  AGGCTCGAC 
SAV_2269 69 1.72e-15 TCGAGCCT TGCAATATACCTTCGCGCAGGTATATTAAT  GATGCCTAG 
SAV_2267 22 1.98e-14 CCGAAGCA TAAAAGATACGTTCGTGAACGAATTCTAAT  CATCGAGTG 
SAV_2268 14 2.90e-14 ACTCGATG ATTAGAATTCGTTCACGAACGTATCTTTTA  TGCTTCGGT 
SAV_2301 175 3.36e-14 GATTCAAC AGAAAAATACCTTCTCAAAGGAATTATTCT  GTGCGAGGA 
 
Streptomyces hygroscopicus subsp. Jinggangensis 5008 
 
E-value: 4.9e-012 
Name 
Bp 
Upstream 
of start 
codon 
p-value Sites 
SHJG_7318 65 2.20e-13 ACCCCCCAC GTCAAACCTACCTTTGGGAAGGTTTATT  CCCTGGCAA 
SHJG_7319 159 3.04e-13 TTGCCAGGG AATAAACCTTCCCAAAGGTAGGTTTGAC  GTGGGGGGT 
SHJG_7323 211 3.38e-13 GAAACGAAG AGCAAACCATCATTACGGAATTTTTTAT  CAGCGGAGC 
SHJG_7322 27 5.12e-13 GCTCCGCTG ATAAAAAATTCCGTAATGATGGTTTGCT  CTTCGTTTC 
SHJG_7504 3 3.39e-11 CACCCGGTA AGGAAACTTTCCTAACAGAAGGGTCCCC  CA 
SHJG_7505 176 3.63e-11 ACGCATGTG GGGGACCCTTCTGTTAGGAAAGTTTCCT  TACCGGGTG 
SHJG_7324 76 5.70e-11 CCTACATCC GGGAAAACTACCTGTGGGAAGGTATTTT  TGGCTGCGG 
 
 
 
 
 
  
  Chapter 9: Appendices 
  
209 
 
9.3. Appendix C – Refined consensus ARE motifs for S. scerotialus, S. sp. 
HGB0020, S. roseochromogenes and K. cheerisanensis AHFCA-dependent 
signalling systems 
Streptomyces sclerotialus NRRL ISP-5269 
 
E-value: 9.0e-004 
Name 
Bp 
Upstream 
of start 
codon 
p-value  Sites 
 
IG96_ 
RS0135495 
171 5.43e-10 GCGAAAAAAT ATACCTATGGGAAGGTAT ATTGCATGGG 
IG96_ 
RS0135500 
162 6.96e-10 CCCATGCAAT ATACCTTCCCATAGGTAT ATTTTTTCGC 
IG96_ 
RS0135490 
114 3.19e-9 ATCTCAATTG AAACCTTCGCGAAGGTTT GATTCTGTGG 
ORF1 43 1.25e-8 TGACATTTGA ATACCTCCGCGAAGGAAT GATTTCGTGA 
IG96_ 
RS0135515 
52 1.59e-7 TGTGTTGGGC ATCCCAATGAGAAAAGAT CCGCCTTGGA 
IG96_ 
RS0135520 
104 1.75e-7 TCCAAGGCGG ATCTTTTCTCATTGGGAT GCCCAACACA 
 
Kitasatospora cheerisanensis KCTC 2395
 
E-value: 8.4-007 
Name 
Bp 
Upstream 
of start 
codon 
p-value  Sites  
KCH_ 
13210 
117 1.47e-15 GGCTCCGAAG AAAATACCTTCCCAAAGGTATGTT  GCCTGTGGCA 
KCH_ 
13290 
78 3.51e-15 TTGCGCCAAT AACATACCTATTGGAAGGTATGTT  ATCTGTCACC 
KCH_ 
13230 
104 3.83e-15 ACGATGAGAA AATATACCTCTGGGAAGGTATATT  GCTAGGGGGA 
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Streptomyces sp. HGB0020 
 
E-value: 8.5e-022 
Name 
Bp 
Upstream 
of start 
codon 
p-value 
 
 Sites  
HMPREF 
1211_0
6616 
29 1.18e-14 GGATCTCC AAATAATACCTTCTTGAACGCACTTTTT TGCTACC 
HMPREF 
1211_0
6615 
48 1.56e-14 GGGTAGCA AAAAAGTGCGTTCAAGAAGGTATTATTT GGAGATC 
HMPREF 
1211_0
6619 
6 2.03e-14 AAGCCCGG TTAAAAAACCTTCACGAAGGAATTTAAA TGC 
HMPREF 
1211_0
6613 
12 3.42e-14 GCCGCAAC TTACAATACATTCCCGAAGGTATATTTC AAGGAAC 
HMPREF 
1211_0
6614 
70 5.62e-14 TGTTCCTT GAAATATACCTTCGGGAATGTATTGTAA GTTGCGG 
HMPREF 
1211_0
6629 
45 1.32e-13 CCTCCTCA TAGTGATACCTTCTCGAAGGAATTTTTT CGTGAGC 
 
Streptomyces roseochromogenes subsp Oscitans DC 12.976 
  
E-value: 9.4-e025 
Name 
Bp 
Upstream 
of start 
codon 
p-value Sites 
M878_26350 85 1.12e-14 ACCACTTTT AATATACCTTCCTGTAGGTATATT  TGCCACGGGC 
M878_26345 65 1.50e-14 CCCGTGGCA AATATACCTACAGGAAGGTATATT  AAAAGTGGTA 
M878_26320 22 1.44e-12 TGAGCAGTT ATAAAACCTTCTCGAAGGTATCTT  ACGGAGACTG 
M878_26325 183 1.91e-12 AGTCTCCGT AAGATACCTTCGAGAAGGTTTTAT  AACTGCTCAC 
M878_26325 156 1.53e-11 TGAACGGTG AATATTCTGTCCCGTAGGTTTTTT  TCGCGAGCCA 
M878_26365 46 1.62e-11 TCCGCAAAT AACATACCGTTGAGAAGGTATGTT  GTTCCTGCCG 
M878_26320 156 1.84e-11 GGCTCGCGA AAAAAACCTACGGGACAGAATATT  CACCGTTCAA 
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9.4. Appendix D – S. coelicolor A3(2) methylenomycin gene cluster 
 
*Asterisks indicate presence of TTA codon 
 
Protein Homologue (% identity / % similarity) Proposed function 
MmyF 
(SCP1.228c) 
Monooxygenase 
S. mirabilis (62 / 75) 
Oxidoreductase 
MmyY 
(SCP1.229c) 
Hypothetical protein 
S. natalensis (58 / 67) 
Hypothetical protein 
MmyB 
(SCP1.230) 
DNA-binding protein 
S. sclerotialus (46 / 62) 
DNA-binding protein 
MmyQ 
(SCP1.231) 
Monoxygenase 
S. mirabilis (76 / 87) 
Oxidoreductase 
MmyE 
(SCP1.232) 
12-oxophytodienoate reductase 
Paenibacillus alvei (58 / 70) 
Enoyl reductase 
MmyD 
(SCP1.233) 
Hypothetical protein 
S. rochei (48 / 60) 
Hypothetical protein 
MmyX 
(SCP1.233A) 
ATP/GTP-binding protein 
S. mirabilis (79 / 89) 
ATP/GTP-binding protein 
MmyC 
(SCP1.233B) 
3-oxoacyl-ACP synthase 
S. roseus (74 / 84) 
ACP synthase 
MmyA 
(SCP1.234) 
Acyl carrier protein 
S. albus (37 / 60) 
ACP 
MmyP 
(SCP1.235) 
Haloacid dehalogenase family hydrolase 
S. regensis (46 / 58) 
Phosphatase 
MmyK 
(SCP1.236) 
ATP/GTP-binding protein 
S. hygroscopicus (60 / 76) 
ATP/GTP-binding protein 
MmR 
(SCP1.237c) 
MFS transporter 
S. mirabilis (75 / 84) 
Efflux membrane protein 
MmyJ 
(SCP1.238) 
ArsR family transcriptional regulator 
S. bingchenggensis (63 / 82) 
ArsR family transcriptional 
regulator 
MmyG 
(SCP1.239c) 
Oxidoreductase 
S. acidscabies (54 / 64) 
Oxidoreductase 
MmyO 
(SCP1.240c) 
Monoxygenase 
S. albus (55 / 68) 
Monooxygenase 
MmyT 
(SCP1.241c) 
Thioesterase 
S. roseus (38 / 49) 
Thioesterase 
MmfR 
(SCP1.242c) 
TetR family transcriptional regulator 
S. olindensis (66 / 77) 
TetR family transcriptional 
regulator 
MmfL 
(SCP1.243) 
A-factor biosynthesis protein 
Rhodococcus imtechensis (34 / 48) 
AfsA homologue 
MARE MARE MARE
S. coelicolor A3(2)
(19,341 bp)
1 kb
* *
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MmfH 
(SCP1.244) 
Oxidoreductase 
S. aureofaciens (58 / 68) 
Oxidoreductase 
MmfP 
(SCP1.245) 
Haloacid dehalogenase family hydrolase 
Streptomyces himastatinicus (42 / 51) 
Phosphatase 
MmyR 
(SCP1.246) 
TetR family transcriptional regulator 
Streptomyces lavenduligriseus (36/ 50) 
TetR family transcriptional 
regulator 
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9.5. Appendix E – S. venezuelae ATCC 10712 gaburedin gene cluster 
 
*Asterisks indicate presence of TTA codon 
 
Protein Homologue (% identity / % similarity) Proposed function 
SVEN_4178 
Acetyltransferase 
Nocardio gilva (42 / 64) 
Acyltransferase 
GbnA 
(SVEN_4179) 
CadA 
E. coli (25 / 41) 
Glutamate decarboxylase 
GbnB 
(SVEN_4180) 
EntE 
E. coli (25 / 40) 
Urea synthase 
GbnC 
(SVEN_4181) 
EamA family transporter 
Salmonella enterica (55 /71) 
Transmembrane efflux 
SgnR 
(SVEN_4182) 
MmfR 
S. coelicolor (54 / 71) 
MmfR homologue 
SgnL 
(SVEN_4183) 
MmfL 
S. coelicolor (33 / 44) 
MmfL homologue 
SVEN_4184 
LysR family transcriptional regulator 
S. vietnamensis (98 / 100) 
LysR family transcriptional regulator 
SgnP 
(SVEN_4185) 
MmfP 
S. coelicolor (42 / 56) 
MmfP homologue 
SVEN_4186 Hypothetical protein Hypothetical protein 
GbnR 
(SVEN_4187) 
MmyR 
S. coelicolor (47 / 54) 
MmyR homologue 
SgnH 
(SVEN_4188) 
MmfH 
S. coelicolor (45 / 57 
MmfH homologue 
 
  
S. venezuelae ATCC 10712
(11,669 bp)
AREAREARE * *
1 kb
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9.6. Appendix F – S. avermitilis MA-4680 azoxy biosynthetic gene cluster  
 
*Asterisks indicate presence of TTA codon 
 
Protein Homologue (% identity / % similarity) ProposedFunction 
SAV_2263 
TetR family transcriptional regulator 
S. rimosus (66 / 77) 
TetR family transcriptional regulator 
SAV_2264 
Transporter 
S. mirabilis (67 / 77) 
Transmembrane efflux protein 
SAV_2265 Hypothetical protein Hypothetical protein 
SAV_2266 
MmfP 
S. coelicolor (37 / 51) 
MmfP homologue 
SAV_2267 
MmfH 
S. coelicolor (45 / 58) 
MmfH homologue 
SAV_2268 
MmyR 
S. coelicolor (39 / 54) 
MmyR homologue 
SAV_2269 
MmfL 
S. coelicolor (34 / 48) 
MmfL homologue 
SAV_2270 
MmfR 
S. coelicolor (47 / 64) 
MmfR homologue 
SAV_2272 
VlmK 
S. viridifaciens (55 / 70) 
MmgE/PrpD family protein 
SAV_2273 
Isomerase 
S. collius (80 / 89) 
Isomerase 
SAV_2274 
VlmJ 
S. viridifaciens (44 / 59) 
Diacylglycerol kinase 
SAV_2275 
Major facilitator superamily transporter 
S. collinus (51 / 65) 
Transmembrane efflux protein 
SAV_2276 
3-oxoacyl-ACP synthase 
S. griseofuscus (73 / 84) 
3-oxoacyl-ACP synthase 
SAV_2277 
Thioesterase 
S. mutabilis (86 / 93) 
Thioesterase 
SAV_2278 
F420-dependent dehydrogenase 
S. mutabilis (87 / 90) 
F420-dependent dehydrogenase 
SAV_2279 
Long-chain-fatty-acid-CoA ligase 
S. mutabilis (84 / 90) 
Long-chain-fatty-acid-CoA ligase 
SAV_2280 
Modular polyketide synthase 
S. niger (53 / 62) 
Modular polyketide synthase 
SAV_2281 
Modular polyketide synthase 
Longispora albida (48 / 61) 
Modular polyketide synthase 
SAV_2282 
Acyl carrier protein 
S. mutabilis (77 / 90) 
ACP 
SAV_2283 
Aldehyde dehydrogenase 
S. collinus (95 / 97) 
Aldehyde dehydrogenase 
S. avermitilis MA-4680
(50,462 bp)
1kb
ARE ARE ARE
*
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SAV_2284 
VlmH 
S. viridifaciens (56 / 74) 
Isobutylamine N-hydroxylase 
SAV_2285 
Ornithine aminotransferase 
S. collinus (93 / 96) 
Ornithine aminotransferase 
SAV_2286 
Cyclase 
S. mutabilis (86 / 91) 
Cyclase 
SAV_2287 
VlmO 
S. viridifaciens (63 / 71) 
Integral membrane protein 
SAV_2288 
VlmR 
S. viridifaciens (38 / 54) 
NADPH-flavin oxidoreductase 
SAV_2289 
VlmB 
S. viridifaciens (61 / 77) 
Hypothetical protein 
SAV_2290 
3-oxoacyl-ACP synthase 
S. collinus (85 / 92) 
3-oxoacyl-ACP synthase 
SAV_2291 
Acyl carrier protein 
S. bingchenggensis (70 / 81) 
ACP 
SAV_2292 
3-oxoacyl-ACP synthase 
S. mutabilis (93 / 96) 
3-oxoacyl-ACP synthase 
SAV_2293 
VlmC 
S. viridifaciens (54 / 71) 
Amino acid permease 
SAV_2294 
VlmL 
S. viridifaciens (59 / 70) 
Seryl-tRNA synthetase 
SAV_2295 
Enoyl-ACP reductase 
S. collinus (87 / 91) 
Enoyl-ACP reductase 
SAV_2296 
Ferredoxin 
S. mutabilis (81 / 87) 
Ferredoxin 
SAV_2297 
Major facilitator superfamily transporter 
S. collinus (83 / 89) 
MFS transporter 
SAV_2298 
Fatty acid desaturase 
S. collinus (91 / 95) 
Fatty acid desaturase 
SAV_2299 
Hypothetical protein 
S. aureocirculatus (52 / 65) 
Hypothetical protein 
SAV_2300 
VlmA 
S. viridifaciens (57 / 68) 
Integral membrane lysyl-tRNA 
synthetase 
SAV_2301 
VlmI 
S. viridifaciens (47 / 61) 
SARP family transcriptional regulator 
SAV_2302 
Membrane protein 
S. mutabilis (81 / 82) 
Membrane protein 
SAV_2303 
Methylmalonyl-CoA carboxyltransferase 
S. griseofuscus (89 / 93) 
Methylmalonyl-CoA carboxyltransferase 
SAV_2304 
Hypothetical protein 
S. griseofuscus (68 / 77) 
Hypothetical protein 
SAV_2305 
Enamine deaminase 
S. sviceus (84 /91) 
Enamine deaminase 
SAV_2306 
Acyl-CoA dehydrogenase 
S. fulvoviolaceus (89 / 92) 
Acyl-CoA dehydrogenase 
SAV_2307 
Fatty acid-CoA synthetase 
S. collinus (89 / 91) 
Acyl-CoA synthetase 
SAV_2308 
PaaX family transcriptional regulator 
S. fulvoviolaceus (91 / 92) 
PaaX family transcriptional regulator 
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9.7. Appendix G – S. hygroscopicus subsp. Jinggangensis 5008 gene cluster 
 
*Asterisks indicate presence of TTA codon 
 
Protein Homologue (% identity / % similarity) Proposed function 
SHJG_7318 
(ShbR1) 
MmfR 
S. coelicolor (51 / 67) 
MmfR homologue 
SHJG_7319 
(ShbA1) 
MmfL 
S. coelicolor (36 / 46) 
MmfL homologue 
SHJG_7320 
MmfH 
S. coelicolor (48 / 57) 
MmfH homologue 
SHJG_7321 
MmfP 
S. coelicolor (42 / 53) 
MmfP homologue 
SHJG_7322 
MmyR 
S. coelicolor (37 / 53) 
MmyR homologue 
SHJG_7323 
5,10-methylene tetrahydromethanopterin reductase 
S. scabiei (46 / 61) 
Monooxygenase 
SHJG_7324 
TylR 
S. fradiae (32 / 45) 
TylR-like regulatory protein 
SHJG_7325 
StrR 
S. griseus (48 / 63) 
Streptomycin biosynthesis 
operon regulator 
SHJG_7326 Hypothetical protein Hypothetical protein 
SHJG_7327 
Hypothetical protein 
S. pluripotens (46 / 56) 
Hypothetical protein 
SHJG_7328 
Hypothetical protein 
S. lavendulae (42 / 51) 
Hypothetical protein 
SHJG_7329 
Hypothetical protein 
S. rapamycinicus (44 / 57) 
Hypothetical protein 
SHJG_7330 
Acyl-CoA dehydrogenase 
S. achromogenes (75 / 85) 
Acyl-CoA dehydrogenase 
SHJG_7331 
Alcohol dehydrogenase 
S. achromogenes (86 / 93) 
Alcohol dehydrogenase 
SHJG_7332 
Trehalose-phosphate synthase 
S. achromogenes (71 / 78) 
Trehalose-phosphate 
synthase 
SHJG_7333 
UTP-glucose-1-phosphate uridylyltransferase 
S. vietnamensis (80 / 87) 
UTP-glucose-1-phosphate 
uridylyltransferase 
SHJG_7334 
Flavin reductase 
S. achromogenes (77 / 82) 
Flavin reductase 
SHJG_7335 
Oxidoreductase 
S. achromogenes (48 / 54) 
Oxidoreductase 
 
S. hygroscopicus subsp. Jinggangensis 5008
(17,307 bp)
1kb
ARE ARE ARE* *
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9.8. Appendix H – S. sclerotialus NRRL ISP-5269 gene cluster 
 
Protein Homologue (% identity / % similarity) Proposed function 
IG96_RS0135470 
4-phosphopantetheinyl transferase 
S. pristinaespiralis (99 / 54) 
4-phosphopantetheinyl 
transferase 
IG96_RS0135475 
QncL 
S. melanovinaceus (37 / 49) 
QncL-like acyltransferase 
IG96_RS0135480 
QncL 
S. melanovinaceus (97 / 51) 
QncL-like dehydrogenase 
IG96_RS0135485 
QncN 
S. melanovinaceus (96 / 61) 
QncN-like dehydrogenase 
IG96_RS0135490 
QncM 
S. melanovinaceus (97 / 32) 
QncM-like ACP 
IG96_RS0135495 
MmfR 
S. coelicolor (56 / 73) 
MmfR-like transcriptional 
regulator 
IG96_RS0135500 
MmfL 
S. coelicolor (35 / 47) 
MmfL homologue 
IG96_RS0135505 
LysR family transcriptional regulator 
S. venezuelae (92 / 61) 
LysR family transcriptional 
regulator 
IG96_RS0135510 
MmfP 
S. coelicolor (46/ 56) 
MmfP homologue 
IG96_RS0135515 
MmyR 
S. coelicolor (43 / 61) 
MmyR homologue 
IG96_RS0135520 
MmfH 
S. coelicolor (49 / 59) 
MmfH homologue 
ORF-1 
Non-ribosomal peptide synthetase 
S. sp. DSM 40835 (96 / 34) 
Non-ribosomal peptide 
synthetase 
IG96_RS0135530 
Thioesterase 
S. sviceus (45 / 56) 
Thioesterase 
IG96_RS0135535 
Anthranilate synthase 
S. griseus (57 / 70) 
Anthranilate syntase 
IG96_RS0135540 
Phospho-2-dehydro-3-deoxyheptonate aldolase 
S. scabiei (60 / 71) 
Phospho-2-dehydro-3-
deoxyheptonate aldolase 
IG96_RS0135545 
Isochorismatase 
S. scabiei ( 59 / 70) 
Isochorismatase 
IG96_RS0135550 
Hypothetical protein 
S. yeochonensis (50 / 65) 
Hypothetical protein 
IG96_RS0135555 
Major Facilitator Superfamily Permease 
S. tsukubaensis (30 / 49) 
MFS transporter 
IG96_RS0135560 
Chorismate synthase 
S. ochraceiscleroticus (62 / 63) 
Chorismate synthase 
1 kb
ARE ARE ARE ARE
S. sclerotialus NRRL ISP-5269
(19,981 bp)
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9.9. Appendix I – S. sp. HGB0020 gene cluster 
 
 
*Asterisks indicate presence of TTA codon 
Protein 
Homologue (% identity / % 
similarity) 
Proposed function 
HMPREF1211 
_06613 
MmfR 
S. coelicolor (52 / 70) 
MmfR homologue 
HMPREF1211 
_06614 
BarX 
S. virginiae (36 / 48) 
AfsA homologue 
HMPREF1211 
_06615 
MmyR 
S. coelicolor (48 / 58) 
MmyR homologue 
HMPREF1211 
_06616 
MmfH 
Streptomyces coelicolor (45 / 56) 
MmfH homologue 
HMPREF1211 
_06617 
MerR family transcriptional regulator 
S. griseus (42 / 51) 
MerR Family transcriptional 
regulator 
HMPREF1211 
_06618 
Hypothetical protein 
S. pristinaespiralis (45 / 53) 
Hypothetical protein 
HMPREF1211 
_06619 
Methylmalonyl-CoA carboxyltransferase 
S. vinaceus (82 / 90) 
Methylmalonyl-CoA 
carboxyltransferase 
HMPREF1211 
_06620 
Major Facilitator Superfamily Protein 
S. natalensis (77 / 86) 
MFS transporter 
HMPREF1211 
_06621 
Tautomerase 
S. xiamenensis (86 /76) 
Tautomerase 
HMPREF1211 
_06622 
3- oxoacyl-ACP reductase 
S. avermitilis (39 / 50) 
3-oxoacyl-ACP reductase 
HMPREF1211 
_06623 
TetR family transcriptional regulator 
S. incarnatus (52 / 68) 
TetR family transcriptional 
regulator 
HMPREF1211 
_06624 
A-factor biosynthesis protein 
S. clavuligerus (35 / 48) 
AfsA homologue 
HMPREF1211 
_06625 
Hypothetical protein 
S. roseus (57 / 72) 
Hypothetical protein 
HMPREF1211 
_06626 
Hypothetical protein 
S. roseus (94 / 66) 
Hypothetical protein 
HMPREF1211 
_06627 
3-oxoacyl-ACP synthase 
S. virginiae (69 / 77) 
3-oxoacyl-[acyl-carrier-
protein] synthase III 
HMPREF1211 
_06628 
Hypothetical protein 
S. griseorubens (67 / 66) 
Hypothetical protein 
HMPREF1211 
_06629 
MmfP 
S. coelicolor (40 / 53) 
Phosphatase 
HMPREF1211 
_06631 
Hypothetical protein 
S. cyaneogriseus (72 / 33) 
Hypothetical protein 
1 kb
AREAREAREARE
*
Streptomyces sp. HGB0020
(16,378 bp) 
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9.10. Appendix J – S. roseochromogenes subsp. Oscitans DC 12.976 cluster 
 
Protein Homologue (% identity / % similarity) Proposed function 
M878_26380 
Hypothetical protein 
S. avermitilis (64 / 70) 
Hypothetical protein 
M878_26375 
Methylglyoxal synthase 
Leptospira santarosai (59 / 76) 
Methylglyoxal synthae 
M878_26365 
MmyR 
S. coelicolor (45 / 65) 
MmyR homologue 
M878_26360 
MmfP 
S. coelicolor (47 / 56) 
MmfP homologue 
M878_26350 
MmfH 
S. coelicolor (74 /59) 
MmfH homologue 
M878_26345 
MmfR 
S. coelicolor (61 / 78) 
MmfR homologue 
M878_26340 
Hypothetical protein 
S. lydicus (79 / 86) 
Hypothetical protein 
M878_26335 
MarR family transcriptional regulator 
S. rimosus (85 / 89) 
MarR family transcriptional 
regulator 
M878_26330 
Hypothetical protein 
Streptacidiphilus rugosus (51 / 55) 
Hypothetical protein 
M878_26325 
BarX 
S. virginiae (43 / 54) 
AfsA homologue 
M878_26320 
SARP family transcriptional regulator 
S. albus (45 / 59) 
SARP family transcriptional 
regulator 
M878_26310 
Carboxylate-amine ligase 
S. roseus (48 / 55) 
Carboxylate-amine ligase 
 
 
  
1 kb
ARE ARE ARE ARE
S. roseochromogenes subsp. 
Oscitans DC 12.976
(13,607 bp)
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9.11. Appendix K – K. cheerisanensis KCTC 2395 gene cluster 
 
Protein 
 
Homologue (% identity / % similarity) Proposed Function 
KCH_13040 
Polyketide cyclase 
S. aureofaciens (46 / 59) 
Polyketide cyclase 
KCH_13050 
4'-phosphopantetheinyl transferase 
S. actuosus (62 / 68) 
4'-phosphopantetheinyl transferase 
KCH_13060 
Hypothetical protein 
S. nodosus (50 / 61) 
Hypothetical protein 
KCH_13070 
Methylmalonyl-CoA carboxyltransferase 
S. iranensis (88 / 93) 
Methylmalonyl-CoA 
carboxyltransferase 
KCH_13080 
Malonyl CoA-ACP transacylase 
Nocardia vinacea (63 / 74) 
Malonyl CoA-ACP transacylase 
KCH_13090 
3-hydroxyacyl-ACP dehydratase 
S. lavendulae (37 / 53) 
3-hydroxyacyl-ACP dehydratase 
KCH_13100 
3-hydroxyacyl-ACP dehydratase 
Stappia stellulata (42 / 55) 
3-hydroxyacyl-ACP dehydratase 
KCH_13110 
3-oxoacyl-ACP reductase 
Streptacidiphilus melanogenes (91/ 95) 
3-oxoacyl-ACP reductase 
KCH_13120 
Haloacid dehalogenase 
Rothia dentocariosa (33 / 53) 
Haloacid dehalogenase 
KCH_13130 
A-factor biosynthesis protein 
S. himastatinicus (37 / 48) 
AfsA homologue 
KCH_13140 
3-oxoacyl-ACP synthase 
S. katrae (41 / 49) 
3-oxoacyl-ACP synthase 
KCH_13150 
3-oxoacyl-ACP synthase 
S. lavenduligriseus (57 / 76) 
3-oxoacyl-ACP synthase 
KCH_13160 
Polyketide-8 synthase ACP 
Catelliglobosispora koreensis (34 / 60) 
Polyketide-8 synthase ACP 
KCH_13170 
Monoxygenase 
S. scabiei (38 / 47) 
Monooxygenase 
KCH_13180 
3-oxoacyl-ACP synthase 
S. toyocaensis (36 / 53) 
3-oxoacyl-ACP synthase 
KCH_13190 
MFS transporter 
S. virginiae (46 / 61) 
MFS transporter 
KCH_13200 
Serine hydrolase 
Nocardia aobensis (49 / 61) 
Serine hydrolase 
KCH_13210 
Thioesterase 
S. avermitilis (44 / 60) 
Thioesterase 
KCH_13220 
SgnP 
S. venezuelae (47/ 58) 
MmfP homologue 
KCH_13230 
MmfR 
S. coelicolor (59 / 76) 
MmfR homologue 
1 kb
ARE ARE ARE
K. cheerisanensis KCTC 2395
(23,758 bp)
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KCH_13240 
MmfL 
S. coelicolor (44 / 57) 
MmfL homologue 
KCH_13250 
MmfH  
S. coelicolor (53 / 61) 
MmfH homologue 
KCH_13260 
Oxidoreductase 
S. aureofaciens (54 / 63) 
Oxidoreductase 
KCH_13270 
AraC family transcriptional regulator 
S. azureus (78 / 85) 
AraC family transcriptional regulator 
KCH_13280 
Sacchraopine dehydrogenase 
S. venezuelae (73 / 82) 
Sacchraopine dehydrogenase 
KCH_13290 
MmyR 
S. coelicolor (39 / 47) 
MmyR homologue 
KCH_13300 
Patatin 
S. vietnamensis (44 / 53) 
Patatin 
 
   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
